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ABSTRACT 
Corneal disease is the second most common cause of blindness in the word. It is 
estimated that 45 million people worldwide are bilaterally blind and 10 million are affected 
by corneal blindness. Corneal blindness mostly affects the population in the equatorial 
zone, due to the high exposure to UV light. Corneal grafting presents complications such 
as rejections and the lack of donor material and resources. Conventional cornea grafting 
(keratoplasty) is not advised for patients with bilateral corneal blindness or for those who 
suffer from a range of clinical problems including tear deficiency, chemical burns and 
uncontrollable intraocular pressure. At present, an artificial cornea, i.e. a keratoprosthesis 
(KRPO), is the only alternative to keratoplasty (corneal donor transplantation). 
Cornea implants consist of a clear optic part and a surrounding ring known as the 
skirt, which needs to integrate with the sclera of the eye. Currently used skirt materials lead 
to poor tissue integration, a major failure of cornea implants. Better integration may be 
achieved when using a bioactive skirt material, which adapts to the metabolic activity of 
the cornea. For this purpose, high density polyethylene (HDPE), polyether ether ketone 
(PEEK)  and  ultra-high  molecular  weight  polyethylene  (UHMWPE)  films  provide 
interesting possible alternatives, if they can be rendered bioactive. This study investigated 
the potential of using surface modified polymer films to fabricate the skirt. To improve 
bioactivity  of  the  materials  a  two-step  treatment  using  chemical  surface  modification 
(immersion in NaOH) and formation of apatite layers from Simulated Body Fluid (SBF) 
was applied. The effectiveness of the different molarity of the NaOH on the formation of 
the  bioactive  layer  was  investigated.  Results  showed  that  with  an  increase  in  NaOH 
concentration  the  wettability  improved  but  also  some  changes  to  the  topography 
(increase/decrease of roughness) of the polymers were observed. Moreover, 10M NaOH 
treatments resulted in more rapid formation of the apatite layer when compared with a non-
treated  and  lower  molarity  solution.  As  immersion  time  in  SBF  increased,  further 
nucleation and growth produced a thicker apatite layer which can be expected to be highly 
bioactive. Interestingly, the apatite growth is dependent on both the concentration of NaOH 
solution and the structure of the polymer surface. It was concluded that hydroxyapatite 
layers were formed on HDPE, PEEK and UHMWPE films after they were incubated in 1.5 
SBF, which promises to render such thin-film structures bioactive – a necessity if they are 
to be integrated into artificial cornea. The Ca/P molar ratio of the apatite deposited on the Monica Pino 
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polymers increases with NaOH strength and SBF incubation time. The favourable effect of 
NaOH on apatite formation may at least partly be attributed to an increased wettability of 
the polymer films after such treatment, as well as to the modified topography. The apatite 
layer  contained  phosphate  and  carbonates  ions,  providing  potentially  good  in  vitro 
bioactivity on polymeric films. The inorganic layers are chemically stable as the calcium 
deposited on the films did not dissolve fully when immersed in water for one week. This 
demonstrates that polymer films can be rendered bioactive, using the described approach, 
hence providing potential materials suitable for artificial cornea implants. Monica Pino 
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ABBREVIATIONS 
AAS  Atomic Absorption Spectroscopy 
AFM  Atomic Force Microscopy 
B  Bright side of PEEK film 
CA  Contact angle 
Ca/P  Calcium/phosphorus molar ratio 
CaHA  Calcium hydroxyapatite 
CDHA  Calcium-deficient hydroxyapatite 
CHA  Carbonate hydroxyapatite  
DCPD  Di-calcium phosphate dihydrate 
EDX  Energy dispersive X-ray spectroscopy 
ePTFE  expanded Polytetrafluoroethylene  
FACIT  Fibril Associated Collagens with Interrupted Triple Helices 
FCI  France Chirurgerie Industries  
FTIR  Fourier transform infrared spectroscopy 
HA  Hydroxyapatite 
HDPE  High density polyethylene 
KP  Penetrating keratoplasty 
KPRO  Keratoprosthesis 
LK  Lamellar keratoplasty 
M  Matt side of PEEK film 
MCPM  Mono-calcium phosphate monohydrate 
NaOH  Sodium hydroxyl Monica Pino 
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OCP  Octa-calcium phosphate 
OOKP  Osteo-odonto-keratoprosthesis 
PDMS  Polydimethylsiloxane 
PEEK  Polyether ether ketone  
PET  Polyethylene terephthalate 
PHEMA  Poly(2-hydroxyethyl methacrylate)  
PMMA  Poly(methyl methacrylate)  
PTFE  Polytetrafluoroethylene  
PVP  Polyvinylpyrrolidone 
Ra  Roughness (a) value 
SAMs  self-assembled monolayers  
SBF  Simulated Body Fluid 
SD  Standard Deviation 
SEM  Scanning electron microscopy 
TCP  Tricalcium phosphate  
UHMWPE  Ultra-high molecular weight polyethylene 
WAXD  Wide-angle X-ray diffraction 
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CHAPTER 1 
INTRODUCTION 
Corneal blindness is the second most common cause of blindness in the world. It is 
estimated that 45 million people worldwide are bilaterally blind and 10 million are affected 
by  corneal  blindness  (WHO,  2001).  Corneal  blindness  affects  children  and  those  of  a 
younger  age  than  those  who  suffer  from  cataracts  (Sinha  et  al.,  2005).  From  this 
perspective, corneal blindness presents a greater impact in total blindness in number of 
years. In addition, corneal blindness mostly affects the population in the equatorial zone, 
due to the high exposure to UV light (Biswell, 1995; WHO, 1998). 
A simple option to address corneal blindness is keratoplasty, a surgical intervention 
in which the damaged cornea is replaced by corneal tissue from a human donor, frequently 
donated by an eye bank. However, this corneal grafting presents complications such as 
rejection and post-astigmatism and there is also a lack of donor materials and resources 
(Biswell, 1995). The rejection rate has been lowered to 20% in the last decade by ensuring 
that the blood type between the donor and the recipient patient corresponds. Besides this 
improvement, allografts (collagen-base implants) still exhibit problems with the supply of 
corneas  and  disease  transmissions.  Approximately  20,000  corneas  (eyes)  are  available 
annually, but about 40,000 new patients a year are added to the waiting list. It is clear that 
corneal blindness is not fully solved by this  approach. Moreover, conventional corneal 
grafting is not advised for patients with bilateral corneal blindness who suffer from tear 
deficiency, chemical burns, trachoma, vascularization, Stevens-Johnson syndrome, ocular 
cicatricial pemphigoid, or uncontrollable intraocular pressure (Hicks et al., 1997; Legeais 
and Renard, 1998; Kim et al., 2002; Falcinelli et al., 2005). 
At present, an artificial cornea, i.e. a keratoprosthesis (KPRO) possibly provides an 
alternative to keratoplasty, and there is an urgent necessity to meet the demand.  Monica Pino                                                                                                         Introduction 
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KPROs consist of a clear optic portion and a surrounding ring known as the skirt, 
which needs to integrate with the sclera of the eye to anchor the implant. However, the 
current failure rate of the commercially-available artificial corneas is unacceptably high 
(40% at one year) due to the non-integration of the “skirt” used to hold the implant in situ. 
The  skirt  is  implanted  between  the  sclera  and  the  ocular  conjunctive,  and  it  must  be 
bioactive to encourage the metabolic nourishment of the cornea and to be firmly integrated 
(Legeais et al., 1992; Chirila et al., 1993; Legeais and Renard, 1998; Kim et al., 2002; 
Albon, 2003; Hicks et al., 2003; Hollick et al., 2006; Meek, 2008). Integration may be 
improved by using a bioactive skirt material, which adapts to the metabolic activity of the 
cornea. 
A few promising routes for the fabrication of keratoprostheses have been proposed. 
The Osteo-Odonto-KPro (OOKP) uses tooth enamel for the production of the skirt, that is 
an hydroxyapatite of biological origin. A central polymethyl methacrylate (PMMA) optic 
is glued into the enamel tooth. OOKP has been implanted since the 1960s. Falcinelli et al. 
(Facinelli et al., 2005) found excellent long term retention results (85% survival in 18 
years)  with  75%  of  patients  seeing  6/12  or  better.  Liu  et  al.  (2007)  reported  an  80% 
improvement of vision. However, poor tissue integration results in failure of the devices. 
Furthermore, it should be noted that, it would be desirable to restore the metabolic activity 
of the cornea by use of a more bioactive material. 
Besides  keratoprostheses  based  on  biological  hydroxyapatite,  which  need  to  be 
obtained from tooth enamel – a procedure that requires the donation of one of the patient‟s 
teeth  –  synthetic devices  have been investigated as  they promise easier fabrication.  In 
addition, clinically, it is easier to implant a polymeric skirt than rigid skirts, such as OOKP. 
Furthermore, one can expect the mechanical compatibility to be improved between the 
sclera and polymers compared to the sclera and tooth enamel. 
Thus, it is clear that there is a strong desire to develop an artificial skirt material that 
can adapt to the sclera of the eye, but  which is also bioactive. Polymer films such as 
HDPE, PEEK and UHMWPE could provide the basis for ophthalmic biomaterials related 
to KPROs, primarily because clinically, it is easier to implant a polymeric skirt than rigid 
skirts,  such  as  OOKP  and  secondly  because  the  mechanical  compatibility  could  be Monica Pino                                                                                                         Introduction 
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improved between the sclera and polymers compared to the sclera and osteo-odonto lamina 
(dental lamina). 
These polymers, UHMWPE, PEEK and HDPE, have a clinical history as successful 
biomaterials for other medical implants (Kurtz, 2004; Roeder et al., 2009) and, in a few 
cases,  for  ophthalmological  implants  (Allan,  1999)  but  none  for  the  sclera  implants. 
Therefore, from this perspective, these polymers are promising candidates to tackle at least 
some of the problems with current KPRO technologies. In addition, these materials can be 
engineered with a wide range of physical, mechanical and surface properties. However, the 
bioactivity of these polymers has to be significantly improved for them to be used as skirt 
materials for artificial cornea implants.  
The skirt materials for the corneal implants should also be porous, which is required 
for good fixation in vivo, to allow fibroblast in-growth and collagen deposition to provide 
adequate anchorage of the skirt into the sclera. The porosity of polymer films therefore 
may need to be enhanced, e.g. by expanding the films biaxially during the production, or 
by perforating the films after production. 
1.1  IDEAL ARTIFICIAL CORNEA 
A KPRO must perform the functions of the cornea that is: be transparent, have a 
refractive surface to transmit and refract light, produce protection to give globe integrity, 
be non-immunogenic (Albon, 2003), and to allow the nourishment mechanism to carry out 
the normal metabolic process of the cornea. Also, a KPRO must secure long term fixation 
that is be able to withstand trauma, and for a wet eye requires an epithelialized surface 
(Hicks et al., 1997). Therefore, the ideal KPRO should be coated with an epithelial layer, 
flexible, clear, and most important to be jointed permanently to the surrounding tissues, 
especially to the sclera (Li et al., 2008; Meek, 2008; Deng et al., 2010). The most feasible 
solution for the artificial cornea implant would be the development of a material that would 
accept growth and attachment of transparent epithelium on its surface (Refojo, 2005), in 
other words, a bioactive material. Also, a biomaterial that would heal into the recipient‟s 
corneal tissue would be desirable.  Monica Pino                                                                                                         Introduction 
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The  successful  integration  of  the  KPRO  with  the  cornea  depends  in  part  on 
peripheral host keratocyte adhesion to anchor the implant in place and prevent epithelial 
downgrowth  (Sandeman  at  al.,  2000).  Therefore,  the  skirt  must  be  porous,  to  allow 
fibroblast ingrowth, and collagen deposition to provide good anchorage. Also, the anterior 
surface should allow epithelialization, be free from inflammation or mutagenesis, and be 
implantable  without  extensive  surgery.  The  posterior  surface  should  inhibit  cellular 
attachment  and  proliferation  to  prevent  the  formation  of  opaque  retro-prosthesis 
membranes. The optic must act as an UV filter (Hicks et al., 1997). 
The fundamental key for an ideal artificial cornea is to construct a one-piece device 
with  similar  layers  of  the  normal  cornea,  which  interact  with  each  other  to  fulfill  the 
functions of the cornea.  
Consequently, the corneal material should allow the keratocytes to adapt and grow, 
and the cells should be re-shape the material into a cornea equivalent stroma, which is 
allowed  to  be  colonized  with  layers  of  endothelial  and  epithelial  cells  on  it  surface. 
Therefore, the corneal materials must accept growth and bond of clear and transparent 
layers of epithelium on its outer surface. The ideal artificial cornea must allow examination 
of the retina and checking the ocular pressure. Lastly and less important, the ideal artificial 
cornea should be aesthetically acceptable and have a reasonable cost. 
1.2  BIOCOMPATIBILITY AND BIOACTIVITY  
Biocompatibility was recently defined by Ratner (Ratner and Bryant, 2004) as: „the 
ability of materials to locally trigger and guide normal wound healing, reconstruction and 
tissue regeneration‟. The earlier definition of biocompatibility was as: „A biocompatible 
material  is  one  that  has  the  ability  to  perform  with  an  appropriate  host  response  in  a 
specific  application‟  (Williams,  1999).  Amongst  various  materials  used  to  produce 
implants,  which  are  supposed  to  satisfy  these  definitions,  are  polymers.  Thus,  HDPE, 
PEEK and UHMWPE polymer films have been used in the biomedical field for many 
years and have proved that they are biocompatible (Bonfield et al., 1984; Allan, 1999; 
Kurtz, 2004; Kurtz and Devine, 2007; Roeder et al., 2009). They might therefore provide Monica Pino                                                                                                         Introduction 
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interesting alternatives, specifically in an ophthalmological implant if they can be made 
bioactive and fulfil the mechanical compatibility of the skirt of the artificial cornea. 
The term bioactivity was defined in the early 70s as: „A bioactive materials is one 
that elicits a specific biological response at the interface of the materials which results in 
the formation of a bond between the tissue and the material‟ (Hench et al., 1972). This 
term  was  also  defined  by  Williams  as:  „A  bioactive  material  is  one  which  has  been 
designed to induce specific biological activity‟ (Williams, 1987).  
Accordingly, the concept of bioactivity relates strictly to the biological interactions 
of materials with the surrounding environment in a body or a simulated body environment. 
Bioactivity can be defined as generation of positive response of the tissue in contact with 
another material which is not biological in origin. On the other hand, more commonly, 
bioactivity is understood as inducing biologically associated reactions on the surface of the 
materials;  for  instance,  formation  of  apatite  layers  from  body  fluids  (Kokubo,  1998; 
Ryhänen, 2000; Abou-Neel et al., 2007; Yousefpour, 2007; Chrzanowski et al., 2008), 
which enable the prediction of bone bonding ability of the materials. Thus, Kokubo and 
Takadama  (2006)  consider  bioactive  materials  as  bone  bonding  materials  (Bohner  and 
Lemaitre, 2009). In other biomaterial applications different definitions of bioactivity will 
apply. 
This  study has  not  intended to  develop  a material  which triggers bone bonding 
ability. The main purpose of this study is to find a material which will produce a similar 
response as tooth dentine, which is the bioactive material, known as the dentil lamina used 
successfully  as  skirt  in  the  osteo-odonto-keratoprothesis  (OOKP),  the  KRPO  that 
demonstrated good retention of the implant due to its non-rejection issue from the host eye 
because the patient‟s own tooth is used to make the skirt  of the semi-artificial cornea 
implant. Interestingly, the Ca/P molar ratio of dentine is 1.61 and the Ca/P molar ratio of 
dental  enamel  is  1.63  (Legeros,  1991;  Daculsi  et  al.,  1997).  The  apatite  contained  in 
dentine,  enamel  and  bone  mineral  is  calcium  deficient  biological  apatite  related  to 
hydroxyapatite (Legeros at al., 2003). The tooth enamel is the most highly mineralized 
tissue of human body (Tadic et al., 2001; Gutierrez-Salazar and Reyes-Gasga, 2003). Monica Pino                                                                                                         Introduction 
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Finally, in vitro and in vivo testing has shown that the common characteristic of 
bioactive implant materials is that a layer of biologically active carbonate hydroxyapatite 
(CHA) forms on the implant surface after soaking in physiological fluids (Cao and Hench, 
1996). Additionally, the mineral phase of calcified tissue (enamel, dentine and bone) is 
biological apatite, which is carbonate hydroxyapatite (CHA) (Cao and Hench, 1996). 
To produce a CHA on the surface of polymers, 1.5 SBF can be used as a treatment 
to make them bioactive, before implantation; rather than to evaluate bioactivity (Tiffany et 
al., 1989; Renke-Gluszko and Fray, 2004). Thus, 1.5 SBF solution is part of the process to 
form  a  HA layer, and such supersaturated  concentration  can be  used to accelerate the 
precipitation of HA.  
1.3  AIMS AND OBJECTIVES 
The main aim of this research was to increase the bioactivity of polymer materials 
which  may  be  suitable  for  the  design  of  skirt  implants  in  artificial  corneas.  For  this 
purpose, polyether ether ketone (PEEK), high-density polyethylene (HDPE) and ultra-high 
molecular  weight  polyethylene  (UHMWPE)  films  have  been  investigated.  In  order  to 
improve the bioactivity of the polymer films a two-step treatment using chemical surface 
modification (immersion in NaOH) and the formation of apatite layers from supersaturated 
Simulated Body Fluid (1.5 SBF) was applied.  
The  objectives  of  the  present  study  were  therefore  to  investigate  the  effect  of 
different  molarities of the NaOH pre-treatments on the polymer film  structures  and to 
determine the optimum NaOH concentration for stimulating apatite deposition from SBF, 
to get better understanding of the apatite nucleation and growth on polymer surfaces and to 
identify the apatite deposited (composition and crystalline phase) over the immersion time 
in  SBF,  as  well  as  the  morphology  and  dispersion  of  apatite  on  the  films.  Finally,  to 
examine the stability of the apatite in a common medium such water, the release of calcium 
from the specimens was evaluated. Monica Pino                                                                                                         Introduction 
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1.4  OVERVIEW AND STRUCUTURE OF THIS THESIS 
This thesis is divided into six chapters as follows: 
Chapter one is the introduction, which explains the motivations of this work, and 
considerations for an ideal artificial cornea. Also, the concept of Biomaterial is explained 
in  detail.  Finally  the  aims  and  objectives  of  this  research  is  given  together  with  the 
structure of this thesis.  
Chapter two is a literature survey, covering the physiology and pathology of the 
cornea and its surrounding structures such as conjunctive, tears and aqueous humor fluids, 
treatments of corneal damage, materials used in artificial cornea implants and the current 
complications of the artificial cornea devices.  
Chapter three describes the materials and methods, the properties of the materials 
used to produce the polymer films, the preparation of the NaOH and SBF solutions and 
finally  the  characterisation  techniques  employed  to  study  the  morphology  and  the 
composition of the layers deposited on the films. 
Chapter four describes the results, showing the outcomes of the assessment of the 
skirt  materials  with  a  view  to  evaluating  the  bioactivity  on  the  layers  formed  on  the 
polymers. 
Chapter five is the discussion, which examines the implications of bioactivity in an 
implant,  the  effectiveness  of  NaOH  and  the  influence  of  immersion  time  in  SBF,  the 
apatite phase formed on our polymers and lastly the applications for skirt materials in 
cornea implants. 
Chapter six contains the conclusions drawn from this work and a summary of future 
work. 
The peer-reviewed publications which have resulted from this research are listed 
prior chapter one. Monica Pino                                                                                                 Literature Survey 
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CHAPTER 2 
LITERATURE SURVEY 
2.1  INTRODUCTION 
The cornea is the transparent portion of the eye; it covers the iris and the pupil and it 
is continuous with the sclera. The cornea is a highly specialized avascular (without blood 
vessels)  tissue  that  is  nourished  by  the  tears.  For  vision,  the  cornea  must  remain 
transparent. Thus, all layers of the cornea must be free of any cloudy or opaque areas and 
refract light correctly. The cornea can become opaque due to corneal diseases and trauma 
to the extent of causing corneal blindness, one major type of which mostly affects the 
population of the equatorial zone, due to their high exposure to UV light. To restore vision, 
the cornea can be replaced either by a donor corneal graft (keratoplasty) or by an artificial 
cornea.  At  the  present  time,  an  artificial  cornea  implant  (keratoprosthesis)  is  the  only 
alternative to cornea transplantation (keratoplasty) for patients with corneal blindness that 
can not under go keratoplasty due to other eye disorders such as dry eye (Hicks et al., 
1997; Falcinelli et al., 2005). On the other hand, the current failure rate of the available 
artificial cornea is unacceptably high due to non-integration of the “skirt” used to hold the 
implant in situ (Legeais and Renard, 1998; Kim et al., 2002; Albon, 2003; Meek, 2008). 
The skirt is placed between the sclera and the ocular conjunctive, and in addition to being 
biocompatible must be bioactive to maintain the metabolic activity of the cornea and to be 
firmly integrated. A biocompatible material by definition has “the ability to perform with 
an  appropriate  host  response  in  a  specific  application”  (Williams,  1999).  A  bioactive 
material is defined as “a material that elicits a specific biological response at the interface 
of  the  material,  which  results  in  the  formation  of  a  bond  between  the  tissue  and  the 
materials” (Hench, 1998). The use of bioactive materials that allow colonization of the 
optic by host keratocytes and epithelial cells has shown that it is possible to integrate Monica Pino                                                                                                 Literature Survey 
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alloplastic materials into the recipient cornea (Legeais et al., 1992; Legeais and Renard, 
1998; Chirila et al., 1993; Hicks et al., 2003). Thus, an understanding of the structure, 
functions  and  properties  of  the  cornea  and  its  surrounding  tissues  (the  sclera  and  the 
conjunctiva)  and  also  reasons  for  the  failure  of  the  artificial  cornea  helps  in  the 
development of the skirt materials.  
In this chapter, the cornea physiology, together with its associated structures, such as 
the sclera, the conjunctiva, and the tears and aqueous humour fluids are described. The 
cornea pathology is outlined as well as the different treatments for the corneal damage. The 
materials used in the corneal implants are also detailed together with the materials used in 
this  research  for  the  skirts  of  the  artificial  cornea  devices,  high  density  polyethylene 
(HDPE),  ultra  high  molecular  weight  polyethylene  (UHMPE),  polyether  ether  ketone 
(PEEK), apatites and Simulated Body Fluid (SBF). Then, the artificial cornea implants are 
reviewed, including the results from the artificial cornea in human clinical trials since the 
1960s. Finally, the current complications of the artificial cornea devices are recounted. Monica Pino                                                                                                 Literature Survey 
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2.2  THE CORNEA 
The cornea is the transparent circular tissue of the external part of the eyeball (NHS, 
2006) that covers the iris and the pupil, and admits light to the interior of the eye (IPAC, 
2004) (Figure 2.2.1). Therefore, the main functions of the cornea are: 1) Globe integrity 
and protection, 2) transmission and refraction of the light, and 3) UV screening (Hicks et 
al., 1997). The cornea is avascular (Refojo, 2005), that is there are no blood vessels to 
nourish or protect it against infection; instead, the cornea receives its nourishment from the 
tears and aqueous humour (NEI, 2006). The average adult cornea is 0.54 mm thick at the 
centre, gradually increasing to 0.65 mm thick at the periphery and 11.5 mm in diameter 
(Hodge, 1995). 
 
 
 
Figure 2.2.1 Structure of the eye (from Martini, 1995) 
Figure 2.2.1 has been removed due to the Copyright restrictions Monica Pino                                                                                                 Literature Survey 
 
 
  30 
The transparency of the cornea is due to its uniform and avascular structure and 
relatively dehydrated state of the corneal tissue (Hodge, 1995). The collagen contained in 
some layers of the cornea gives the cornea its strength, elasticity and form. Collagen's 
unique  shape,  arrangement  and  spacing  are  essential  in  producing  the  cornea's  light-
conducting transparency. The structure of the cornea consists of five layers (Figure 2.2.2): 
the epithelium, Bowman‟s layer, the stroma, Descemet‟s membrane, and the endothelium 
(NMP, 2003; Hodge, 1995). The description and functions of the cornea layers are detailed 
in the following paragraphs, and the main characteristics and composition are summarised 
in Table 2.2.1.  
 
 
 
 
Figure 2.2.2 Structure of the cornea (from James et al., 2003) 
 
 
Figure 2.2.2 has been removed due to the Copyright restrictions Monica Pino                                                                                                                                                                                                     Literature Survey 
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Table 2.2.1 Cornea layers functions (data from Hodge, 1995; Hicks et al., 1997; IPAC, 2004; Refojo, 2005; NEI 2006; NHS, 2006) 
 
 
Layer name 
 
Characteristics 
 
Composition 
 
Functions 
Epithelium  5 or 6 layers of cells, filled with thousands of tiny 
nerve endings that make the cornea extremely 
sensitive to pain when rubbed or scratched. 
Keratinocytes 
(Epithelial cells) 
Block the passage of foreign material (dust, water, 
bacteria) into the eye. 
Provide a smooth surface that absorbs oxygen and cell 
nutrients from tears. 
Bowman’s 
membrane 
A clear acellular layer, a modified portion of the 
stroma. 
Collagen type I 
(Protein fibres) 
Protects the stroma. Once injured, this membrane can 
form a scar if it heals. 
Stroma  A thick, transparent middle layer, approximate 
200 layers of type I collagen fibrils. This layer is 
responsible for most of the focusing that occurs in 
the cornea. 
3-5% Keratocytes, 
16% type I collagen, 
78% water, and 
1%proteoglycans 
Collagen gives the cornea its strength, elasticity, and 
form. The collagen‟s unique shape, arrangement and 
spacing are essential in producing the cornea‟s light-
conducting transparency. 
Descemet’s 
membrane 
A clear elastic membrane, which regenerates 
readily after injury. 
Collagen   Serves as a protective barrier against infection and 
injuries. 
Endothelium  Only one thin layer of cells. Once the endothelial 
cells are destroyed by diseases or trauma, they are 
lost for ever; if too many are destroyed, corneal 
oedema and blindness ensue. 
Endothelial cells  The stroma tends to absorb water; the endothelium‟s 
primary task is to pump this excess fluid out of the 
stroma. Without this pumping action, the stroma would 
swell with water, become hazy and opaque. Monica Pino                                                                                                 Literature Survey 
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The epithelium occupies about 10% of the overall thickness of the cornea, and is a 
thin multicellular tissue layer. The epithelial cells have the ability to regenerate when the 
cornea suffers from minor injuries. The functions of the corneal epithelium include: 1) 
blocking of the passage of foreign materials (dust, water or bacteria) inside the eye; 2) 
absorbing oxygen and nourishing from the tears and distributing these nutrients to the rest 
of  the  cornea.  From  a  mechanical  point  of  view,  the  most  important  function  of  the 
epithelium is for the cells to anchor and organize themselves in a manner that creates the 
basement membrane, which covers the surface of the cornea (Sanhermelando et al., 2002). 
Bowman‟s layer is composed of fine collagen type I layers in a random orientation, 
but very compact form which makes it a tough layer providing good protection for the 
stroma (Fratzl and Daxer, 1993). There is also a transition zone between the Bowman‟s 
layer and the stroma, where these two layers are joined, which is part of the Bowman‟s 
layer.  It  is  composed  of  collagen  fibrils  arranged  obliquely  to  be  attached  to  the 
collagenous  lamellae  of  the  superficial  stroma  (James  et  al.,  2003).  The  acellular 
Bowman‟s layer is about 10 µm thick. 
The stroma is the middle and major layer of the cornea, about 90% of the thickness 
of the cornea (Sanhermelando et al., 2002). The stroma is composed of collagen fibres 
arranged regularly along with sparsely distributed keratocytes. Indeed, the collagen fibrils 
are obliquely  oriented and bounded tightly  forming a lamellae  embedded in  a cellular 
matrix mostly composed by sulphate glycosaminoglycans, and between the lamellae are 
the  sparse  keratocytes  (fibrocytes).  This  structure  makes  the  stroma  a  thick  layer  of 
approximately 200 layers of collagen type I fibrils, and the direction of the collagen fibrils 
differs in each layer providing high mechanical strength (Sanchis-Gimeno at al., 2006). 
Descemet‟s membrane is a thin acellular layer, very similar to the endothelium, since 
it  is  a  sort  of  modified  epithelial  membrane.  Descement‟s membrane  is  composed  of 
collagen fibres (different from those in the stroma) and is generated by the endothelial cells 
that lie below it, explaining why Descemet's membrane can be regenerated readily after a 
minor  injury.  Apart  from  this  regenerating  function,  one  of  the  main  functions  of 
Descemet‟s membrane is to serve as a protective barrier against infection and injuries. Monica Pino                                                                                                 Literature Survey 
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Descemet‟s membrane is thin in infancy, increases in thickness to approximately 5 μm in 
childhood, and then to 8 to 10 μm in adulthood (Merindano-Encima et al., 2002). 
The endothelium is a single layer of mitochondrial cells, 5 to 6 μm thick arranged 
hexagonally in a very flattened manner. These cells are responsible for regulating fluid 
between the aqueous humour and the stroma; these endothelial cells do not regenerate, on 
the contrary they tend to stretch in order to compensate for dead cells reducing the overall 
cell density of the endothelium, which ultimately will have an impact on fluid regulation. 
When the endothelium can no longer maintain a proper fluid balance, the stroma starts to 
swell due to excess fluids and subsequent loss of transparency will occur (Sanchis-Gimeno 
et al., 2006). Thus, the main function of the endothelium is to pump this excess fluid out of 
the stroma. If too many endothelial cells die, corneal edema and blindness will occur, and 
the only available procedure is corneal transplantation (Sanhermelando et al., 2002). 
2.3  THE SCLERA  
The sclera is the opaque outer layer of the eye. It is a continuation of the cornea to 
the optic nerve at the back of the eye, and it is covered by the conjunctiva (Fig. 2.2.1). The 
sclera is a tough tissue that contains collagen and elastic fibres. The connective tissue 
present in the sclera as well as in the cornea contains the collagen fibrils embedded in a 
proteoglycan fibrillar matrix. This tissue therefore requires strength to maintain the internal 
pressure in the eye and to resist external knocks or any rubbing or other forces applied 
when the eyes are moved by the extraocular muscles. The mechanical strength is given by 
the deposition of collagen in a lamellar structure, where the lamellae lie parallel to the 
surface of the tissue rather than through its thickness (Meek, 2008). The fibrous connective 
tissue in the sclera give the eye its unique shape, and also serves as an attachment for the 
extraocular muscles (intrinsic muscles), which move the eye. Thus, providing attachment 
for the extraocular muscles of the eye is one of the most important function of the sclera 
(McBrien et al, 2009). The sclera provides support for the retina on the posterior part of the 
eye and has essential physiological functions such as containing fluid outflow channels to 
prevent excessive pressure in the eye; and provided for the mechanical functions including 
maintaining eye shape during any movement of the eye (Meek, 2008). Monica Pino                                                                                                 Literature Survey 
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The  sclera  starts  at  the  limbus  (Fig.2.2.1)  as  a  contiguous  tissue  of  the  cornea, 
constituting  the  major  part  of  the  eye  globe.  It  is  connected  to  the  conjunctiva  and 
continues until it attaches to Tenon‟s capsule (McBrien and Gentle, 2003). The sclera is 
about 0.1-1.0 mm thick (Edwards and Prausnitz, 1998), with an average diameter of 24 
mm; however, its thickness varies from 0.53 mm at the limbus, 0.39 mm at the equator, to 
0.9 mm near to the optic nerve (Olsen et al., 1998).  
The constituents of the sclera are shown in Table 2.3.1 as wet weight percentages. 
The sclera is composed mainly of collagen, interfibrillar proteoglycans, glycoproteins, and 
the  tissue  is  populated  by  fibroblasts  (Meek,  2008).  It  also  contains  about  2%  elastin 
(Watson and Young, 2004). The collagen is mostly type I (75% of the dry weight), plus 
10% non-collagen protein, and 1% glycosaminoglycans (Montgomery, 2008). The sclera 
also contains a small number of isolated fibroblast cells (Montgomery, 2008). 
 
Table 2.3.1 Composition of the sclera in percentage of wet weight (from Meek, 2008) 
 
Constituent  Wet weight (%) 
Collagen  30 
Elastin  0.7 
Other proteins  < 3 
Proteoglycans  <1 
Water  68 
 
The hydration of the sclera is as important as that of the cornea; however, in the case 
of the sclera, this activity is governed by the hydrophilic proteoglycans only, since there 
are no epithelial or endothelial barriers as in the cornea (Meek, 2008). On the contrary, the 
cornea is dehydrated, so the corneal endothelium acts as a pump to keep the fluid out of the 
tissue, retaining the clarity of the cornea. The sclera tissue, on the other hand, is opaque 
because it is hydrated (Nemeth and Shea, 2007). 
Both  cornea  and  sclera  have  similar  collagen  content,  however  differences  in Monica Pino                                                                                                 Literature Survey 
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collagen types and their distribution between the two tissues results in radically different 
optical  properties  (Meek  and  Fullwood,  2001).  There  are  around  20  different  collagen 
types currently known and these can be classified into three super families: 
1) Class 1 or banded fibrillar collagens have the classic D-period fibril appearance 
and include Types I, III and V (Meek and Fullwood, 2001). In both corneal and scleral 
collagen, Type  I is  the  major component,  comprising some 68% of the dry weight  in 
cornea (Maurice, 1984) and 50–70% in sclera (Keely et al., 1984). 
2) Class 2 or FACIT (Fibril Associated Collagens with Interrupted Triple Helices) do 
not form fibrils by themselves, but do interact with fibrillar collagens and include Types 
XII and XIV (Meek and Fullwood, 2001).  
3) Class 3 collagens have fibrous structures which are different from the structure of 
Class I collagens and include Type VI (Meek and Fullwood, 2001).  
In addition, collagen Types III, V, VI, XII and XIV have all been detected in the 
corneal stroma and Types III, V and VI in the scleral stroma (Panjwani, 1997).  
The collagen fibrils are surrounded by a matrix containing proteoglycans (sulphated 
glycosaminoglycans  attached  to  a  protein  core)  and  various  other  proteins  (Meek  and 
Fullwood, 2001). The collagen fibrils are arranged in lamellae that lie roughly parallel to 
the surface of the eye (Meek and Fullwood, 2001). 
2.4  THE CONJUNCTIVA 
The conjunctiva is the vascular mucous membrane (transparent layer of cells) that 
covers the inner surface of the eye lids and the anterior part of the sclera to the cornea (Fig. 
2.2.1). Over the lids it is thick and highly vascular and called the palpebral conjunctiva. 
Over the sclera it is known as the ocular or bulbar conjunctiva and is much thinner while 
over the cornea it is reduced to a single layer of epithelium (Ellis, 1977). At the junction 
between the posterior eyelid and the eyeball, there is a transition portion, which links the 
palpebral conjunctiva and the ocular (bulbar) conjunctiva, known as the fornix (Fig. 2.2.1) Monica Pino                                                                                                 Literature Survey 
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which is considered part of the overall conjunctiva.  
Basically, the conjunctiva is nourished by small blood vessels, and it also secrets oils 
and mucous, which add moisture to and lubricate the eye; this process is part of the corneal 
metabolic activity. Moreover, the sclera also contributes to immune surveillance and helps 
to prevent the entrance of microbes into the eye. 
The palpebral conjunctiva is firmly attached to the eyelids (Nemeth and Shea, 2007), 
and forms the lines of the eyelid. The palpebral conjunctiva is thick and opaque. It is red, 
especially at the lower eye lid in its normal stage. 
The bulbar (ocular) conjunctiva is loosely attached and is composed of a modified 
non-keratinized, staggered scaly epithelium. The bulbar conjunctiva has certain levels of 
mobility, for instance sliding back and forth over the front of the eyeball that it covers. 
Within the bulbar, conjunctivae are composed by the so-called goblet cells that secrete an 
important  component  of  the  pre-corneal  tear  layer,  which  protects  and  nourishes  the 
cornea.  The  superficial  bulbar  conjunctival  epithelium  is  continuous  with  the  corneal 
epithelium.  When  the  corneal  epithelium  is  debrided,  it  may  be  resurfacing  by  limbal 
conjunctival epithelial cells „sliding‟ over it (Nemeth and Shea, 2007). 
The fornix is a loose pocket of conjunctiva that permits the eyeball to rotate freely. 
The fornix conjunctiva is coated by a staggered cubical to columnar epithelium of different 
thickness. This particular epithelium has a very uneven surface since it retains some scale-
like features and many adhering spots, and has a hairy structure. 
All three parts of conjunctiva (palpebral, bulbar and fornix) produce a viscous fluid 
(mucous), which lubricates the ocular surface, and they also produce some tears, which 
help to keep the eye clean. However, most of the tears are produced by the lacrimal glands, 
which are located at  the upper outer corners of each orbit, and spread a thin layer of 
mucous and tears over the eye every time blinking occurs. After blinking, the fluid spreads 
over the eye and then flows into narrow canals in the lids that lead to the lacrimal sac, a 
pouch at the lower corner of each orbit. The mucous and tears from the lacrimal glands and 
the conjunctiva eventually drain through a passage into the nose.  Monica Pino                                                                                                 Literature Survey 
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Mucus is an excellent lubricant and it is believed to contain infection-fighting cells 
(Nemeth  and  Shea,  2007).  Thus,  the  conjunctiva  plays  an  important  role  in  the 
immunological defense system of the eye and produces mucus that is critically needed for 
tear film stability. In tear film without this mucin layer, the tear layers destabilize, and then 
the cornea metabolic system is severely affected (Nemeth and Shea, 2007). 
2.5  TEARS AND AQUEOUS HUMOUR FLUIDS 
Tears are composed of lacrimal fluid produced in the lacrimal glands normally at 1 
ml day
-1. Tears reduce friction on eyelids over the eye, remove debris from the cornea, 
prevent infection entering the eye, and provide nutrients and oxygen to the cornea. Tears 
are composed of a lipid layer and an aqueous/mucin gel layer that contains a complex mix 
of  electrolytes,  proteins  and  mucins.  The  lipid  layer  protects  the  tear  film  against 
evaporation while the mucins allow the wetting of the epithelial surface of the cornea, 
despite  its  natural  hydrophobic  state.  The  electrolytes  (Na
+,  Cl
-,  Ca
2+  and  K
+)  help  to 
increase the solubility of all the proteins and mucins found in the aqueous phase of the tear 
film, and also to maintain a constant osmolarity (295-300 mOsm L
-1) and pH (7.4). The 
proteins resist invasion by infectious agents, promote growth and healing of the epithelium 
(Tiffany et al., 1989). 
The aqueous humour is the liquid that occupies the anterior and posterior chambers 
of  the  eye  (Fig.  2.2.1),  i.e.  it  fills  the  space  between  the  cornea  and  the  iris  (anterior 
chamber) and the part of the eye that lies just behind the iris (posterior chamber) since the 
aqueous humour fluid flows from the ciliary body. The aqueous humour fluid resembles 
blood plasma in composition, but contains less protein and glucose and more lactic acid 
and ascorbic acid because the aqueous humour is formed from blood by filtration, secretion 
and diffusion through the ciliary body. Thus, the aqueous humour is a filtrate of plasma 
secreted by the vessels of the iris and ciliary body into the posterior chamber of the eye; 
from here it passes through the pupil into the anterior chamber and is re-absorbed into the 
ciliary veins by way of the sinus venous sclera or canal of Schlemm (Nagyova and Tiffany, 
1999). Therefore, the functions of the aqueous humour are: to provide substrates (glucose, 
oxygen,  electrolytes)  for  the  metabolic  requirements  of  the  cornea,  remove  metabolic Monica Pino                                                                                                 Literature Survey 
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products (carbon dioxide, lactate, pyruvate) and maintain intraocular pressure. 
2.6  DISEASES AND TRAUMA OF THE CORNEA 
The corneal layers contribute to the function of the cornea. A healthy tear film and 
eyelids  are  vital  to  maintain  corneal  integrity  and  clarity.  Disturbance  of  the  eyelids, 
conjunctiva or tear film may lead to corneal problems. 
Bilateral corneal blindness: Loss of sight in both eyes due to corneal diseases. The 
definition of blindness is a visual acuity of 3/60 or less, according to the World Health 
Organisation  (WHO,  1998),  and  it  is  estimated  that  45  million  people  worldwide  are 
bilaterally blind, and in 10 million of these people the cause is primarily corneal diseases 
and secondly cataract (Whitcher et al., 2001). 
Climatic droplet keratopathy: Corneal degeneration caused by exposure to UV light. 
It is characterised in the early stages by fine sub-epithelial yellow droplets in the peripheral 
cornea. As the disease advances, the droplets become central, with subsequent corneal 
clouding causing blurred vision (Biswell, 1995). 
Corneal dystrophies: These are hereditary and occur at any level in the epithelium, 
stroma and endothelium. They include conditions in which there is defective development 
or degeneration of corneal tissue, such as fingerprint and map-dot, keratoconus, and Fuch‟s 
(Langley and Ledford, 2007). Fingerprint and map-dot epithelial dystrophies may cause 
corneal erosion. Keratoconus (conical cornea) is the most common corneal dystrophy, and 
leads  to  corneal  thinning,  cone  formation,  and  irregular  myopic  astigmatism;  it  causes 
painless  visual  distortion  and  loss  (Langley  and  Ledford,  2007).  Fuchs’s  endothelial 
dystrophy results in corneal clouding (Olver and Cassidy, 2005). 
Corneal Injuries: Corneal abrasion, chemical burn, and corneal penetrating injury 
can all arise accidentally (Olver and Cassidy, 2005). Corneal abrasion occurs when tissues 
are  scraped  from  the  corneal  surface,  commonly  involving  the  corneal  epithelium  but 
possibly  extending more deeply (Langley and Ledford, 2007).  Chemical burns can be 
produced by substances such as alkalis (lime, cement, plaster or ammonia), acids, solvents, Monica Pino                                                                                                 Literature Survey 
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detergents,  irritants  and  super-glue.  Alkali  in  high  concentrations  causes  subsequent 
scarring and blindness. 
Dry  eye:  A  disorder  of  the  tear  film  due  to  tear  deficiency  or  excessive  tear 
evaporation.  If  untreated  dry  eye  may  lead  to  dry  epithelium,  corneal  ulceration  and 
perforation, and blindness (AET, 2006). 
Infiltrates:  Appearance  of  white  or  yellow  particles  in  the  cornea,  commonly 
rounded in shape and cloudy, makes the cornea partially cloudy. Excessive contact lens 
wear and/or infections are the cause of these infiltrates (Langley and Ledford, 2007). 
Keratitis: Inflammation of the cornea resulting from infection caused by bacteria, 
fungi,  virus,  exposure,  or  injury  among  others  causes  (Langley  and  Ledford,  2007). 
Bacterial  keratitis  can  cause  corneal  abrasion,  opacification,  melt,  perforation, 
endophthalmitis, and loss of vision. Acanthamoeba keratitis can induce cornea scarring. 
Viral  keratitis  can  originate  ulcers  and  stromal  necrosis  that  is  scarring  with 
vascularization reducing cornea sensation, clarity and vision (Olver and Cassidy, 2005). 
Oedema:  Refers  to  hydration  of  the  corneal  tissue,  presenting  swelling  and 
cloudiness,  usually  indicates  a  dysfunction  in  the  endothelium.  If  corneal  swelling  is 
greater than 15%, a gross separation of the collagen fibres of the stroma occurs, results in a 
hazy  or  cloudy  appearance  of  the  cornea  (Langley  and  Ledford,  2007).  The  corneal 
swelling is 4% under normal conditions. 
Ocular  cicatricial  pemphigoid:  A  rare  inflammatory  conjunctival  disease,  whose 
early signs are redness, painful, tearing, and photophobia eyes. Later it may result in dry 
eye, corneal scarring and opacity (Olver and Cassidy, 2005). 
Pterygium: A triangular growth of tissue that extends from the conjunctiva over the 
cornea  (Vaughan  et  al.,  1995).  It  leads  to  inflammation  and  blurred  vision  due  to 
obstruction of the visual axis or to astigmatism (Olver and Cassidy, 2005). Pterygium can 
be surgically removed especially if it blockes the optic axis (Langley and Ledford, 2007). 
The cornea may become scarred before or after the surgical intervention. Monica Pino                                                                                                 Literature Survey 
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Stevens-Johnson  syndrome:  Inflammatory  disorder  of  the  skin  and  mucous 
membranes. The ocular disease can result in bilateral blindness. Prognosis of the corneal 
transplantation  in  the  acute  phase  is  poor  because  of  the  difficulty  of  overcoming  the 
severe inflammation and allograft rejection (Kiozumi et al., 2001). 
Trachoma:  A  serious  form  of  infection  of  the  eye  such  as  keratoconjunctivitis 
(Vaughan  et  al.,  1995).  When  the  infection  is  repeated  it  leads  to  trachoma,  which  is 
contagious, and frequently passes from child to child, and develops into a chronic stage 
during the adulthood. Trachoma occurs in areas with shortage of water, large number of 
flies and crowded living conditions (Whitcher et al., 2001). This chronic infection can lead 
to further symptoms: swollen eye lid, eye discharge, scarring in the eye lid, and corneal 
scarring (Taylor, 1999). 
Vascularization: Growth of blood vessels into the cornea from limbus (Fig.2.2.1) 
into the normally avascular tissues (Langley and Ledford, 2007). This is produced as a 
physiological response to long term low oxygen leads in the cornea in contact lens wearers 
(EyeMD, 2006).  
A  consequence  of  these  corneal  diseases  and  trauma  as  well  as  eye  surgery, 
glaucoma can develop. Glaucoma is an ocular condition in which the fluid pressure inside 
the eye is too high due to slow fluid drainage from the eye. 
2.7  TREATMENTS OF CORNEAL DAMAGE 
The healthy cornea is clear and avascular. Corneal clarity depends on the normal 
functioning of its layers. Of particular importance is the endothelium that maintains the 
cornea in a state of partial dehydration and hence transparency by means of a „pump-leak‟ 
mechanism.  Swelling,  tissue  proliferation  and  vascularization  may  compromise  the 
transparency of the cornea (Olver and Cassidy, 2005; Refojo, 2005). However, the major 
causes  of  corneal  blindness  are:  climatic  droplet  keratopathy,  corneal  injuries  (corneal 
abrasion, chemical burn and corneal penetrating injury), failed corneal grafting, keratitis, 
ocular  cicatricial  pemphigoid,  post-irradiation  injury  (Skelton  et  al.,  2000),  Stevens-Monica Pino                                                                                                 Literature Survey 
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Johnson syndrome and trachoma.  
Patients  who  suffer  from  corneal  conditions  such  as  corneal  injuries  (corneal 
abrasion, chemical burns), oedema, vascularization and corneal dystrophies (keratoconus) 
when a contact lens can no longer be effective for keratoconus, are advised to undergo 
keratoplasty (donor corneal transplantation). 
Patients with corneal blindness in whom the epithelium or endothelium diseases and 
trauma are the cause of the blindness, are suitable for a partial cornea replacement such as 
artificial endothelium or epikerotoprosthesis (artificial epithelium). 
On the other hand, patients with bilateral corneal blindness in whom donor corneal 
transplantation (keratoplasty) has failed or keratoplasty is not advised for their specific 
health circumstances, are potential subjects for keratoprosthesis (KPRO) surgery, assuming 
the optic nerve and the retina are functioning normally. A KPRO is a type of artificial 
cornea containing an optical implant. One such procedure is described in detail in section 
2.10.2. 
In addition, some complications such as rejection and post-astigmatism are reported 
in  keratoplasty  (Biswell,  1995)  which  might  be  due  to  the  collagen  based  implants  in 
corneal allograft material, which may fail to sustain normal corneal epithelial or stromal 
tissues in the hostile ocular surface environment (Hollick et al, 2006). Additionally with 
allograft  there  are  problems  with  the  supply  of  cornea  and  disease  transmission. 
Keratoplasty is not advised for patients with bilateral corneal blindness or who suffer from 
a range of clinical problems including dry eye, corneal injuries (chemical burn, corneal 
abrasion or corneal penetrating injury) and uncontrollable intraocular pressure (Hicks et 
al., 1997; Legeais and Renard, 1998; Kim et al., 2002; Falcinelli et al., 2005). At present, 
an  artificial  cornea  that  is  a  keratoprosthesis  (KPRO),  is  the  only  alternative  to 
keratoplasty. 
The  three  main  approaches  to  treat  cornea  blindness,  keratoplasty,  artificial 
endothelium and epikeratoprosthesis, are briefly described below.  Monica Pino                                                                                                 Literature Survey 
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2.7.1  KERATOPLASTY (DONOR CORNEAL TRANSPLANT) 
Keratoplasty is indicated for corneal conditions such as opacity, scaring, oedema, 
thinning and corneal dystrophies, and when a contact lens can no longer be effective for 
keratoconus. There are two types of keratoplasty: 1) Penetrating keratoplasty (PK), which 
is the transplantation of the full-thickness of the cornea, and 2) lamellar keratoplasty (LK), 
which is a partial-thickness procedure. The donor cornea may be of human (homograft), or 
another species (heterograft) origin (Biswell, 1995).  
For PK, a cornea from younger donors is preferred because of the direct correlation 
between age and number of the endothelial cells. The donor eyes should be enucleated 
soon after the death and refrigerated, and should be used within 24 to 48 hours. Cornea-
scleral caps are stored in nutrient media and used within 6 days, or with preservation in 
tissue culture media used for up 6 weeks. For LK, cornea can be frozen for several weeks 
as the endothelial cells are not important (Biswell, 1995). 
In PK, the cornea-scleral cap is placed endothelium up on a Teflon block; a trephine 
is  pressed down into the cornea, and a full-thickness  button is  punched out.  In  LK,  a 
partial-thickness  trephine  incision  is  made  in  the  cornea  and  the  lamellar  button  is 
dissected free. Fine sutures are used to sew the transplant in position (Biswell, 1995). 
Corneal graft rejection and controlling post-graft astigmatism are the major problems 
with keratoplasty (Biswell, 1995). There are additional problems with the supply of cornea 
and there are concerns over disease transmission as HIV or the hepatitis viruses can be 
transferred with the transplant. 
2.7.2  ARTIFICIAL ENDOTHELIUM 
The  endothelium  can  be  replaced  by  a  silicone-rubber  membrane.  However,  this 
procedure is not very successful because of the barrier properties of the membranes which 
do not allow the cornea to get nutrients from the aqueous humour (Refojo, 2005). Monica Pino                                                                                                 Literature Survey 
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2.7.3  EPIKERATOPROSTHESIS (ARTIFICIAL EPITHELIUM) 
An epithelium which has become irregular through swelling and proliferation may be 
replaced by an artificial epithelium made of a hard PMMA (poly methyl methacrylate) 
contact lens glued to the stroma using a cyanoacrylate adhesive. However, commonly this 
technique is not successful due to failure of the glue and penetration of the epithelium 
between the prosthesis and the cornea (Refojo, 2005). 
2.8  BIOMATERIALS 
The term biomaterial was defined in the 1980s as “a non-viable material used in a 
medical  device,  intended  to  interact  with  biological  systems”  (Williams,  1987).  This 
definition was very exclusive to the medical field. In the more inclusive applications the 
term biomaterial refers to the interactions between synthetic materials and modified natural 
materials. Biomaterials involve interactions with chemistry, chemical engineering, material 
science, mechanics, surface modifications, bioengineering, biology and medicine (Ratner 
and Bryant, 2004). Thus, the definition of a biomaterial has overtime with the so-called 
third-generation (Hench and Polak, 2002) and other new terms having been developed 
(Williams, 2008), which are beyond the scope of this thesis (e.g. biotolerability – Ratner 
and Bryand, 2004). 
The  first  generation  of  biomaterials  was  materials  that  “achieve  a  suitable 
combination of physical properties to match those of the replaced tissue with a minimal 
toxic response in the host” (Hench, 1980). A common feature of most of the biomaterials 
was their biological “inertness” (Hench and Polak, 2002). The principle underlying the 
biomaterials  development  was  to  minimise  the  immune  response  to  the  foreign  body 
(Hench and Polak, 2002) and to an extend this is still valid. 
The  second  generation  of  biomaterials  was  designed  to  be  either  resorbable  or 
bioactive  (Hench  and  Polak,  2002).  This  concept  involved  biomaterials  interactions 
occurring  on  the  surface  of  the  materials  and  for  bone  bioactive  materials  in  certain 
applications involved rapid ion exchange of Na
+ with H
+ and H3O
+, which provided a large Monica Pino                                                                                                 Literature Survey 
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number of sites for nucleation and crystallisation of carbonate hydroxyapatite (CHA) layer 
similar to the inorganic mineral phase of bone (Hench and Polak, 2002). The growing 
CHA  layer  on  the  surface  of  the  materials  provided  an  ideal  environment  for  cellular 
reactions to form new bone once implanted (Hench and Polak, 2002) and relates also to the 
broad  extension  of  cellular  growth  in  other  fields  such  as  dental,  spinal  and 
ophthalmological applications. 
First and second generations biomaterials are limited because living tissues respond 
to changes in physiological loads or biomechanical stimuli; however synthetic materials 
are not capable of responding to the environment (Hench, 1980). 
Third  generation  of  biomaterials  is  being  designed  to  stimulate  specific  cellular 
responses at the molecular level (Hench and Polak, 2002). Therefore, these biomaterials 
are referred to as cell and gene-activating materials, which combine the two properties: 
bioactive and resorbable, with the aim of developing materials that, once implanted, will 
help the body to heal itself (Hench and Polak, 2002). Toxicology is therefore implicit in 
the definition of biocompatibility (Ratner and Bryant, 2004). 
The most important factor which differentiates a biomaterial of any generation from 
any other material is its ability to exist in contact with tissues of the body without causing 
an unacceptable degree of harm to the body (Williams, 2008). The mutual acceptance and 
co-existence of biomaterials and tissue interactions, are in essence called biocompatibility. 
Thus, these interactions are involved in any of the situations where biomaterials are used 
such as tissue engineering, invasive sensors, drug delivery and gene transfection systems, 
medically oriented nanotechnology and biotechnology in general (Williams, 2008). 
A biocompatible material is a material that should not harm the patient. Thus, the 
definition of biocompatibility was given in the 1980s as “Biocompatibility refers to the 
ability of a material to perform with an appropriate host response in a specific situation” 
(Williams, 1987). By default, biocompatible materials as those that are non-toxic, non-
immunogenic, non-thrombogenic, non-carcinogenic, non-irritant, etc. This early definition 
and its default status led to a later definition of biocompatibility as:  Monica Pino                                                                                                 Literature Survey 
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“Biocompatibility  is  the  ability  of  materials  to  locally  trigger  and  guide  normal 
wound healing, reconstruction and tissue regeneration” (Ratner, 2004). 
The  second  and  third  generations  of  biomaterials  refer  to  their  bioactivity. 
Bioactivity was defined as: “A bioactive material is one that elicits a specific biological 
response at the interface of the material which results in the formation of a bond between 
the tissue and the material” (Hench et al., 1972). This definition lies somewhere between 
resorbable and bioinert material (Hench and Ethridge, 1982; Hench, 1988; Gross et al., 
1988).  
The most important issue about bioactivity is that all the in vitro and in vivo test 
results  showed  that  the  only  common  characteristic  of  the  known  bioactive  implant 
materials is that a layer of biologically active hydroxyl carbonates apatite forms on the 
implant surface (Cao and Hench, 1996). 
Resorbable implants are designed to degrade gradually with time and be replaced 
with natural host tissues (Cao and Hench, 1996). For instance, tricalcium phosphate (TCP) 
ceramics degrade to calcium and phosphate salts. Large quantities of material must be 
handled by cells; the constituents of a resorbable implant must be metabolically acceptable 
(Cao and Hench, 1996). Another requirement for a resorbable implant is that the resorption 
rate must be matched to the repair rates of body tissues (de Groot, 1983). A good example 
are resorbable sutures.  
Focusing on the specific field of ophthalmology there are several devices with a 
reasonable  long  record  of  use,  including  intraocular  lenses  and  artificial  cornea 
(keratoprosthesis), the main focus of this thesis. Thus, functionality is mainly determined 
by the optical properties, the physical compatibility with the scleral and corneal tissues and 
the insertion into and retention within the cornea location. Interestingly, biocompatibility is 
determined by the need to minimise the tissue reaction in order to avoid compromising the 
light  transmission  (Williams,  2008).  So  far,  bioactive  transparent  and  non-transparent 
polymers appeared to give good results, but the anchorage of the artificial corneal implant 
is still a challenge (Hick et al., 2003; Steinert, 2003), which is one of the problems that is 
tackled in this thesis. Monica Pino                                                                                                 Literature Survey 
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2.9  MATERIALS USED IN ARTIFICIAL CORNEA IMPLANTS 
The materials used for either full-thickness or partial replacement of cornea must 
meet the needs of metabolic activity requirements of the cornea and the mechanical and 
optical properties of the corneal surface. Furthermore, the material used for any corneal 
implant must not be degraded by host proteases and have sufficient porosity to support 
optimal nutrient flow, and the right pore size to allow diffusion of low-and high molecular 
weight  molecules.  More  over,  the  ability  of  the  cornea  to  tolerate  synthetic  materials 
depends on the pore size and porosity of the material to accommodate stromal fibroblasts 
(Hicks et al., 2000; Sweeney, 2006). 
Most of the implants produced, starting from the most frequently applied synthetic 
biomaterials, do not possess functional groups on the surface to attach any coating on their 
surface (i.e apatite layer) (Desmet et al., 2009). Therefore polymers are usually modified in 
order to enhance the biological response, i.e. apatite deposited from SBF is attached to the 
polymer surface after an initial surface modification. There are different methods that have 
been used to modify substrates for this approach, such as wet chemical treatment (e.g. 
immersion in NaOH, (Stancu et al. 2004; Chirila et al. 2007), and as used in this thesis), 
and plasma techniques. Oehr (2003) detail surface modification by plasma polymerization, 
with retention of the functional groups of the monomers used and listed some possible 
applications of plasma-modified polymers. 
Plasma  treatment  can  be  used  to  directly,  or  indirectly  introduce  different 
functionalities on inert surfaces. Direct modification includes the reactive NH3 plasma, 
which  is  known  to  introduce,  among  others,  amines,  where  O2  plasmas  introduces  a 
mixture of mainly COOH and OH functionalities. Argon plasmas are typically used to 
introduce free radicals (Desmet et al., 2009). 
The use of plasma modification techniques has some major advantages. First of all, 
some techniques will influence the mechanical properties of the outer layer of an implant. 
It is clear that wet chemical treatment of a surface (such as immersion in NaOH) will cause 
a partial degradation and scissions of the polymers at the surface, leading to a decrease of 
mechanical strength and to a faster degradation (Desmet et al., 2099).  Monica Pino                                                                                                 Literature Survey 
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Interestingly,  a  comprehensive  study  showed  that  the  structural  and  chemical 
integrity  of  PLGA  3D  scaffolds  was  adversely  affected  by  wet  chemical  methods 
(Djordjevic et al., 2008).  
Another advantage is that plasma enables uniform surface modification, regardless of 
their geometry (Deesmet et al., 2009). The plasma technique can therefore be used on 
complex objects such as 3D components for tissue engineering or artificial organs (Lee et 
al., 1996), nano-particles, and films (Ryu et al., 2005). In addition, the use of hazardous 
solvents might be avoided, as plasma is a solvent-free method.  
Despite the advantages of plasma treatment, NaOH-treatment is relatively easy and 
straightforward to apply, without the need for specialized equipment. For these reasons, 
NaOH was used to achieve chemical surface modification of the polymers.  Monica Pino                                                                                                 Literature Survey 
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2.9.1  POLYMERS 
Artificial cornea materials are usually polymer based. In this section an overview is 
therefore given of polymer materials such as polymethyl methacrylate (PMMA), poly(2-
hydroxyethyl  methacrylate)  (PHEMA),  polytetrafluoroethylene  (PTFE),  polyethylene 
terephthalate  (PET)  and  those  used  in  this  research  (HDPE,  PEEK  and  UHMWPE). 
Finally,  apatites  and  Simulated  Body  Fluids  (SBFs)  used  to  make  the  polymer  films 
bioactive are introduced. 
Polymers  or  macromolecules  have  two  basic  „shapes‟, each  possessing  its  own 
characteristic  properties.  They  may  be  linear  (or  branched)  or  crosslinked.  Linear  or 
branched polymers consist of an assembly of chains. Each chain consists of a number of 
similar units. Figure 2.9.1 shows a small section of a polyethylene chain, the simplest of all 
polymers. 
 
 
 
Figure 2.9.1 Part of polyethylene chain (from Ward et al., 2005) 
 
The different properties in polyethylene are due to the fact that polyethylene can 
have different types and degrees of side branches: 
 -  High  density  polyethylene  (HDPE)  consists  of  mostly  linear  chains  of 
polyethylene. 
 -  Low  density  polyethylene  (LDPE)  contains  both  short  and  long  branches  of 
polyethtylene. 
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-  Ultra  high  molecular  weight  polyethylene  (UHMWPE)  exhibits  extremely  long 
chains of polyethylene.  
The  most  immediate  difference  caused  by  short  branches  is  the  density.  In  the 
presence of both long and short branches, molecular chains cannot pack closely together 
and  hence  in  the  solid  state  produce  low  density  polyethylene,  which  also  has  lower 
crystallinity. Long branches affect the melt properties and increase entanglements,  thus 
modifying the processability of the polymer.  
Crosslinked  polymers  consist  of  continuous  networks.  They  may  be  lightly 
crosslinked, producing flexible products (e.g. vulcanised rubbers) or highly crosslinked, 
producing rigid materials (e.g. thermosets). These systems are insoluble and infusible, so 
they must be shaped prior to crosslinking. More specialised materials include thermoplastic 
elastomers (or rubbers) and crosslinked thermoplastics. 
Polyethylene  is  produced  by  chain  polymerisation,  which  may  be  represented  as 
follows: 
 
nCH2=CH2  =>  (-CH2CH2-)n  (equation 2.9.1) 
 
In  equation  (2.9.1),  n  is  the  number  of  molecules  reacting  together,  which  is 
described as the degree of polymerisation. CH2=CH2 is the chemical formula of ethylene, 
or ethene, the monomer from which polyethylene is produced. In ethylene, each carbon is 
linked to two hydrogen atoms, so it is said to be unsaturated, which means that it contains 
a double bond between the two carbons. Polymerisation proceeds via breaking of a double 
bond in the presence of an initiator (free radical, anionic, cationic or heterogeneous), which 
enables individual repeat units to join together to form a chain. Monica Pino                                                                                                 Literature Survey 
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2.9.2  POLY(METHYL METHACRYLATE) (PMMA) 
Polymethyl  methacrylate  (PMMA)  is  a  thermoplastic  acrylic  resin  (Figure  2.9.2) 
formed by polymerization of methyl methacrylate, and its molecular formula is (C5O2H8)n 
(Myer, 2002). 
 
 
 
Figure 2.9.2 Polymethyl methacrylate (PMMA) (from Smith and Javad, 2006) 
 
PMMA was initially the polymer of choice for artificial cornea (Chapoy and Lally, 
2008)  and  it  was  indeed  the  first  synthetic  polymer  used  in  KPRO  materials  (Chirila, 
2001). It is still used now a days as an optic and as skirt in keratoprosthesis devices since it 
is optically clear, but it is not permeable and does not promote epithelialization (Xie et al., 
2001).  
On the other hand, PMMA is biologically inert, transparent, and easy to fabricate and 
can be manufactured to a broad range of optical powers (Guo, 2001).  
However, the success of the PMMA keratoprosthesis has been plagued by problems 
including  extrusion,  glaucoma  and  opaque  fibrous  membrane  formation  (Patel  et  al., 
2006). 
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2.9.3  POLY(2-HYDROXYETHYL METHACRYLATE) (PHEMA) 
Poly(2-hydroxyethyl  methacrylate)  (PHEMA)  (Figure  2.9.3)    has  the  molecular 
formula (C6H10O3)n and forms a hydrogel in water.  
 
 
 
Figure 9.2.3 Poly(2-hydroxyethyl methacrylate) (PHEMA) (from Ratner, 2004) 
 
PHEMA is a biomaterial with a record of ocular tolerance in applications such as 
contact lenses and intraocular lenses (Chirila, 2001). PHEMA has been used for the optic 
and skirt of KPROs because of its hydrophilicity, flexibility and the ability to change its 
porosity (porous or non-porous) by altering the water content. Thus, the optic is made of a 
transparent PHEMA gel to provide a refractive power similar to that of the human cornea. 
The skirt is made of an opaque high water content PHEMA sponge to encourage  bio-
integration with host tissue and thus promote retention of the implant. In the AlphaCor 
Type II device, the optic and the skirt were joined and the permanent bond formed at the 
molecular level is designed to prevent the down-growth of cells around the optic, which 
can lead to the formation of retro-prosthetic membranes, one of the major complications 
historically associated with artificial cornea (Chirila, 2001).  
However,  the  PHEMA  optic  used  in  the  BioKpro  I,  Collar-button  Dohlman  and 
AlphaCor Type II (see Table 2.10.1) devices does not promote epithelialization and there 
is evidence that in the thick and central part of the cornea there are insufficient nutrients to 
maintain a healthy cornea because the PHEMA is not permeable to large molecules (Xie et 
al., 2001). 
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2.9.4  POLYTETRAFLUOROETHYLENE (PTFE) 
Polytetrafluoroethylene (PTFE) (Figure 9.2.4) has the linear formula (CF2CF2)n.  
 
Figure 9.2.4 Polytetrafluoroethylene (PTFE) (from Houde et al., 2006) 
 
PTFE is chemically inert and has very high oxygen permeability, good transparency, 
low refractive indices and high oxidative stability. The advantage of this polymer is that 
the  porosity  and  pore  size  can  be  modified  (Sweeney,  2006)  and  it  promotes  bio-
integration  of  corneal  tissue  (Xie  et  al.,  2001).  The  disadvantage  of  PTFE  is  that 
epithelialization is not possible. PTFE has been used as the skirt on the BioKPROs I – III 
(Table 2.10.1). 
Proplast
TM is a composite of polytetrafluoroethylene (PTFE, Teflon
TM) and vitreous 
carbon. Proplast
TM skirt was incorporated in human patients using the Cardona nut-and-
bolt Kpro by Girard (1993) for the first time, but fibroblast invasion into the Proplast
TM, 
glaucoma and retinal detachment occurred. 
Gore-Tex
TM  is  another  form  of  porous  PTFE,  known  as  an  expanded 
Polytetrafluoroethylene (ePTFE), which has been used as skirt material by Legeais in his 
BioKPRO,  which  was  reported  successful  in  clinical  trials  in  human  patients  and  is 
presently marketed in Europe (Hicks et al., 1997; Chirila, 2001). However, ePTFE 200µm 
thick  with  50µm  pores  showed  that  collagen  filled  the  pores  and  the  opaque  material 
became translucent, but not sufficiently transparent to be used as an optic (Hicks et al., 
1997). 
Proplast
TM and Gore-Tex
TM (or ePTFE) have been compared in animal trials. ePTFE 
was found to be the most satisfactory in terms of biocompatibility with host tissue, but in 
some cases Gore-Tex
TM had become encapsulated with host tissue. Proplast
TM presented 
Figure 2.9.4 has been removed due to the Copyright restrictions Monica Pino                                                                                                 Literature Survey 
 
 
  53 
inflammatory response, giant foreign body cells and fibrovascular invasion (Hicks et al., 
1997). 
2.9.5  POLYETHYLENE TEREPHTHALATE (PET) 
Polyethylene terephthalate (PET) is a thermoplastic polymer resin of the polyester 
family, with a molecular formula of (C10H8O4)n (Figure 3.9.5). 
 
 
 
Figure 9.2.5 Polyethylene terephthalate (PET) (from Fakirov, 2002) 
 
PET has been used as skirt in KPRO designs since it promotes bio-integration of 
corneal tissue; however it does not promote epithelialization. 
Pintucci et al. (1995) used a flexible polyethylene terephthalate (Dacron
TM) as a skirt 
material in their KPRO design implanted in humans in a manner similar to the OOKP 
technique (section 2.10.2, page 66), with the skirt fixed to the corneal surface and covered 
with buccal mucosa. The optic was made of PMMA. The optic core-and-skirt junction 
presented some fixing problems related to the dissimilarity of the two materials, and 10% 
extruded in clinical trials. 
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2.9.6  HIGH DENSITY POLYETHYLENE (HDPE) 
High density polyethylene (HDPE) is a polyethylene which consists of mostly linear 
chains  (Figure  2.9.6).  Therefore,  highly  linear  polyethylene  molecules  can  be  closely 
packed and result in high density polyethylene, making it highly crystalline (up to 95%).  
 
 
 
Figure 2.9.6 High density polyethylene (HDPE) (from Ward et al., 2005) 
 
HDPE is a flexible thermoplastic polymer. Thus, HDPE is of particular interest as a 
biomaterial since it can easily be processed using conventional thermoplastic moulding and 
extrusion methods due to the fact that linear polymers can be shaped by application of heat 
(Ward et al., 2005) and the process is reversible provided that chemical degradation does 
not occurs.  
2.9.7  ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE (UHMWPE) 
Ultra high molecular weight polyethylene (UHMWPE) is a thermoplastic polymer 
with extremely long chains of polyethylene (Figure 2.9.1), which are aligned in the same 
direction and have a molecular weight between 2 and 6 million. Each chain is bonded to 
the others through van der Waals bonds between the molecules. The longer chains help to 
transfer load to the polymer bonds by strengthening intermolecular interactions, so that the 
UHMWPE can support high tensile loads,  making this  polymer very tough, with  high 
impact strength. UHMWPE has a high resistant to chemicals and UV radiation, and is non-
toxic.  
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UHMWPE has over 40 years of clinical history as a successful biomaterial for use in 
hip,  knee,  and  most  recently  (since  the  1980s),  for  spine  implants  (Kurtz,  2004). 
UHMWPE  is  widely  used  as  a  biomaterial  due  to  its  excellent  mechanical  properties, 
including resistance to wear and impact. Most interesting is that a variety of synthetic 
implants made of UHMWPE have been used in ophthalmology (Allan, 1999). 
2.9.8  POLYETHER ETHER KETONE (PEEK)  
Polyether ether ketone (PEEK) is a thermoplastic polymer and an aromatic polyether 
(Sakamoto, 2003), consisting of repeating monomers of two ether groups and a ketone 
group (Figure 2.9.7).  
 
 
 
Figure 2.9.7 Polyether ether ketone (PEEK) (from Sakamoto, 2003) 
 
An  ether  group  contains  an  oxygen  atom  connected  to  two  (substituted)  alkyl 
(general formula CnH2n+1) or aryl (simple aromatic ring) groups, with general formula R-
O-R‟. A ketone group contains a carbonyl group (O=C) linked to two other carbon atoms, 
and it can be generally represented by the chemical formula R1 (CO) R2.  
Because of the symmetry of the benzene rings along the polymer backbone, PEEK 
has  high  mechanical  strength  and  from  the  characteristic  of  almost  linear  chemical 
structure,  the  polymer  has  a  crystalline  phase  (Sakamoto,  2003).  PEEK  is  a  semi-
crystalline material, with excellent mechanical properties (Table 3.2.3) maintained to high 
temperatures. It exhibits two glass transition temperatures at around 140 °C and around 
275 ºC, depending on cure cycle and formulation.  
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PEEK has high resistance to chemicals, electricity and temperature, and excellent 
dimensional stability and large processing capabilities (Sakamoto, 2003).  
PEEK film is an opaque (brown) material, which presents two distinctive sides: 
1)  Bright side, which is shine/glossy and smoother.  
2)  Matt side, which is slightly rough and lacking highlights or gloss. 
PEEK  is  considered  an  advanced  biomaterial  used  in  medical  implants.  A  great 
emphasis on the physiochemical and micro-morphology of the surfaces on PEEK implant 
has been investigated to produce an hydroxyapatite-like surface after the immobilisation of 
calcium ions. Also, the effects of the surface modification of PEEK implants and models 
have been assessed on their in vivo performance. 
PEEK has been used as biomaterial due to its relative inertness, and hydroxyapatite 
(HA) and tricalcium phosphate (TCP) have been blended into sintered PEEK. It has also 
been used in spinal implants as a radiolucent alternative to metallic biomaterials in the 
spine (Kurtz and Devine, 2007).  
PEEK biomaterials research has also focused on compatibility of the polymer with 
bioactive  materials,  including  hydroxyapatite  (HA),  either  as  composite  filler,  or  as  a 
surface coating (Yu et al., 2005; Fan et al., 2004; Tan et al., 2003; Abu Bakar et al., 2003; 
Ha et al., 1997). This material can be engineered today with a wide range of physical, 
mechanical,  and  surface  properties,  depending  on  their  implant  application  (Kurtz  and 
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2.9.9  APATITES 
Apatites are groups of phosphate minerals. Phosphate minerals are those minerals 
that  contain  the  tetrahedral  coordinated  phosphate  (PO
 3
4 )  anion  along  with  the  freely 
substituting arsenate (AsO
 3
4 ) and vanadate (VO
 3
4 ). Also, chlorine (Cl
-), fluorine (F
-), and 
hydroxyl (OH
-) anions also fit into the crystal structure (Cruz et al., 2005). Therefore, 
apatites are compounds that contain a divalent metal cation (primarily Ca
2+, Sr
2+, Ba
2+, 
Cd
2+, and Pb
2+), a phosphate (PO
 3
4 ) and a monovalent anion (OH
−, F
−, Cl
−, and Br
−). The 
calcium derivatives are by far the most abundant (Greenwood and Earnshaw, 1997).  
Calcium phosphate is a compound of a family of minerals containing calcium ions 
(Ca
2+)  together  with  orthophosphates  (PO
 3
4 )  (Kingston  et  al.,  2003).  Calcium 
orthophosphates are minerals of biological origin and are the most important inorganic 
constituent of hard tissue in vertebrate (Lowenstam and Weiner, 1989; Vallet-Regi and 
Gonzalez-Calbet, 2004). In the form of a non-stoichiometric, ion-subtituted and calcium 
deficient hydroxyapatite (known also as biological apatite), calcium phosphates are present 
in bones, teeth, deer antlers and tendons of mammals (Dorozhkin, 2009). Apatite is an 
important biological mineral found in teeth and bones of vertebrates (Nickel, 1995).  
Hydroxyapatite (HA) is referred to as an apatite with a high concentration of OH
- 
ions  in  the  crystal.  The  formulae  of  HA  is  Ca5(PO4)3(OH),  usually  written  as 
Ca10(PO4)6(OH)2 to denote the two molecules of the crystal unit cell.  
Calcium phosphate related to the hexagonal hydroxyapatite, Ca10(PO4)6(OH)2, with 
small quantities of other elements such as Na
+, Cl
- and Mg
2+ substituted into the crystal 
structure are found in the inorganic part of the tooth enamel of human (Gutierrez-Salazar 
and Reyes-Gasga, 2003; Tadic et al., 2001). The apatite contained in enamel, dentine and 
bone mineral is calcium-deficient biologic apatite (Legeros et al., 2003). Dental enamel 
contains approximately 98% of biological apatite (calcium deficient hydroxyapatite) and 
2%  of  bio-organic  compounds  and  water.  Dentine  contains  approximately  50%  of 
biological  apatite,  30%  of  bio-organic  compounds  and  20%  of  water  (Nelson,  2009; 
Dorozhkin, 2009). Interestingly, the Ca/P molar ratio of dental enamel is 1.63 and the Ca/P Monica Pino                                                                                                 Literature Survey 
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molar ratio of dentine is 1.61 (Legeros, 1991; Dacusi et al., 1997). 
In biological apatites (as in tooth and bone) the OH
- or PO
 3
4  ions can be replaced by 
carbonate, CO
 2
3 . It crystallizes in an hexagonal crystal system. The substitution of the 
carbonate group occurs either in the PO site (for the B type apatite substitution), or in the 
OH site (for the A type of apatite substitution) (Jokanovic et al., 2006; Tadic et al., 2001). 
Additionally, the chemical composition of many calcium orthophosphates includes 
hydrogen, either as part of an acidic orthophosphate anion (HPO
 2
4 or H2PO

4 ), hydroxide 
(Ca10(PO4)6(OH)2) and/or incorporated water (CaHPO4·2H2O). Different combinations of 
CaO and P2O5 (both in the presence of water and without it) provide a large variety of 
calcium phosphates, which are differentiated by the type of the phosphate anion: ortho- 
(PO
 3
4 ), meta- (PO

3 ), pyro- (P2O
 4
7 ) and poly- ((PO3)
 n
n ). In the case of multi-charged 
anions (orthophosphates and pyrophosphates), calcium phosphates are also differentiated 
by the number of hydrogen ions attached to the anion, for instance, mono- (Ca(H2PO4)2), 
di- (CaHPO4), tri- (Ca3(PO4)2) and tetra- (Ca2P2O7) calcium phosphates (Legeros, 1991; 
Elliot, 1994, Amjad, 1997; Dorozhkin, 2009). 
The atomic arrangement of calcium orthophosphates is built up around a network of 
orthophosphate (PO4) groups, which provides stability to the structure. The majority of 
calcium  orthophosphates  are  soluble  in  water  and  insoluble  in  alkaline  solutions 
(Dorozhkin,  2009).  However,  the  calcium  phosphates  that  can  be  precipitated  from 
aqueous solutions will be discussed in detail this thesis. 
Calcium phosphates can be prepared by precipitation from supersaturated aqueous of 
calcium  and  phosphate-containing  salts  (Hofmann  et  al.,  2007).  Synthetic  calcium 
phosphates are used as implant materials due to their biocompatibility, bonding ability, and 
their similarity to the mineral phase of bone (Gutierrez-Salazar and Reyes-Gasga, 2003; 
Hofmann et al., 2007).  
Therefore,  calcium  phosphates  can  be  used  as  biomaterials  due  to  the  excellent 
biocompatibility (Ginebra et al., 2004; Cai and Tang, 2008) since their chemical similarity Monica Pino                                                                                                 Literature Survey 
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to the mineral  component of bones  and teeth (Vallet-Regi and Gonzalez-Calbet, 2004; 
Weiner  and  Wagner,  1998;  Dorozhkin,  2007;  Dorozhkin,  2009).  Moreover,  calcium 
phosphates  are  non-toxic,  not  recognized  as  foreign  materials  in  the  body  and,  most 
importantly, exhibit bioactive behaviour and integrate into living tissue (Dorozhkin, 2009). 
The calcium phosphates that can be precipitated from aqueous solutions are listed in Table 
2.9.1 together with their Ca/P molar ratio and their chemical formula. 
Table 2.9.1 Calcium phosphate compounds that can be deposited from aqueous solutions 
(data from Dorozhkin, 2007; Dorozhkin, 2009) 
 
Calcium Phosphate Compounds  Chemical formula  Ca/P molar ratio 
Hydroxyapatite (HA)  Ca10(PO4)6(OH)2  1.67 
Calcium-deficient hydroxyapatite (CDHA)  Ca9(HPO4)(PO4)5(OH)  1.5 
Calcium-deficient hydroxyapatite (CDHA)  Ca10-x(HPO4)x(PO4)6-x(OH)2-x 
(x=1 when Ca/P=1.5) 
1.5>1.67 
Mono-calcium phosphate monohydrate (MCPM)  Ca(H2PO4)2 H2O  0.5 
Di-calcium phosphate dihydrate (DCPD)  CaHPO4 H2O  1.0 
Octa-calcium phosphate (OCP)  Ca8(HPO4)2(PO4)4 5H2O  1.33 
 
The  hydroxyapatite  (HA)  structure  was  described  as  aggregation  of  Ca9(PO4)6 
clusters in 1964 (Kay et al., 1964; Treboux et al., 2000). This hexagonal structure of HA 
(Ca10(PO4)6(OH)2)  is  a  more  common  one  for  biomedical  applications  (Elliot,  1994; 
Mathew and Takagi, 2001; Hughes and Rakovan, 2002; White and Dong, 2003) since it 
can be formed from precipitated solutions such as Simulated Body Fluids (SBFs). In fact, 
the  precipitates  are  generally  non-stoichiometric,  suggesting  intermediate  formation  of 
precursor phases (Dorozhkin, 2009). The surface of freshly precipitated HA is composed 
of  a  structured  hydrated  layer  containing  easily  exchangeable  mobile  ionic  species 
(Cazalbou  et  al.,  2004).  Usually  unsintered  HA  is  poorly  crystalline  and  often  non-
stoichiometric, resembling calcium deficient hydroxyapatite (CDHA). Monica Pino                                                                                                 Literature Survey 
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Interestingly,  pure  HA  never  occurs  in  biological  systems.  However,  due  to  the 
chemical  similarities  to  bone  and  teeth  mineral,  HA  is  widely  used  as  a  coating  on 
orthopedic, dental implants (Hench, 1991; Suchanek and Yoshimura, 1998; Hench, 1998; 
Willmann, 1999; Ong and Chan, 1999; Sun et al., 2001; Geesink, 2002) and other diverse 
biomedical implants (Aoki, 1991; de Groot et al., 1998; Gross and Berndt, 2002; Ferraz et 
al., 2004; Damien and Revell, 2004; Barinov and Komlev, 2008). HA particles can also be 
implanted (Mangano et al., 2008).  
Moreover, HA has been used for a long time in liquid chromatography of nucleic 
acids, proteins and other biological compounds (Dickinson, 1956; Bernardi, 1965; Doonan, 
2004; Jungbauer et al., 2004; Smith and Gingrich, 2005; Yoshitake et al., 2006; Xia et al., 
2008; Brand et al., 2008) and for drug delivery purposes (Liu et al., 2005; Palazzo et al., 
2005) due to its similarity to biological apatite. 
Calcium-deficient hydroxyapatites (CDHA) have a variety of Ca/P molar ratios and 
this has been explained through various models: Surface adsorption, lattice substitution and 
intercrystalline mixtures of HA and octa-calcium phosphate (OCP) (Rodriguez-Lorenzo, 
2005). Due to a lack of stoichiometry, CDHA usually contains other ions (Rey  et al., 
2006). The extent depends on the counter-ions of the chemicals used for preparation (Na
+, 
Cl
-). 
CDHA may be considered as HA with some ions missing (Brown and Martin, 1999; 
Zahn  and  Hochrein,  2008).  The  more  calcium  is  deficient,  the  more  disorder  and 
imperfections are in the CDHA structure (Honghui et al., 2007). According to the chemical 
formula of CDHA (Table 2.9.1), there are vacancies of Ca
2+ (mainly on Ca sites) and OH
- 
ions in crystal structure of this compound (Mortier  et al., 1989; Jeanjean et al., 1996; 
Brown and Martin, 1999; Wilson et al., 2003; Wilson et al., 2005; Zahn and Hochrein, 
2008).  However,  the  vacancies  of  orthophosphate  ions  are  not  known,  for  instance  in 
CDHA, a portion of PO

3  ions is either protonated (as HPO
 2
4 ) or substituted by other ions 
(CO
 2
3 ) (Ivanova et al., 2001). 
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Therefore, in CDHA: Ca
2+ can be substituted by Na
+, K
+, Mg
2+, Sr
2+, the PO
 3
4  by 
CO
 2
3 , the HPO
 2
4 by CO
 2
3  and OH
- by F
-, Cl
-, CO
 2
3 plus some water forming biological 
apatite, which is the main inorganic part of animal and human calcifications (Legeros, 
1991; Rey et al., 2006; O‟Neill, 2007). Thus, CDHA is a very promising compound for 
industrial  manufacturing  of  artificial  bone  and  teeth  substitutes  as  well  other  artificial 
compounds (Tsuchida et al., 2008). 
Mono-calcium phosphate monohydrate (MCPM) is a highly acidic compound, which 
due to its acidity is not found in biological calcification. In addition, pure MCMP is not 
biocompatible (Koster et al., 1977; Williams, 1999). Despite this, MCPM can be used as a 
component  of  self-hardening  calcium  orthophosphate  cements  in  the  medical  field 
(Bermudez et al., 1994; Bermudez et al., 1994; Driessens et al., 1994; Huan and Chang, 
2009). 
Di-calcium phosphate dihydrate (DCPD) can be precipitated from aqueous solutions 
(Arsic et al., 2004; Qiu and Orme, 2008). DCPD is mostly found in calcification in humans 
due  to  the  pathological  lesions  (Legeros,  1991;  Legreos,  2001;  Becker  et  al.,  2004; 
O‟Neill, 2007). DCPD has been studied as an intermediate in bone mineralization and 
dissolution  of  enamel  in  acid  (dental  acidity)  (Legeros,  1991;  Legeros,  2001;  O‟Neill, 
2007). Moreover, DCPD may be used in calcium orthophosphates cements and in tooth 
remineralisation  in  the  medical  field  (Bermudez  et  al.,  1994;  Kurashina  et  al.,  1997; 
Driessens et al., 1998; Takagi et al., 1998; Yamamoto et al., 1998). 
Octa-calcium phosphate (OCP) is usually found in unstable intermediate compounds 
during the precipitation of the calcium phosphates in aqueous solutions (Legeros, 1985; 
Bigi et al., 1999; Nakahira et al., 2001; Shelton et al., 2006). OCP is of great biological 
importance because it is one of the stable components of human dental and urinary calculi 
(Schroeder, 1969; Legeros, 1974; Chow and Eanes, 2001). OCP plays an important role in 
vivo in the formation of apatitic biominerals. In the medical field, OCP is used for bone 
defect as implantable filler (Kamakura et al., 1999; Kamakura et al., 2001; Sargolzaei-
Aval et al., 2004; Suzuki et al., 2006; Suzuki et al., 2008; Kikawa et al., 2009). 
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To conclude calcium hydroxyapatite (CaHA) is a biocompatible material because it 
contains  Ca
2+,  PO
 3
4   and  OH
-  ions;  the  ions  that  human  tissue  has  in  relatively  high 
percentage  (Jokanovic  et  al.,  2006).  However,  most  synthetic  apatites  differ  from 
stoichiometric apatite as well as from biogenetic carbonate hydroxyapatite (CHA) by their 
composition and particularly their CO
 2
3 content (Hofmann et al., 2007). A common feature 
of  bioactive  materials  is  that  their  surfaces  develop  a  biologically  active  carbonate 
hydroxyapatite layer after implantation. For a material to be bioactive in vivo, it must have 
the ability of induce CHA formation on its surface in vitro (Ni and Wang, 2002). 
2.9.10  SIMULATED BODY FLUID (SBF) 
1.5 SBF was used in this study as a treatment to produce Ca/P layer on the surface of 
the polymers to make them bioactive, before implantation. While it is important to perform 
the material tests in conditions which replace or simulate the body environment this was 
not the primary purpose for the use of 1.5 SBF in this study. It should, however, be noted 
that since SBF has an ion concentration and pH which is close to that of the human blood 
serum  (Renke-Gluszko  and  Fray,  2004),  its  characteristics  are  similar  to  those  of  the 
aqueous humour fluid in tears which resembles blood plasma in composition, but contains 
less  protein  and  glucose  and  more  lactic  acid  and  ascorbic  acid  (Tiffany  et  al.,  1989; 
Nagyova and Tiffany, 1999). 
Simulated Body Fluids (SBFs) are acellular solutions suitable to study the bioactivity 
behaviour of a material in vitro on the basis that the ion concentration in SBF is similar to 
that of human blood plasma. The first SBF was developed by Kokubo and his colleagues in 
1987, in order to perform in vitro simulation of in vivo conditions (Kokubo et al., 1987). It 
was designed to explore in vitro bioactivity of different materials intended for implants as a 
preliminary  analysis.  Since  then  this  technique  has  been  widely  used  to  evaluate  the 
potential of materials, coatings and surgical implant devices to predict the bone bonding 
ability. This means that the in vivo bone bioactivity of materials may be predicted by 
examining apatite formation on its surface after being immersed in SBF for a period of 
time (Kokubo and Takadama, 2006).  Monica Pino                                                                                                 Literature Survey 
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The history of the SBF was summarised by Kokubo and his group recently (Kokubo 
and Takadama, 2006), where the interaction between the ability to form apatite on different 
materials soaked in SBF and their in vivo bone bioactivities were reported from the first 
time SBF was used through to the latest formulations. This review included the different 
approaches to produce biomaterials up to the development of novel bioactive materials 
based on the formation of apatite on their surfaces. 
Various Simulated Body Fluids (SBFs) have been used to assess the bioactivity of 
artificial  materials  in  vitro  (Chan  et  al.,  2004;  Juhasz  et  al.,  2008).  The  materials  are 
exposed to a SBF to evaluate its bioactivity and to analyse its evolution over the time 
(Auclair-Daigle et al., 2005). The evaluation is assessed by examining the ability to form 
apatite from the solution, and the evolution is assessed by testing structure, chemistry and 
mechanical adhesion of the coatings on the surface (Gu et al., 2003). 
Simulated Body Fluids (SBFs) have been used in vitro to study apatite formation or 
apatite precipitation  on  the surfaces of different types  of biomaterials,  such as metals, 
polymers, ceramics and composites (Kokubo et al., 1990; Kokubo et al., 1991; Huang et 
al., 1997; Tanahashi and Matsuda, 1997; Kawashita et al., 2003; Jonasova et al., 2002; 
Oyane et al., 2005; Muller and Muller, 2006; Kokubo and Takadama, 2006).  
The apatite layer formed on the materials surfaces after being exposed to SBF could 
define its bioactivity in the process of biomineralisation. Therefore, the formation of the 
calcium phosphate deposits that occur on the surface of materials soaked in SBF is used to 
predict  the  bioactivity  of  a  material.  The  process  of  producing  minerals  from  living 
organisms  to  modify  or  restore  functionally  the  existing  tissues  is  known  as 
biomineralisation. By definition, a bioactive material is “a material that elicits a specific 
biological response at the interface of the material, which results in the formation of a bond 
between the tissue and the materials” (Hench, 1998) (see detail discussion in sections 2.8, 
and 2.13). Thus, a material may be considered bioactive is it reacts with or affects cells or 
tissues in the human body. Hence, the in vitro deposition of calcium and phosphate formed 
on the surface of a material as layers or coatings of apatite is a potential biomaterial. 
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Apatite is a form of calcium phosphate, known as hydroxyapatite, Ca5(PO4)3OH; 
fluorapatite,  Ca5(PO4)3F;  and  chlorapatite,  Ca5(PO4)3Cl,  depending  on  the  high 
concentration  of  hydroxide  (OH
-),  fluorine  (F
-),  or  chlorine  (Cl
-)  ions,  respectively. 
Calcium phosphates can also be prepared by precipitation from supersaturated aqueous of 
calcium and phosphate-containing salts (Hofmann et al., 2007), such SBFs. 
Recently, Kokubo and his colleagues (2006) reviewed the SBF method for the two 
decades since SBF was first developed, and they insisted that SBF could be used to assess 
bioactivity, and that the formation of apatite on a material immersed in SBF is a proof of 
its bioactivity and can be used to predict its bone bonding ability in vivo; those statements 
are in agreement with Ohtsuki et al. (1992), Kawashita et al. (2003), Renke-Gluszko and 
Fray (2004), and Auclair-Daigle et al. (2005). Slightly contradictory, Oyane et al. (2003) 
assessed  the  conventional  SBF  and  developed  a  revised  SBF  for  in  vitro  bioactivity 
assessment of artificial materials and for biomimetic production of bone-like apatite, on the 
basis of the finding that a large amount of calcium and magnesium ions present in the SBF 
is bound to proteins and hence apatite formation did not arise. More recently, Bohner and 
Lemaitre (2009) published an interesting paper arguing that a SBF method is insufficient 
evidence to test the bioactivity of a material and concluded that such an assumption needs 
improvement; the SBF ion concentration is not identical to the body fluids in humans and 
the test is usually not conducted in the appropriate conditions, for example, an adequate 
partial pressure since human serum is in equilibrium with a CO2 partial pressure of 0.05 
atm. This lack of correlation between in vitro and in vivo bioactivity results, which has 
been commented on by Ohura et al. (1996), Walsh et al. (2003), Apelt et al. (2004); Chan 
et al. (2004), Theiss et al. (2005) and Juhasz et al. (2008) require to be further investigated 
until consistent results are obtained.  
Many  attempts  have  been  made  to  produce  apatite-polymer  composites  in  a 
biomimetic manner since apatite nucleation could be formed on organic polymers due to 
the presence of functional groups. The polymers are then immersed in SBF for the further 
growth of apatite (Kawashita at al., 2003). Despite all experimental trials, the ability to 
form apatite on polymers is still poor. However, over a decade ago Tanahashi and Matsuda 
(1997) demonstrated that carboxyl groups (-COOH) were effective to nucleate apatite in 
self-assembled  monolayers.  Thus,  since  then,  it  has  been  believed  that  polymers  with Monica Pino                                                                                                 Literature Survey 
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certain  functional  groups  such  as  carboxyl  could  form  apatite  on  their  surfaces  when 
immersed in SBF. 
Basically, the biomimetic process of the apatite layer formation on polymers occurs 
in two stages. During the first stage, the polymer is subjected to a severe alkaline solution; 
for instance, highly concentrated NaOH, and then immersed in SBF at 37 
oC, to induce the 
apatite nuclei formation on the polymer surface. In the second stage, the SBF solution, in 
which the polymer is immersed, is renewed with a fresh SBF solution, to make the apatite 
nuclei  grow  and  with  time  cover  the  polymer  surface.  The  apatite  coating  thickness 
depends on the SBF immersion time of the second stage. The adhesion properties of the 
coatings may depend on the polymer type (Renke-Gluszko and Fray, 2004).  
The apatite nuclei induction time is usually from 1 to 3 days for the majority of the 
polymers  reported  in  the  literature:  Polyethylene  terephthalate  (PET),  polymethyl 
methacrylate  (PMMA),  polyether  sulfone  (PESF),  polyethylene  (PE),  polyamide  6,  or 
poly(tetrafluorethylene) (PTFE) (Kokubo, 1996; Huang et al., 1997; Kokubo, 1998; Kim et 
al., 1999; Kawashita et al., 2003). The apatite deposition on the polymer may occur on day 
1 of the SBF immersion of the second stage; however, it has been reported that it mostly 
happens after day 3 and could grow to form a thick apatite layer after 15 to 30 days of 
incubation in SBF. Kawashita et al. (2003) have reported that carboxyl group-containing 
polymers gels in SBF can form apatite on the fibres. Huang et al. (1997) used SBF to 
investigate  the  apatite  formed  on  Bioglass®-reinforced  high  density  polyethylene 
composite, to mention few examples from literature. 
In the last decade, different strengths of SBF have often been used in vitro to aid 
apatite formation or precipitation on surfaces of different types of biomaterials, such as 
metals,  polymers and  ceramics  (Kokubo et  al.,  1990 and 1991;  Janasova  et  al.,  2002; 
Oyane et al., 2005; Yu et al., 2005; Muller and Muller, 2006; Huang et al., 2007). The 
modifications of SBFs have shown that it is possible to obtain thicker carbonated apatite 
layers and also the formation of homogeneous apatites. It is believed that a concentrated 
SBF could be used to accelerate the SBF coating processes. For instance, Kim et al. (1999) 
have used 0.75-2.00 SBF on polyethylene terephthalate (PET) to study the apatite formed. 
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materials. 
As  mentioned  early,  NaOH  induces  the  formation  of  apatite  nuclei  (calcium 
phosphate) on the polymeric film surfaces. On the other hand, any potential released Na
+ 
might cause external alkalization that triggers an inflammatory response and leads to cell 
death (Jonasova et al., 2002). Therefore, the lower the concentration of NaOH, the less 
harmful it would be for the patient. The apatite nuclei formed initiate the deposition of 
calcium and phosphate ions from the surrounding fluid (Kokubo et al., 1991). Thus apatite 
nuclei stimulate the growth of carbonate hydroxyapatite (CHA) layers when immersed in 
SBFs producing bioactive material. Kim et al. (2000) suggested that the bioactivity of the 
apatite-polymer depends on the structure and composition of the formed apatite. 
Finally, the aim for the artificial materials is to be implanted in the human body to 
support or restore the normal functionality in a specific area. For instance, an artificial 
cornea  implant  may  replace  the  cornea  functionality  including  its  metabolic  process. 
Therefore,  it  is  extremely  important  to  perform  the  material  tests  in  conditions  which 
replace or simulate the body environment. SBF offers such conditions to a certain extend, 
due to its ion concentration being close to the human blood serum, typically at temperature 
of 37 
oC and a PH of 7.4. Thus, SBF is proposed to be used in order to predict material 
behaviour through the apatite layer formation on the material surface (Renke-Gluszko and 
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2.10  ARTIFICIAL CORNEA IMPLANTS 
Commonly,  there  are  two  procedures  to  replace  the  damaged  cornea  using  an 
artificial device: 
The keratoprosthesis (KPRO), which consists of a clear central optic and a sewing 
skirt to anchor the implant. 
The Osteo-odonto-keratoprosthesis (OOKP) is a KPRO device with a tooth dentin 
based skirt and a PMMA optic.  
First, KPROs are described in general followed by detailed discussion of OOKP. 
2.10.1  KERATOPROSTHESIS (KPRO) 
In the instance of failure of cornea transplant from donor eyes, an opaque cornea can 
be replaced with an artificial cornea, keratoprosthesis, (KPRO) (Refojo, 2005). KPRO is 
required  for  patients  with  bilateral  corneal  blindness  who  suffer  from  tear  deficiency, 
chemical burns, trachoma, vascularization, Stevens-Johnson syndrome, ocular cicatricial 
pemphigoid, or uncontrollable intraocular pressure. Patients with these conditions cannot 
be treated with penetrating keratoplasty (PK) (Hicks  et al., 1997; Legeais and Renard, 
1998; Kim et al., 2002; Falcinelli et al., 2005). 
KPRO is also advised for the treatment of severe corneal opacities not suitable for 
PK  procedure  (Falcinelli  et  al.,  2005).  Patients  with  severe  ocular  surface  diseases, 
successive graft failures and paediatric patients with congenital corneal opacities are not 
recommended to undergo a PK procedure (Moffatt et al., 2005); thus, KPRO might be an 
alternative for these patients. On the other hand, some patients cannot undergo PK with 
donor tissue due to disease severity, religious or ethical objection to the use donor tissue, 
failed past donor tissue transplants, or where measures required to prevent graft rejections 
are medically contraindicated (IPAC, 2004). Therefore, the best alternative at the moment 
for the majority of these patients is a keratoprosthesis (KPRO) intervention. Monica Pino                                                                                                 Literature Survey 
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Generally, there are two types of cornea replacement designs:  
Central optic-and-skirt keratoprosthesis (Figure 2.10.1), which consists of a clear 
central  optic  and  an  annular  porous  surround,  or  skirt,  designed  to  provide  tissue 
integration between the prosthesis and the recipient cornea (Albon, 2003; Hicks et al., 
2005; Myung et al., 2007). 
 
 
 
Figure 2.10.1 Central optic-and-skirt keratoprosthesis (from Ilhan-Sarar, 2005) 
 
Collar-button keratoprosthesis, which holds the optical cylinder of the prosthesis to 
the recipient cornea by means of front and back plastic plates (Figure 2.10.2). PMMA is 
the most commonly used material in cornea replacements (Refojo, 2005). 
 
 
 
Figure 2.10.2 Collar-button keratoprosthesis (from Dohlman and Harissi-Dagher, 2007) 
 
Figure 2.10.2 has been removed due to the Copyright restrictions 
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The different designs of KPRO vary mainly in their skirt (Myung et al., 2008), while 
the optical is basically the same being PMMA. Various KPRO models have been used in a 
few  countries  for  small  number  of  patients  with  varying  degrees  of  success.  The 
Strampelli, Cardona and Dohlman KPROs have become the most commonly used models, 
which involve a rigid polymethylmethacrylate (PMMA) optic (Hicks et al., 2000; Guo, 
2001) with an anchoring surround with a front plate and a back plate. There are currently 
two totally synthetic KPROs and a semi-synthetic KPRO available commercially: 
The  Legeais  BioKPRO  III,  which  uses  a  skirt  of  porous  polytetrafluoroethylene 
(PTFE).  The  device  (Figure  2.10.3)  consists  of  a  central  5  mm  clear  silicone  optic 
chemically bonded to a 10 mm opaque fluorocarbon PTFE porous skirt (Hollick et al., 
2006). 
 
 
Figure 2.10.3 The Legeais BioKpro III before implantation (from Hollick et al., 2006) 
 
AlphaCor  (previously known as  the Chirila  KPRO, Figure 2.10.4), which uses  a 
porous polyhydroxyethylmethacrylate (PHEMA) (Chirila et al., 1995).  
 
 
 
Figure 2.10.4 AphaCor
TM keratoprosthesis (from Chirila et al., 1995) 
Figure 2.10.4 has been removed due to the Copyright restrictions 
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Osteo-odonto-keratoprosthesis  (OOKP),  a  semi-synthetic  KRPO  (Figure  2.10.5), 
uses an autologous tooth as a form of biological hydroxyapatite (Viitala et al., 2009) as a 
skirt and an optical cylinder (Figures 2.10.5 and 2.10.6). Further details on this approach 
are given in section 2.10.2. 
 
 
 
Figure 2.10.5 Schematic representation of the tooth lamina and optical cylinder of the 
OOKP design (from Tan et al., 2005) 
 
 
 
Figure 2.10.6 Dentil lamina used a skirt in the OOKP (from Liu et al., 2007) 
 
Table 2.10.1 summaries the KPRO most recognized designs, whose developments 
and modifications are further detailed, including the results in human trials. 
Figure 2.10.6 has been removed due to the Copyright restrictions 
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Table 2.10.1 Keratoprosthesis used in human clinical trials (data from Cardona, 1962; Strampelli, 1963; Cardona, 1969; Dohlman and Doane, 1994; 
Legeais et al., 1997; Legeais and Renard, 1998; Hicks et al., 2000, Crawford et al., 2002; Allan, 2002; Albon, 2003; Falcinelli et al., 2005; Bleckmann 
and Holak,2006; Hollick et al., 2006; Viitala et al. 2009) 
Author  KPRO design  Optic Material  Skirt  Results  Complication 
Strampelli 
(1963) 
OOKP  PMMA  Tooth surrounded by buccal 
mucosa sutured to cornea 
17/85 retained the KPRO but 
poor aseptic eyes 
Glaucoma, membrane 
formation, extrusion 
Falcinelli 
(2005) 
Strampelli 
modified OOKP 
PMMA  Osteodental lamina and mucous 
epithelium 
Rate unknown: 108 excluded 
and 40 retained of 153 
Extrusion, glaucoma 
Cardona 
(1962, 1969) 
Central optic and 
skirt 
Acrylic PMMA  Intra-lamellar plate 
Attached by screws 
17/31 retained the KPRO and 
vision was improved 
Membrane formation, 
glaucoma, extrusion 
Dohlman 
(1994) 
Collar button  PMMA  PMMA  6/13 KPRO were retained and 
vision was improved 
Aqueous leakage, extrusion, 
membrane formation, retinal 
detachment, 2/13 removed 
Chirila 
(2000) 
AlphaCor Type I  PHEMA  PHEMA 
Attached by PIN 
KPRO removed and PK  Conjunctivitis  
Chirila 
(2002) 
AlphaCor Type II  PHEMA  PHEMA  28/38  retained  the  KPRO  and 
uncomplicated post-surgery 
Aqueous leakage, membrane 
formation 
Legeais 
(1997) 
BioKPRO I  PMMA 
Lens removal 
PTFE 
Attached by clips 
47/73 retained the KPRO and 
34/73 improved vision 
Extrusion, membrane 
formation, glaucoma 
Legeais 
(1998) 
BioKPRO II  PDMS coated PVP  PTFE 
Chemically fused 
11/13 KPRO clinically stable 
and 7/13 improved vision 
No epithelial coverage, 
membrane formation, necrosis, 
extrusion 
Legeais 
(2001) 
BioKPRO III  PDMS coated PVP  PTFE 
Chemically fused 
1/7 retained the KPRO and 
improved vision 
Extrusion, membrane formation Monica Pino                                                                                                 Literature Survey 
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The Strampelli, Cardona and Dohlman KPROs have been the implants mostly used 
in Europe. These models have been implanted in humans and there are plenty of published 
results  from  their  trials,  which  will  be  discussed  later.  There  are  also  two  completely 
synthetic  KPROs:  the  Legeais  BioKPRO  III  and  AlphaCor  (previously  known  as  the 
Chirila  KPRO).  These  devices  recently  have  been  implanted  into  patients  and  the 
published outcomes are detailed in this section. 
The  Strampelli  osteo-odonto-keratoprosthesis  (OOKP)  replaces  the  cornea  with  a 
PMMA optical cylinder glued to a biological support (haptic) made by human living tissue 
(ie, the autologous  osteodental lamina) (Falcinelli  et  al., 2005). The Strampelli OOKP 
remains the KPRO of choice for end-stage corneal blindness not amenable to penetrating 
keratoplasty (PK), its rigid optical cylinder gives excellent image resolution and quality 
(Moffatt et al., 2005).  
Early British followers of the Strampelli technique reported poor retention results 
(Casey, 1999). Falcinelli modified this technique and it was re-introduced into Britain in 
1996 (Liu et al., 1998). The Falcinelli OOKP is capable of providing acceptable results, 
particularly for patients with corneal blindness untreated by other approaches (Parel and 
Sweeney, 2005). Published results from clinical trails using a modified OOKP (Falcinelli 
et al., 1987; Falcinelli et al., 1993; Falcinelli et al., 1999) suggest good long term retention 
(85% in 18 years) with 75% of patients seeing 6/12 or better (Liu et al., 1998; Parel and 
Sweeney, 2005).  
The  modified  OOKP  provides  satisfactory  long-term  anatomical  and  functional 
results mainly because the OOKP is an autograft made of living human tissue, the haptic is 
made  of  dentine,  an  avascular  hard  tissue  with  a  slow  metabolic  exchange.  All  these 
biological  properties  prevent  retro-prosthetic  membrane  formation  and  infections  and 
provide protection and nutrition to the underlying bone (Ricci et al., 1992; Falcinelli et al., 
2005).  
However, the Falcinelli OOKP implant failure is related to poor tissue integration, 
which  would  appear  to  be  significantly  less  than  for  the  BioKPRO  III  and  AlphaCor 
devices (Viitala et al., 2009). Also the OOKP requires the extraction of at least one of the Monica Pino                                                                                                 Literature Survey 
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patient‟s teeth which has disadvantages compared with using synthetic materials (Falcinelli 
et al., 2005). 
The  Cardona  KPRO  is  a  combined  intra-lamellar/perforating  KPRO  with  a 
transparent central perforating cylinder and a holding lamellar plate. A later design known 
as a „nut-and-bolt‟ KPRO consists of an external cosmetic contact lens of coated PMMA 
and a PMMA cylinder, which screwed into the contact lens and also into the PMMA nut 
that is placed against the endothelium (Cardona, 1991; Hicks et al., 1997). This device 
reduces evaporation, has a thicker supporting tissue. It also has a covered junction between 
the cylinder and the host stroma, and no need for donor corneal tissue.  
Hicks  et  al  (1997)  explained  that  the  Cardona  KPRO  design  reduces  extrusion 
because  the  front  plate,  which  is  fixed  to  the corneal  surface,  is  also  buried.  Cardona 
KPRO designs reinforced with donor sclera, autologous tissue (i.e. lid skin) or synthetic 
materials  have  been  developed  by  others  (Chilaris  and  Liaricos,  1973;  Cardona  and 
DeVoe,  1977;  Cardona,  1983;  Girard,  1983)  and  their  outcomes  include  serious 
complications such as retro-prosthetic formation and glaucoma. However, of 31 patients, 
22 improved their independence level, 17 achieved 6/60 visual acuity, 5 maintained 6/12 
visual acuity, and the best outcome was 6/6 in 1 patient. Cardona KPROs modified with a 
nylon skirt, a Dacron
TM skirt, a PMMA flange, and a modified nut-and-bolt arrangement 
with  Dacron
TM  reinforcement  have  all  presented  serious  problems  (Rao  et  al.,  1979; 
Aquavella et al., 1982; Cardona, 1983; Girard, 1983). Cardona described in detail his latest 
KPRO with good average results and pointed out that it was a more less invasive surgery 
(Cardona, 1991). 
The Dohlman KPRO is a „collar-button‟ of PMMA. The anterior plate has a short 
stem which pierces a donor corneal button, and a back plate is either threaded onto it or 
glued. Initial results from 1974 were disappointing, due to „melting‟ of the surrounding 
corneal stroma, causing complications such as aqueous leakage, exposure, extrusion and 
retinal detachment. Ulceration could be avoided if cyanoacrylate glue were used to prevent 
the epithelium and tears from getting under the anterior plate (Hicks et al., 1997).  
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There are two types of Dohlman‟s latest designs: 
Type I is used in eyes with good tear and blinking conditions.  
Type II has an added anterior nub for through-the-lid placement in end-stage dry eye 
(Yaghouti and Dohlman, 1999).  
These  modified  devices  are  simple,  minimum  swelling  of  the  tissue  around  the 
prosthesis is achieved and repair of necrosis is relatively easy (Dohlman and Doane, 1994). 
In a recent report, 91.1% of Dohlman KPROs were retained, although glaucoma shunting 
was performed in 60.4% of the patients (Dohlman et al., 1996). 
AlphaCor is a synthetic cornea implant made from PHEMA that has a peripheral 
region with interconnecting pores allowing bio-integration with surrounding corneal tissue. 
The surgery is performed in two stages. In stage I, the PHEMA cornea is placed within a 
lamellar corneal pocket with tissue posterior to the optic, which is removed at the time of 
implantation.  In  stage  II,  the  tissue  anterior  to  the  optic  is  removed.  The  porous  skirt 
remains enclosed with corneal stromal tissue, both (skirt and stroma tissue) bio-integrate 
due to the cellular colonization of the skirt and collagen deposition (Hicks et al., 2005). 
More than 150 AlphaCor devices have been implanted into human recipients. In a 
follow-up  of  40  patients  30%  exhibited  complications  associated  with  poor  tissue 
integration.  Of  14  extruded  cases,  5  presented  complications  related  to  the  optic 
(calcification caused by topical medication or fungal invasion of the optic), of which 3 
developed  stromal  leakage  and  breakdown.  Also,  8  were  removed  due  to  melting  of 
corneal tissue anterior to the device skirt and 1 due to a retro-prosthetic membrane (Hicks 
et al., 2005). Importantly, this device can be replaced with a donor graft in the event of the 
development  of  significant  complication.  Moffatt  et  al.  (2005)  concluded  that  the 
AlphaCor  devices,  despite  the  different  designs  available,  has  yet  to  show  that  it  is 
clinically superior and further evaluation and development is required. 
 
 Monica Pino                                                                                                 Literature Survey 
 
 
  75 
Legeais  developed  a  KPRO  made  of  a  porous  PTFE  skirt  and  a  PMMA  optic 
(Legeais et al., 1991; Legeais et al., 1992; Legeais et al., 1993) and his modified devices 
are known as BioKPROs I, II and III: 
The BioKPRO I had four pieces: a PMMA optic, a PTFE skirt, PMMA fixation clips 
and a PMMA sealing ring (Hollick et al., 2006). Thus, the optic made of PMMA was 
attached by clips to a supporting skirt of a biocolonizable expanded PTFE. The crystalline 
lens was removed in all patients because of the thickness of the central optic. Visual acuity 
was improved in half of the patients, but a high rate of implant extrusion had occurred, and 
other  severe  problems  such  as  retroprosthetic  membrane  formation,  leakage  and 
endophthalmitis.  
The BioKPRO II has only 2 fused pieces: a soft optic and a skirt. The optic was a 
soft polydimethylsiloxane (PDMS) copolymer coated with  polyvinylpyrrolidone (PVP), 
and the skirt was white opaque of hydrophobic fluorocarbon haptic (PTFE). The optic was 
chemically fused with the supporting colonisable skirt instead of the clips that formed the 
mechanical junction between the optic and the skirt. The dimensions of the new optic were 
close  to  those  of  the  human  cornea.  Also,  the  biocolonisation  was  faster  due  to  the 
modification of the optic support, but the optic and junction were not covered by epithelial 
cells  (Legeais  and  Renard,  1998).  This  device  was  successful  in  human  clinical  trials 
(Legeais et al., 1997; Legeais and Renard, 1998), and is presently marketed in Europe 
(Chirila, 2001), available from France Chirurgerie Industries (FCI) SA, Paris, France as the 
BioKPsil.  
However, in clinical series of patients implanted with BioKPROs I and II failure was 
up to 40% within 1 year, with retraction of the surface tissue over the haptic element, retro-
prosthesis  membrane  formation,  infection,  or  aqueous  leakage,  and  in  many  cases  the 
implant was removed.  
The BioKPRO III (FCI Ophthalmics, Marshfield Hills, MA, USA) has two fused 
pieces (a silicone optic and a PTFE skirt) similar to the BioKPRO II, but the optic was 
smaller  and  the  skirt  larger.  The  porous  material  used  as  the  skirt  surround  for  tissue 
integration  was  made  of  opaque  polytetrafluoroethylene  (PTFE),  which  is  a  synthetic Monica Pino                                                                                                 Literature Survey 
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element of the device that can be produced fairly simply. Trials of BioKPRO III have been 
in progress at Moorfield Eye Hospital in London since January 2001 and visual acuity, 
visual field, device retention and incidence of adverse events will be published after 10 
years (Allan, 2002). Although, Hollick et al. (2006) recently reported results of BioKpro 
III implanted in seven patients: only one was successful at 5 years with improved vision of 
6/12, but presented mucus accumulation on the optic, in six cases extrusions occurred, 
retro-prosthetic membranes in three, and inflammation in one patient. 
2.10.2  OSTEO-ODONTO-KERATOPROSTHESIS (OOKP) 
One of the major complications in the KPROs is the poor integration of the KPRO 
with surrounding tissue, especially with the stroma in the host cornea. Many attempts have 
been made to overcome this problem, for instance to use a skirt with autologous tissue, 
such as tooth, bone or cartilage (Temprano, 1993; Liu et al., 2005; Michael et al., 2008) 
with hydroxyapatite. These were however still not successful (Allan, 2002), for instance, 
the Osteo-odonto-keratoprosthesis (OOKP) which used a tooth base-lamina, resulted in 30-
75% progressive glaucoma, 10% retinal detachment and limited vision (Bleckmann and 
Holak, 2006).  
To date, there are no KPROs that fulfill all the optimal requirements, i.e. are not to 
be rejected by the immune system of the patient, are completely inert but biologically 
functional, with long term stability and clarity, easy to maintain, with reasonable cost for 
the device, surgery and post-surgery, and also easy to implant. However, results of the 
OOKP have shown a good success over a long time as the implant is retained. Thus, the 
principle of the OOKP is still valid but needs to be improved upon. Actually, the Osteo-
odonto-keratoprosthesis  (OOKP)  is  a  standard  technique  for  surgery  for  visual 
rehabilitation  in  corneal  blind  patients  at  the  end-stage  of  ocular  surface  diseases  and 
trauma (as mentioned earlier) not treatable with penetrating keratoplasty (KP). 
Hille et al. (2006) published a special article summarising the protocol of the OOKP 
procedure  including  indications  and  contraindications,  patient  selection  criteria, 
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Strampelli‟s OOKP procedure by Falcinelli‟s group and their results in a series of 234 
patients who underwent for OOKP with follow-up at 5, 10 and up to 20 years. 
The OOKP technique was pioneered in the early 1960s by Strampelli, who chose a 
tooth  as  the  skirt  material.  The  Strampelli  procedure  is  very  complex and  the  surgery 
involves stages over a period of months, however, the outcome of his technique was fairly 
successful because the reproduction of mucosal epithelium was limited by the contact with 
the alveolar dental ligament, reducing the membrane formation and extrusion (Ricci et al., 
1992). The Strampelli OOKP was then modified by Falcenelli‟s group over the years, but it 
is still based on the same principle as the original Strampelli OOKP. The OOKP basic 
principle is the use of a tooth with the root and surrounding alveolar bone (Figure 2.10.7) 
to form a plate (skirt) as a holder for the optical cylinder made of PMMA.  
 
 
 
Figure 2.10.7 Schematic representation of cross section of a normal tooth (from Shah, 
2009) 
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In the OOKP (Figure 2.10.8), the PMMA optical cylinder is glued to the host cornea 
with cement. Therefore, the optical cylinder becomes the central part of the OOKP lamina 
(Figures 2.10.5 and 2.10.6). The dentine is joined to the alveolar bone by the dentoalveolar 
ligament.  The  OOKP  lamina  is  secured  and  fixed  to  the  cornea  by  the  surrounding 
periosteum, a dense membrane composed of fibrous connective tissue that coats bones, and 
also the OOKP lamina is fixed and sewn to the sclera surface with sutures. Finally, a thick 
buccal mucous membrane graft is placed on the OOKP device except on the top of the 
optic cylinder in order to protect and cover the device (Hille et al., 2006). This buccal 
mucous graft also supplies the alveolar living bone with nutrients making it bioactive and 
restoring part of the metabolic process of the cornea. 
 
 
 
Figure 2.10.8 Schematic representation of the cross section of an OOKP device (from Liu 
et al., 2008) 
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The OOKP surgery is performed in two stages (I and II) separated by 1 year: 
In stage I, a circular flap of buccal mucosa from the cheek is sutured over the cornea 
and sclera. The flap is removed when it is about 2 mm thick. A crown tooth is harvested 
and with it alveolar dental ligament. The tooth root and surrounding bone is sectioned to 
obtain a lamina with dentine on one side and bone on the other. A hole is drilled through 
the  dentine  to  place  a  PMMA  optical  cylinder.  The  assembled  device  (osteo-odonto 
lamina) is placed in a lower eyelid subcutaneous pocket to acquire a soft tissue covering 
(Hicks et al., 1997; Liu et al., 1998; Falcinelli, 2005; Liu et al., 2008).  
In  stage  II,  up  to  1  year  later,  the  osteo-odonto  lamina  is  removed  from  its 
subcutaneous pocket and the excess soft tissue is cleaned from the bone surface, therefore, 
no soft tissue remains on the dentine surface. The buccal mucosal flap is opened to uncover 
the cornea. A small hole is trephined for one end of the optical cylinder and the other end 
passes through a hole in the buccal mucosa. Incisions are then made to extract the lens. The 
lamina is inserted in the corneal hole and sutured onto the cornea and sclera. The eye is re-
inflated with filtered air. Finally, the mucosal flap is replaced (Hicks et al., 1997; Liu et al., 
1998; Falcinelli, 2005; Liu et al., 2008). 
The  Stampelli  OOKP  technique  was  modified  by  the  Falcinelli  group  and  this 
modified OOKP surgery is still one of the most successful procedures for KPROs in terms 
of retention of the implant for patients with corneal blindness untreatable by other surgical 
procedures. 
The disadvantages of the OOKP certainly are the long term surgery, and that it is 
usually not performed in both eyes at the same time. The complication of degree varies and 
mostly  depends  on  the  pre-conditions  of  the  patient‟s  eyes,  for  instance  indications 
including  dry  eye,  chemical  burns,  glaucoma  pre-surgery,  and  failed  keratoplasty. 
However,  the  most  common  complications  in  the  OOKP  procedure  are  glaucoma  (an 
ocular condition in which the fluid pressure inside the eye is too high due to slow fluid 
drainage from the eye), haemorrhage into the vitreous, endophalmitis (inflammation of the 
internal tissues in the eye), retinal detachment, alteration of the mucus, infection of the 
lamina  in  the  pocket,  membrane  formation  (retro-prosthetic  membrane),  corneal Monica Pino                                                                                                 Literature Survey 
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perforation,  expulsion  of  the  optic  cylinder,  absorption  of  lamina,  expulsion  of  the 
prosthesis, optic cylinder instability, and rupture of the sclera (Chirila, 2001; Hille et al., 
2006; Bleckmann and Holak, 2006; Chirila et al., 2007). There are only a few centres in 
the world for OOKP surgery due to the complexity of the medical intervention. In the UK, 
OOKP is carried out at the Sussex Eye Hospital in Brighton, which has been the national 
referral centre for the OOKP medical procedure since 1996 (Liu et al., 2008). 
2.11  PRESENT COMPLICATIONS OF ARTIFICIAL CORNEA DESIGNS  
The most common complications of KPROs are the inadequate integration between 
the skirt of the artificial implant and host tissue, specially the sclera; and between the 
cylindrical optic and its skirt (Hicks et al., 1997; Legeais and Renard, 1998; Kim et al., 
2002; Albon, 2003; Meek, 2008). Therefore, the fixation methods and the bio integration 
of the skirt in the artificial cornea must be evaluated and improved, without compromising 
the mechanical strength of the KPRO. 
Legeais and Renard (1998) addressed that the poor integration between the artificial 
implant and host cornea, results in infection and/or inflammation and eventual extrusion. 
Albon (2003) added that a poor interface seal between optic and skirt, leads to epithelial 
down-growth and aqueous leakage. Hicks et al. (1997) and Albon (2003) stated that a 
retro-corneal membrane can be formed behind the optic and leads to extrusion of the optic. 
Refojo (2005) reported faulty tissue-prosthesis interface, epithelium down growth, retro 
corneal membranes, tissue ulceration and infections around the prosthesis as the common 
problems associated with central optic-and-skirt keratoprosthesis. Albon (2003) outlined 
similar problems and added some cases of glaucoma have been found.  
Certainly, the interfaces between the optic and the skirt of the KPROs, which are 
joined by using either different glues or sewing procedures with threads, constitute very 
risky sites, where epithelial down growth, leakage and infection are prone to occur. The 
same risks can also be present in the interface between the KPRO and the host sclera. 
Meek (2008) explained that rigid components on KPROs can produce mechanical stress in 
the cornea causing ulceration on the surface of the KPRO or opacification of the cylinder Monica Pino                                                                                                 Literature Survey 
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optical interface. Kim et al. (2002) and Albon (2003) have reported low biocompatibility 
in  KPRO  devices,  and  the  result  is  an  inability  of  recipient  cells  (epithelial  cells  and 
keratocytes)  to  colonise  the  optics,  which  leads  to  inflammation,  retro-prosthetic 
membrane  formation,  tissue  breakdown,  leakage  and  eventual  implant  extrusion. 
Undoubtedly, all surgery which involves full or partial replacement of part of the body is 
highly complex and causes inflammation. In particularly in the case of KPROs, intraocular 
inflammation and glaucoma are definitely the results of an extremely complex medical 
procedure, which is predisposed to retro-prosthetic membrane formation.  
On the other hand, the available KPROs are not covered with a layer that can protect 
the  implant  itself,  the  optic  from  the  external  environment;  therefore  extrusion  and 
infection are prone to occur. The natural cornea and sclera are protected from these normal 
surroundings with an epithelial layer. Thus, the KPROs must somehow allow to solve this 
problem,  for  instance  to  allow  coating  the  KPRO  with  an  artificial  epithelial  surface 
without interfering with the clearness of the optic. 
To overcome the main problem of the KPROs, the poor integration of the KPRO 
with its surrounding tissue, the tissue must be autologous, following the principle of the 
OOKP, and address the subsequent complications. It would therefore be very important to 
consider an ideal artificial cornea and evaluate the feasibility in a more realistic approach. Monica Pino                                                                                        Materials and Methods 
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CHAPTER 3 
MATERIALS AND METHODS  
3.1  INTRODUCTION 
Polymer-based  materials  are  preferentially  used  for  the  skirts  (scleral  part)  of 
artificial  cornea  (KPRO)  because  clinically  it  is  easier  to  implant  a  prosthesis  with  a 
flexible polymeric skirt than an implant with a rigid skirt such as the tooth lamina from the 
OOKP (Osteo-odonto-keratoprosthesis) design. Secondly, the mechanical compatibility is 
closer between the sclera and polymers compared to sclera versus tooth enamel. Moreover, 
it  is  desirable  that  polymers  for  KPRO  skirt  are  both  biocompatible  and  bioactive  to 
interact with the metabolic activity of the cornea.  
Possible materials include high-density polyethylene (HDPE), ultra high molecular 
weight polyethylene (UHMWPE)  and polyether ether ketone (PEEK).  These were pre-
treated with different concentration of sodium hydroxyl (NaOH) solutions for 48 hours 
followed by soaking in 1.5 Simulated Body Fluid (SBF) for up to 30 days to stimulate the 
growth of apatite and to accelerate calcium and phosphate depositions on the pre-treated 
substrate forming an apatite layer. 
Apatite layers can be formed on the polymers by using a suitable treatment in 1.5 
SBF to produce Ca/P layer on its surface before implantation, potentially rendering these 
polymers  bioactive.  To  this  end,  a  NaOH  pre-treatment  may  be  necessary  to  activate 
functional groups (OH
-) that can act as potential nuclei on the polymer surface for the 
apatite deposition during the 1.5 SBF treatment. 
In this chapter, the materials used are described with a summary of the physical 
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the  NaOH  and  SBF  solutions  are  detailed.  Also,  the  immersion  of  HDPE,  PEEK  and 
UHMWPE films in 1M, 5M or 10M NaOH pre-treatments and the incubation in the 1.5 
SBF  treatments  are  described.  Finally,  the  characterisation  techniques  to  study  the 
morphology and the composition of the layers deposited on the films are described in detail 
in order to assess in vitro bioactivity of the layers. Monica Pino                                                                                        Materials and Methods 
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3.2  MATERIALS  
3.2.1  HIGH DENSITY POLYETHYLENE (HDPE) 
The high density polyethylene (HDPE M30053S) was supplied as granules by Saudi 
Basic Industries Corporation (SABIC- Europe Ltd, Belgium). The physical properties are 
given in Table 3.2.1. 
Table 3.2.1 Physical properties of HDPE (data from SABIC- Europe Ltd. Belgium) 
Polymer Properties      Test Methods 
Density  
Melt flow rate (MFR) 
Melt volume rate (MVR) 
953 
4.0 – 10.5 
5.3 - 14 
  kg m
-3 
g/10 min 
ml/10 min 
ISO 1183 
ISO 1133 
ISO 1133 
Mechanical Properties       
Tensile test 
stress at yield 
stress at break 
strain at break 
tensile modulus 
Creep modulus 
after 1 hour  
after 1000 hours 
Izod impact notched 
at 23 
oC 
at -30 
oC 
Hardness Shore D 
   
25 
31 
>200 
1100 
 
500 
250 
 
5 
5 
61 
   
MPa 
MPa 
% 
MPa 
 
MPa 
MPa 
 
kJ m
-2 
kJ m
-2 
- 
ISO 527-2 
 
 
 
 
 
ISO 899 
 
 
 
ISO 180/A 
 
 
 
ISO 868 
Thermal properties       
Heat deflection temperature 
at 0.45 MPa (HDT/B) 
Vicat softening temperature 
at 10 N (VST/A) 
DSC test 
Melting point 
Enthalpy change 
 
81 
 
 
124 
 
 
132 
203 
   
oC 
 
 
oC 
 
 
oC 
J g
-1 
ISO 75-2 
 
 
ISO 306 
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3.2.2  ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE (UHMWPE) 
The  ultra  high  molecular  weigh  polyethylene  (UHMWPE  1900)  was  supplied  as 
powder by Himont, USA. The physical properties given by the supplier are shown in Table 
3.2.2. 
Table 3.2.2 Physical properties of UHMWPE (data from Himont, USA) 
Polymer Properties      Test Methods 
Physical Properties           
Density   930      kg m
-3  ASTM D792 
Mechanical Properties           
Tensile and compression tests 
strength at yield 
tensile impact 
elongation at break 
shear strength 
Izod impact strength 
at 23 
oC 
Hardness Shore D at 23 
oC 
 
3,100 
800 
300 
3,500 
 
no break 
62-66 
 
psi 
ft lb in
-2 
% 
psi 
 
 
 
 
(21 
(1,700 
 
(24 
 
 
- 
 
MPa) 
kJ m
-2) 
 
MPa) 
 
 
 
 
ASTM D638 
ASTMD1822
ASTM D638 
ASTM D732 
 
ASTM D256 
ASTM D785 
Thermal properties           
Heat deflection temperature 
at 1.8MPa (264 psi)  
at 0.45 MPa (66 psi) 
Vicat softening temperature 
DSC test 
Melting point 
Enthalpy change 
 
47 
80 
124 
 
135-138 
200 
 
oC 
oC 
oC 
 
oC 
J g
-1 
   
 
ASTM D648 
 
 
ASTMD1525 
 
ASTM D789 
ASTMD7696 
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3.2.3  POLYETHER ETHER KETONE (PEEK)  
The polyether ether ketone (PEEK) was supplied by Invibio Ltd. Lancashire, UK as 
films.  The  PEEK  film  presents  two  distinctive  sides  (bright  and  matt).  The  physical 
properties are given in Table 3.2.3. 
Table 3.2.3 Physical properties of PEEK (data from Invibio Ltd. Lancashire, UK) 
Polymer Properties      Test 
Methods 
Physical Properties           
Density   1310    kg m
-3    ASTM D792 
Water absorption, 24 hrs  0.10    %    ASTM D750 
Mechanical Properties           
Tensile and compression tests 
tensile strength 
tensile modulus  
tensile elongation at break 
flexural strength 
flexural modulus 
compressive strength 
compressive modulus 
Hardness (Rockwell) 
Izod impact notched 
 
16,000 
500,000 
20 
25,000 
600,000 
20,000 
500,000 
M100 
1.0 
 
psi 
psi 
% 
psi 
psi 
psi 
psi 
- 
 ft lb in
-1 
 
(110 
(3450 
 
(170 
(4140 
(140 
(3450 
 
(54 
 
MPa) 
MPa) 
 
MPa) 
MPa) 
MPa) 
MPa) 
 
J m
-1) 
 
ASTM D638 
ASTM D638 
ASTM D638 
ASTM D790 
ASTM D790 
ASTM D695 
ASTM D695 
ASTM D785 
ASTM D256 
Thermal properties           
Heat deflection temperature 
at 264 psi (1.8 MPa) 
DSC test 
Melting temperature 
Maximum operating temperature 
 
160 
 
340 
249 
 
oC 
 
oC 
oC 
 
 
 
 
ASTM D648 
 
 
ASTMD3418 
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3.2.4  SODIUM HYDROXIDE (NAOH) 
Sodium hydroxide (NaOH) is a caustic metallic base. Sodium hydroxide is a white 
solid, available in pellets, flakes, granules and as a 50% saturated solution. Anhydrous 
(100%, solid) sodium hydroxide has a chemical formula of NaOH and a molecular weight 
of 40.00. Sodium hydroxide forms a strong alkaline solution when dissolved in a solvent 
such as water; it is very soluble in water with liberation of heat, the reaction is exothermic. 
The sodium hydroxide (NaOH) was supplied by Aldrich as anhydrous pellets reagent 
grade ≥98%, CAS No. 1310-73-2, Cat. No. S5881, F.W. 40, ECC No. 215-185-5, EC label 
WGK1.  The physical  and chemical  properties  of the NaOH pellets  are summarised in 
Table 3.2.4. 
Table 3.2.4 Physical and chemical properties of NaOH 
Properties     
 
Molecular weight 
Odour  
Specific gravity (water = 1.0) at 25 
oC  
Solubility in water at 0 
oC 
pH (5% solution) 
Boiling point 
Melting point 
 
40.00 
Odourless 
2.13 
29.6 
14 
1390 
318 
 
 
 
 
% 
 
oC 
oC 
 
For these experiments, 750 mL of 10M NaOH was prepared by dissolving 300 g of 
NaOH pellets in 500 mL ultra purified water in a 1000 mL volumetric flask with magnetic 
stirring in a fume cupboard. When all the pellets were dissolved and the solution was at 
room temperature, 250 mL of ultra purified water was added to complete the total volume 
of the solution to 750 mL. Then, 500 mL of 10M NaOH solution were poured into another 
volumetric flask and closed with a glass lid and left in a fume cupboard for further use. 
From  the  remaining  250  mL  10M  NaOH,  200  mL  was  diluted  with  200  mL  of  ultra 
purified water to make 400 mL of 5M NaOH, and poured into a new flask with a lid, the Monica Pino                                                                                        Materials and Methods 
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flask was then swirled to mix the solution, and kept in the fume cupboard. The final 50 mL 
of the 10M NaOH were used to make 1M NaOH solution by adding ultra purified water 
until 500 mL was reached, and poured into a new flask, closed with a lid, swirled and kept 
in a fume cupboard for further use. 
3.2.5  SIMULATED BODY FLUID (SBF) 
Simulated  Body  Fluid  (SBF)  with  ion  concentrations  1.5  times  those  of  SBF 
developed  by  Kokubo  et  al.  (1990)  was  prepared  by  dissolving  reagent-grade  NaCl, 
NaOHCO3,  KCl,  K2HPO4·3H2O,  MgCl2·6H2O,  CaCl2·2H2O,  Na2SO4  and 
(CH2OH)3CNH2, as shown in Table 3.2.5, in 750mL of ultra purified water and buffered 
with  1M  HCl  to  pH  7.20  at  37 
oC.  Care  was  taken  to  ensure  that  each  reagent  had 
completely dissolved prior to adding the following reagent as described in Kokubo and 
Takadama (2006). Ultra high purified water was added to bring up the total volume of the 
solution to 1000 mL. The 1.5 SBF solution was poured into a plastic bottle and stored at 4 
oC for 3 days to ensure that no precipitation occurred, indicating that the SBF was in the 
appropriate condition to be used. The ions concentration in human blood plasma and 1.0 
and 1.5 SBF are shown in Table 3.2.6. 
1.5 SBF was used in this study as a treatment to produce Ca/P layer on the surface of 
the  polymers  to  make  them  bioactive,  before  implantation;  not  to  evaluate  bioactivity 
(Tiffany et al., 1989; Renke-Gluszko and Fray, 2004). Thus, the 1.5 SBF solution was part 
of the process to form a HA layer. A supersaturated concentration, rather the normal SBF, 
was used to accelerate the precipitation of HA. Note, however, that this study was not 
intended to develop a material which triggers bone bonding ability, thus, normal SBF was 
not used. Monica Pino                                                                                        Materials and Methods 
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Table 3.2.5 Reagent grade chemicals to prepare 1 litre of 1.5 SBF 
Order  Chemical  Technical information   
1  NaCl  Sodium chloride 
 
Aldrich 99+٪ A.C.S. Reagent, Cat.No.22,351-4, ECC 
No.231-598-3, CAS No. 7647-14-5, Lot. No. TN08028JN 
 
11.994 g 
2  NaHCO3  Sodium hydrogen carbonate 
 
Aldrich 99.7+٪ ACS. Reagent, Cat.No.23,652-7, 
F.W.84.01, Lot. No. 69170 
 
0.525 g 
3  KCl  Potassium chloride 
 
Aldrich 99+٪ ACS. Reagent, Cat.No.20,800-0, CAS No. 
7447-40-7, Lot. No. 74735 
 
0.336 g  
4  K2HPO4·3H2O  Dipotassium hydrogen phosphate 
 
Aldrich 99+٪ (dipotassium hydrogen phosphate), 
Cat.No.22,131-7, F.W.228.23, Lot. No. 69459 
 
0.342 g 
5  MgCl2·6H2O  Magnesium chloride hexahydrate 
 
Aldrich 99+٪ ACS. Reagent, Cat.No.24,696-4, CAS No. 
7791-18-6, Lot. No. 69354 
 
0.458 g 
6  1M HCl  Hydrochloric acid aqueous solution 
 
HCl solution 98.91g 37% HCl (BDH) diluted to 1L in vol. 
 
50mL 
7  CaCl2·2H2O  Calcium chloride dehydrate 
 
Aldrich 98+٪ ACS. Reagent, Cat.No.22,350-6, F.W.147.02 
 
0.552 g  
8  Na2SO4  Sodium sulfate 
 
Aldrich powder 99+٪ ACS. Reagent, Cat.No.23,859-7, 
ECC No.231-820-9, CAS No. 7757-82-6 
 
0.0257 g 
9  (CH2OH )3CNH2  Tris-(hydroxymethyl) amino methane 
 
Aldrich 99+٪ ACS. Reag. Cat.No.25,285-9.CAS No.77861 
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Table 3.2.6 Ion concentration of SBF and human blood plasma (Kokubo et al., 1990; 
Kokubo and Takadama, 2006) 
 
Ion  SBF (mM)  1.5 SBF (mM)  Human Blood Plasma (mM) 
Na
+ 
K
+ 
Mg
+ 
Ca
+ 
Cl
- 
HCO
3- 
HPO
 2
4  
SO
 2
4  
142.00 
5.00 
1.50 
2.50 
147.80 
4.20 
1.00 
0.50 
213.00 
7.50 
2.25 
3.75 
221.70 
6.30 
1.50 
0.75 
142.00 
5.00 
1.50 
0.50 
103.00 
27.00 
1.00 
2.50 
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3.3  METHODS TO PRODUCE THE BIOACTIVE LAYERS 
The coating procedure using Simulated Body Fluid (SBF) is shown in Figure 3.3.1 
along with the characterisation techniques. 
 
Figure 3.3.1 Experimental coating procedures and tests  
Production of films 
HDPE, UHMWPE and PEEK 
 
NaOH pre-treatment 
Films soaked in NaOH for 48 hours 
 
1.5 SBF treatment 
Pre-treated films immersed in 1.5 SBF for up to 30 days at 37 
oC 
 
 
 
Characterization of coatings 
Scanning electron microscopy (SEM) 
Energy Dispersive X-ray spectroscopy (EDX) 
Laser Raman spectroscopy (Raman IR) 
Fourier transform infrared spectroscopy (FTIR) 
Flame Atomic Absorption spectroscopy (AAS) 
Atomic Force Microscopy (AFM) 
Water Contact Angle (CA) 
Reflected light differential contrast (DIC) microscopy  
Thin Film X-Ray Diffraction (TF-XRD) 
Wide Angle X-ray Diffraction (WAXD) 
Scratch test 
 
Renew SBF every 3 days 
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The  procedure  shown  in  Figure  3.3.1  was  applied  in  two  separate  batches  of 
experiments.  Details  of  the  materials  used,  the  treatment  methods  and  the  analysis 
techniques used for each batch are summarised in table 3.3.1. 
 
Table 3.3.1 Experimental procedure and tests for batch I and batch II. 
 
  Batches 
  I  II 
 
Materials  
HDPE 
PEEK  
UHMWPE 
 
PEEK  
UHMWPE 
 
NaOH pre-treatment 
1M 
5M  
10M 
 
5M 
10M 
1.5 SBF treatment  0, 1, 3, 7 and 15-18 days  0, 3, 7, 15 and 30 days 
 
 
Characterisation  
techniques 
SEM 
EDX 
IR 
FTIR 
TF-XRD 
SEM 
EDX 
AAS 
AFM 
CA 
DIC 
WAXD 
Scratch test 
 
3.3.1  PRODUCTION OF HDPE, UHMWPE AND PEEK FILMS  
A  hydraulic  press,  Rondol  Benchtop  Hot  Press  (Rondol  Technology  Ltd.,  Stone, 
UK), was used to produce HDPE and UHMWPE films. Small amounts of granules or 
powder were placed between two polyimide films and two aluminium sheets, which then 
were placed between the platens of the hot press. The polyimide films were used as release Monica Pino                                                                                        Materials and Methods 
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films to avoid contamination of the polymeric films from the aluminium sheets. The plates 
were placed within the platens  preheated at 180 
oC, and left for 3 min for the HDPE 
granules and 10 min for UHMWPE powder to ensure complete melting within the sample 
and the release of air bubbles from the melt. Pressures of 10 kN and 20 kN were applied 
for  3  min  and  10  min  for  HDPE  and  UHMWPE  respectively.  The  platens  still  under 
pressure were then water cooled until a temperature of 80-100 
oC was reached. The cooling 
was stopped, the pressure released and the film removed from the press.  
A  S10316/95  Mackey  Bowley  hydraulic  thermal  press  (Mackey  Bowley 
International Ltd, Norfolk, Kent, UK), was used to produce a second batch of UHMWPE 
films.  25  g  of  UHMWPE  powder  were placed  between two polished  copper plates  of 
dimensions of 255 x 255 x 2 mm, separated by four spacers. The plates were placed within 
the temperature-controlled platens of a hydraulic press; the platens being pre-heated to 140 
oC. A pressure of 10 kN was applied for 10-15 min, the final pressure of 20 kN was applied 
for 25-30 min. After this, the pressure was released and the plates were left in the press to 
cool down cold using water until the platens reached 70 
oC. The plates were removed from 
the press and the film was taken from the plates. 
The thicknesses of the first batch of HDPE, UHMWPE and PEEK films were 0.06, 
0.26 and 0.09 mm, respectively. These were cut to discs 6 mm in diameter using a punch. 
They were soaked in ethanol for 10 min, washed with ultra high purified water and dried 
overnight at room temperature. The water had been purified up to 18ΩM using USF ELGA 
DI water de-ionising equipment. 
The thickness of second batch of UHMWPE and PEEK film were 0.26 mm and 0.09 
mm, respectively. PEEK and UHMWPE films were then cut to 20 x 50 mm stripes and 
cleaned with a damp ethanol cloth and then soaked in 0.1vol% benzalkonium chloride 
solution for 30 min, then rinsed with ultra pure water and dried overnight at 37 
oC. Monica Pino                                                                                        Materials and Methods 
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3.3.2  NAOH PRE-TREATEMENTS  
The HDPE, UHMWPE and PEEK dried samples from the first batch were immersed 
in 1M, 5M or 10M NaOH solutions for 48 hours at 37 
oC. First, 100 mL polyethylene 
bottles and their lids were washed with ethanol, rinsed with ultra high purified water and 
dried at 37 
oC overnight. Secondly, each bottle with its lid was labelled and 10 samples of 
HDPE, UHMWPE and PEEK film were put in the respective bottle in a fume cupboard,  
and approximately 100 mL of 1M NaOH, 5M NaOH or 10M NaOH were poured into each 
bottle. The bottles were closed and shaken manually to assure the samples did not stick to 
each other. Finally, the bottles were left in an oven at 37 
oC for 48 hours. Manual agitation 
was done every 6-8 hours. After 48 hours, all samples were carefully taken out and rinsed 
with ultra high purified water and placed in labelled Petri dishes previously washed with 
ethanol and rinsed with ultra high purified water. The Petri dishes were left overnight 
without a cover to allow the samples to dry at room temperature. After the samples were 
dried,  2  samples  from  each  Petri  dish  were  taken  out  and  placed  in  new  Petri  dishes 
labelled  according  to  the  NaOH  concentration  and  polymer  film  for  further 
characterization analysis. The remaining samples were subjected to 1.5 SBF treatments. 
The UHMWPE and PEEK dried samples from the second batch were soaked in 5M 
or  10M  NaOH  solutions  for  48  hours  at  37 
oC.  132  Sterilin  tubes  30  mL  universal 
container with leak free cap (Sterilin Ltd., London, UK) were used to incubate the samples 
for the NaOH pre-treatment. Firstly, 120 rectangular samples and 30 circular samples of 
UHMWPE  and  PEEK  were  placed  in  the  Sterilin  tubes  and  in  a  fume  cupboard, 
approximately 25 mL of 5M NaOH or 10M NaOH were poured into each Sterilin tube. 
Then, all the Sterilin tubes were left in the oven at 37 
oC for 48 hours. Manual agitation 
was done twice daily. After 48 hours the samples were removed and rinsed with ultra high 
purified water. The samples were replaced in the Sterilin tubes previously washed with 
ethanol and rinsed with ultra high purified water. The Sterilin tubes were left in the oven at 
37 
oC overnight without a cap to dry the pre-treated samples.  Monica Pino                                                                                        Materials and Methods 
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3.3.3  1.5 SBF TREATMENT  
The first batch of NaOH pre-treated samples (HDPE, UHMWPE and PEEK) along 
with a set of samples not subjected to the NaOH pre-treatment were soaked in 1.5 SBF and 
incubated at 37 
oC for 1, 3, 7, 15 or 18 days. Approximately 225 mL of 1.5 SBF were taken 
from the bottle kept in the fridge, and were heated at 37 
oC. Approximately 25 mL of the 
1.5 SBF at 37 
oC was poured into each Petri dish which contained the samples. The Petri 
dishes were closed with their covers and incubated in the oven at 37 
oC. The Petri dishes 
were agitated twice daily and the SBF was replaced every 3 days to maintain the SBF 
concentration. 
On days 1, 3, 7, 15 and 18 of the 1.5 SBF treatments, 1 or 2 samples were taken out 
from the 1.5 SBF solutions in the Petri dishes and rinsed with ultra high purified water. 
The samples were allowed to dry in Petri dishes previously washed with ethanol, rinsed 
with  ultra  high  purified  water  and  dried  at  37 
oC  overnight,  and  used  for  further 
characterisation. 
The second batch of NaOH pre-treated samples (UHMWPE and PEEK) were soaked 
in 1.5 SBF and incubated at 37 
oC for 3, 7, 15 or 30 days. 3000 mL of 1.5 SBF solution 
kept in the fridge was poured into a 3000mL conical flask and heated at 37 
oC on a hot 
place. Approximately 25 mL of the 1.5 SBF at 37 
oC was poured into each Sterilin tube 
which contained samples  pre-treated  with  5M  or  10M  NaOH.  The  Sterilin  tubes  were 
closed and incubated in the oven at 37 
oC. The Sterilin tubes were agitated twice daily and 
the SBF was replaced every 3 days.  
On days 3, 7, 15 and 30 after the 1.5 SBF treatment, 6-8 rectangular samples of 
UHMWPE and PEEK and 25-30 circular samples of PEEK were removed from the 1.5 
SBF solutions in the Sterilin tubes and rinsed with ultra high purified water and placed into 
the Sterilin tubes previously washed with ethanol and rinsed with ultra high purified water. 
These Sterilin tubes were left overnight in the oven at 37 
oC to dry the samples. When the 
samples were dry, all Sterilin tubes were closed until further characterisation. Monica Pino                                                                                        Materials and Methods 
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3.4  CHARACTERSIATION TECHNIQUES 
3.4.1  SCANNING ELECTRON MICROSCOPY (SEM) AND ENERGY 
DISPERSIVE X-RAY SPECTROSCOPY (EDX). 
Scanning electron microscopy (SEM) is a technique that uses an electron beam to 
form magnified images of specimens. The electron beam is scanned across the surface of 
the sample and when the electrons strike the sample, a variety of signals are generated 
(Danilatos, 1988). The detection of specific signals produces an image or an elemental 
composition of the sample. The signals can be secondary electrons, backscattered electrons 
and/or  X-rays.  The  secondary  electrons  are  a)  emitted  from  the  atoms  occupying  the 
surface  and  produce  an  image  of  the  surface,  b)  the  result  of  primary  beam  electrons 
interacting  with  weakly  bonded  electrons  within  the  specimen,  and  c)  one  of  the  two 
particles  emitted  from  the  specimen,  the  other  one  being  backscattered  electrons. 
Backscattered electrons are primary beam electrons reflected from the atoms in the sample; 
the interaction of primary beam with atoms causes shell transitions, which results in the 
emission of an X-ray (Danilatos, 1988). The detection and measurement of the energy by a 
X-ray detector gives the elemental composition of the sample, known as Energy Dispersive 
X-ray spectroscopy (EDX). 
The samples must be conductive otherwise an electron charge will build up. Non-
conductive specimens are coated with carbon or gold (Suzuki, 2002). Carbon is usually 
used for X-ray analysis and gold for high resolution imaging (Danilatos, 1988). 
The morphology of the samples was studied using a JEOL JSM 6300 field emission 
scanning electron microscope (SEM) at an accelerating voltage of 5keV and a working 
distance of 15 mm. The samples were secured onto specimen holders by conductive carbon 
cement and coated with a thin layer of carbon. Fifteen specimens (1, 5 and 10M NaOH and 
times 0, 1, 3, 7 and 15 day SBF incubation) for each polymer film (PEEK, HDPE and 
UHMWPE) were measured at 5 specific areas, taking 3 points randomly on each area to 
allow the calculation of means and standard deviations. The main elemental composition 
of the layers was determined using energy dispersive X-ray spectroscopy (EDX), the Ca/P 
molar ratio was then calculated and averaged.  Monica Pino                                                                                        Materials and Methods 
 
 
  97 
Secondly, the thickness of the apatite layer was also obtained using the shadowing 
technique  under  EDX.  A  strip  cut  from  each  polymer  samples  (PEEK,  HDPE  and 
UHMWPE) treated with 1.5 SBF for 18 days was place transversally on the carbon base 
holders, and then coated with a layer of carbon. The shadowing technique was applied 
since the surface of the coating was uneven, and from the image produced it was possible 
to measure the minimum and maximum thickness of the coating. Basically this technique 
is an exaggeration of the specimen dimensions by accumulation of shown materials, which 
in this case, was mainly Ca
2+, PO
 3
4  and OH
- (Suzuki, 2002).  
Finally, the dispersion and area covered of the deposited layers were assessed from 
the micrographs and image analysis performed. 
A similar procedure was also used for batch II with non-treated specimens and PEEK 
and UHMWPE samples pre-treated with 5M or 10M NaOH for 48 hours, carefully rinsed 
off with high purified water and then immersed in 1.5 SBF treatments for up to 30 days to 
study the morphology of the deposited layers on the films and to determine its elemental 
composition,  mainly  calcium (Ca) and phosphorous (P)  deposited on the layers of the 
films.  The  SEM  and  EDX  scans  were  taken  after  3,  7,  15  and  30  days  of  1.5  SBF 
treatment. Each specimen was tested in triplicate for the SEM and EDX experiments. The 
samples used for the SEM were coated with gold rather than with carbon used for the first 
series since the carbon coating was no longer available. Therefore, the samples used for 
EDX were not coated considering that golden and phosphorous peaks overlap. The SEM 
employed was a Hitachi S-4700 with acceleration voltages of 5 –10 kV and equipped with 
a field emission gun and an EDX spectrometer. The calcium (Ca), phosphorus (P) amounts 
were obtained from the EDX experiments and the Ca/P molar ratio was calculated.  
Therefore, the aim of the SEM was to study the morphology and to assess the growth 
and dispersion of the apatite deposited on the surface of the films non pre-treated with 
NaOH and immersed in 1.5 SBF, and pre-treated with NaOH followed by 1.5 SBF. The 
aim  of  EDX  was  to  determine  the  presence  of  calcium  (Ca)  and  phosphorous  (P) 
quantitatively from the apatite deposition of the layers and then to calculated the Ca/P 
molar ratio. Monica Pino                                                                                        Materials and Methods 
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3.4.2  LASER RAMAN SPECTROSCOPY  
Raman spectroscopy is a technique used to study vibrational, rotational, and other 
low-frequency modes in a system. Therefore, molecules in compounds can be identified 
since vibrational information is specific for the chemical bonds within the molecules. The 
scattering  process  may  occur  either  elastically  (Rayleigh  scattering),  or  inelastically 
(Raman scattering). Thus, Raman spectroscopy measures the wavelength and intensity of 
inelastically scattered light from molecules (Gardiner, 1989). The laser light interacts with 
phonons, which are macroscopic vibrational modes, or other excitations on the system, 
making the photons shift up or down. This shift in energy from the molecular vibrations 
gives information about the phonon modes in the system. Consequently, the Raman shift 
corresponds  to  the  energy  difference  between  the  incident  light  and  scattered  photon 
(Gardiner, 1989). The mechanism of Raman scattering is different from that of infrared 
absorption, and Raman and IR spectra provide complementary information (Matousek and 
Parker, 2006). 
Generally,  a  sample  is  illuminated  with  a  laser  beam.  Light  reflected  from  the 
illuminated spot is collected using a lens and sent to a monochromator (Gardiner, 1989). 
Wavelengths close to the laser line, due to the Rayleigh scattering, are filtered out while 
the rest of the collected light is dispersed onto a CCD (charge-coupled device) detector. A 
graph  of  number  of  photons  detected  (Raman  intensity)  versus  Raman  shift  from  the 
incident laser energy gives the Raman spectrum (Matousek and Parker, 2006). 
In  these  studies,  the  vibrations,  C=C  and  CH2,  and  the  ionic  groups,  CO
 2
3  
(carbonate) and PO
 3
4  (phosphate), from the treated HDPE, UHMWPE and PEEK films 
were detected using  a  Nicolet Amelga Raman spectrometer  (Thermo  Fisher  Scientific, 
Madison Wisconsin, USA). The microscope has a CCD Detector of Andor DV420 Open 
Electrode. The Raman spectra were stimulated by laser light at 785 nm wavelength. The 
spectra were obtained in the ranges of 1800 to 400 cm
-1 and 4000 to 400 cm
-1, averaging 
256 scans at 2.0 s exposure time and 4 cm
-1 resolution.  Monica Pino                                                                                        Materials and Methods 
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3.4.3  FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
Fourier Transform Infrared spectroscopy (FTIR) is an absorption technique used to 
identify chemical bonds and molecular structure of compounds. The FTIR is based on the 
interferometer designed by Michelson and a mathematical procedure developed by Fourier 
that converts response from the time to the frequency domain (Crompton, 2008). 
Infrared (IR) radiation is electromagnetic radiation in the wavelengths between the 
visible and microwave regions of the electromagnetic spectrum. The  IR region can be 
divided into 3 smaller regions: near-IR (14000-4000 cm
-1), mid-IR (4000-400 cm
-1) and 
far-IR (400-20 cm
-1). Changes in fundamental vibrational levels of most molecules occur 
in the mid-IR. Therefore, the spectra in these studies were obtained in the mid-IR region.  
Infrared energy is emitted from a source, this beam passes through an aperture which 
controls the amount of energy presented to the samples (and, ultimately, to the detector). 
The  beam  enters  the  interferometer  where  the  encoding  takes  place.  The  resulting 
interferogram signal then exits the interferometer. The beam passes through the sample. 
Some of the infrared radiation is absorbed by the sample and some of it passes through 
(transmitted). The absorbed frequencies of energy are characteristic of the sample since the 
frequency of vibration is determined mainly by the masses of the atoms and the strength of 
the  bond  between  them,  which  is  only  slightly  altered  by  other  atoms  in  the  vicinity 
(George and McIntyre, 1987). The IR beam finally passes to the detector to measure the 
interferogram signal. The measured signal is digitalized and sent to the computer where the 
Fourier transformation takes place. Thus, the resulting spectrum represents the molecular 
absorption  and  transmission,  creating  a  molecular  “fingerprint”  of  the  sample.  The 
absorption peaks represent the frequencies of vibrations between the bonds of the atoms of 
the  materials  (Crompton,  2008).  In  addition,  the  heights  of  the  peaks  in  the  spectrum 
indicate the relative amount of the materials present.  
The ionic groups, CO
 2
3  (carbonate), PO
 3
4  (phosphate), and OH
- (hydroxyl) from the 
treated  HDPE,  UHMWPE  and  PEEK  films  were  detected  using  a  Nicolet  8700  FTIR 
spectrophotometer (Thermo Electron Corporation, UK). The spectra were obtained in the 
range between 4000 and 500 cm
-1, averaging 128 scans at 4 cm
-1 resolution.  Monica Pino                                                                                        Materials and Methods 
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3.4.4  ATOMIC ABSORPTION SPECTROSCOPY (AAS) 
Atomic absorption spectroscopy (AAS) is an analytical technique used to determine 
the concentration of a particular element in a specimen, usually metals, such as calcium 
(Ca). This technique can analyse the concentration of the particular element in a solution. 
The principle is based on detecting elements by means of atomic absorption since metals 
absorb light at specific wavelengths (Zybin et al., 2005; Skoog et al., 2007). Thus, the 
metal  ions  in  a  solution  can  be  converted  into  atomic  state  using  a  flame.  The  light 
absorbed is measured against a standard curve of the specific metal (L‟vov, 2005). 
The solution is usually turned into a gas in the form of an atomic gas. Firstly, the 
solution  is  evaporated  using  a  flame,  which  can  be  quantified  as  an  input  and  as  a 
remainder at the other side of the detector; this first step is known as a desolvation (drying 
or evaporation of the liquid solvent). Secondly, the solid specimen vaporises into a gas, so 
it is a vaporization step, known as ashing. Thirdly, the compounds present in the specimen 
are broken into free atoms, known as an atomisation process (L‟vov, 1997; Axner, 2000). 
Therefore, the amount of energy, the power, put into the flame is known, and the 
amount of energy remaining at the other side of the detector can then be measured; then, it 
is possible to calculate how many of these transitions occurred, and the signal obtained is 
proportional  to  the  concentration  of  the  particular  element  that  has  been  measured 
(Sperling and Welz, 1999; Skoog et al., 2007). 
In  fact,  the  atomic  absorption  technique  (AAS)  that  uses  a  flame  is  not  always 
referred as AAS, despite being one of the methods of the atomic absorption spectroscopy. 
It is called flame atomic absorption spectroscopy (FAAS), but to make it less complicated, 
AAS is used in this thesis to refer to the flame absorption technique. This flame AAS uses 
a solution which contains the element that needs to be quantified, so the solution is sucked 
into an „L‟ shape tube, and then aerosolised, and finally it is mixed with combustible gas, 
acetylene  (C2H2)  and  nitrous  oxide  (N2O).  The  mixture  is  then  ignited  in  a  flame 
(Broekaert, 1998). The temperature of the flame can range from 2000 
oC up to 3000 
oC. Monica Pino                                                                                        Materials and Methods 
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The atoms are reduced to the free state, meaning that the atoms are no longer excited 
as in their normal state. This process occurs during the combustion. Thus, the unexcited 
atoms absorb light at characteristic wavelengths (Broekaert, 1998; Axner, 2000). 
To study the release of calcium from the specimens, after being pre-treated with 5M 
or 10M NaOH and immersed in SBF treatment for 30 days, the PEEK and UHMWPE 
specimens were immersed in plastic tubes with 25 mL of ultra purified water at 37 
oC for 3 
and  7  days.  Total  Ca  on  the  samples  was  determined  by  immersing  a  separate  set  of 
samples  in  0.6M  HCl  for  24  hours.  The  calcium  concentration  (Ca)  in  homogenised 
aliquots of the water solution after 3 and 7 days, and the 0.6M HCl solution were measured 
using  flame  atomic  absorption  spectrometry  with  a  nitrous  oxide  (N2O)  and  acetylene 
(C2H2) flame on a Thermo Fischer iCE 3000 Series spectrometer. Calibration standards 
were  gravimetrically  diluted  from  Merck  CertiPur  1000  mg/l  Aluminium  Standard 
Solution. Measurement results represent the mean of three repeats. Combined calibration 
and measurement uncertainties are less than 1%. 
Thermo  Fischer  iCE  3000  Series  Atomic  Absorption  Spectrophotometer  used  in 
these studies functioned by:  
1) The solution extracted from the tubes which contains the polymeric samples was 
aspired through a flame in order to convert the calcium to its atomic form,  
2) Light from a hollow cathode lamp, which contains calcium, was passed across the 
flame and the atoms absorbed the light (atomic absorption) and went to an excited state, 
3) The reduction of the intensity of the light beam during the atomic absorption were 
measured, and is directly proportional to the concentration of the calcium atomic species,  
4)  Finally  the  light  absorbance  of  the  calcium  obtained  from  the  samples  were 
compared the light absorbance of the calcium standards calibration. 
The  aim  of  the  AAS  tests  was  to  calculated  the  initial  amount  of  calcium  (Ca) 
deposited on the surface of the specimens, after being pre-treated with NaOH and treated 
with 1.5 SBF for 30 days, and then to study the release of Ca in water for 1 week. Monica Pino                                                                                        Materials and Methods 
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3.4.5  ATOMIC FORCE MICROSCOPY (AFM) 
Atomic force microscopy (AFM) is a method that measures the surface topography 
of a substrate on a scale from 0.1 to 100 microns. This technique involves scanning a 
sample by using a probe, or tip, with a radius of 20 nm. The sharp tip is automatically 
scanned over the sample surface with a feedback mechanism that measures surface-tip 
interactions  on  the  scale  of  nanoNewtons  force.  The  feedback  mechanism  enables  the 
piezo-electric  scanners  to  maintain  the  tip  at  a  constant  force  (to  obtain  height 
information), or height (to obtain force information), producing a topographic image of the 
surface (Roiter and Minko, 2005). Tips are typically made from Si3N4 or Si, and extend 
down from the end of a cantilever. The AFM head uses an optical detection system in 
which the tip is attached to the cantilever. A diode laser is focused onto the back of a 
cantilever.  As  the  tip  scans  the  surface  of  the  sample,  moving  up  and  down  with  the 
contour of the surface, the laser beam is deflected off the attached cantilever into a dual 
element photodiode. The photodetector measures the difference in light intensities between 
the upper and the lower photodetectors, and then converts this to a voltage. Feedback from 
the photodiode difference signal, through software control from the computer, enables the 
tip to maintain either a constant force or constant height above the sample. In the constant 
force  mode  the  piezo-  electric  transducer  monitors  real  time  height  deviation.  In  the 
constant height mode the deflection force on the samples is recorded (Wilson et al., 2006).  
The force between the tip and the sample surface is very small, usually less than 10
-9 
N; typical forces between tip and sample range from 10
-11 to 10
-6 N. For covalently bonded 
atoms the force is of the order of 10
-9 N at separation of approximately 0.01 nm. Typical 
spring  constants  are  between  0.001  to  100  Nm
-1,  and  motions  from  microns  to 
approximately  0.01  nm  are  measured  by  the  deflection  sensor  (Meyer  et  al.,  1992). 
Typically, the deflection is measured using a laser spot reflected from the top surface of the 
cantilever into an array of photodiodes (Martin et al., 1987). Thus, non-destructive imaging 
is possible with these small forces (Meyer et al., 1988; Meyer and Amer, 1988). 
A variety of forces can be sensed by atomic force microscopy. Moreover, the AFM is 
also capable of producing imagines in other modes rather than the basic one described in 
the previous paragraph, thus the AFM can be operated in a number of modes, depending 
on the application (Wilson et al., 2006). According to the interaction of the tip and the Monica Pino                                                                                        Materials and Methods 
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sample surface, the AFM can be classified as Contact Mode (repulsive mode), Non-contact 
Mode (attractive mode) and Tapping Mode (Martin et al., 1987). 
In the contact (repulsive) mode, the instrument lightly touches the tip at the end of a 
leaf sprint (or cantilever) to the sample. Thus, the force on the tip is repulsive with a mean 
value of 10
-9 N. This force is produced by pushing the cantilever against the sample surface 
with the piezo-electric positioning element. The deflection of the cantilever is sensed and 
compared in a direct current (DC) feedback amplifier to some desired value of deflection. 
If the measured deflection is different from the desired value of the feedback the amplifier 
applies voltage to the piezoelectric element to raise or lower the sample relative to the 
cantilever to restore the desired value of deflection. The voltage that the feedback amplifier 
applies to the piezo is a measure of the height of features on the sample surface. It is 
displayed as the lateral position of the sample (Hong-Qiang, 1997). As a raster-scan drags 
the tip over the sample, the detection apparatus measures the vertical deflection of the 
cantilever,  which  indicates  the  local  sample  height.  Thus,  in  contact  mode  the  AFM 
measures the hard-shape repulsion forces between the tip and the sample (Dagani, 2007). 
In  the  non-contact  (attractive)  mode,  the  AFM  derives  topographic  images  from 
measures  of  attractive  forces;  the  tip  does  not  touch  the  sample  (Baselt,  1993).  The 
distances between the tip and the sample surface are greater than 1nm between the tip and 
the  sample  surface;  hence  van  der  Waals,  electrostatic,  magnetic  or  capillary  forces 
produce images of topography, whereas in the contact mode, ionic repulsion forces take 
the leading role (Meyer, 1992).  
In the tapping mode, the tip is placed in contact with the surface to provide high 
resolution and then by lifting the tip off the surface to avoid dragging the tip across the 
surface (Hong-Qiang, 1997). Therefore, the tip oscillates above the sample surface, and 
data may be collected from interactions with surface topography, stiffness, and adhesion 
(Baselt,  1993).  Thus,  it  results  in  an  expanded  number  of  image  contrast  methods 
compared to the basic AFM.  
Other less commonly used modes include magnetic force, electrical force, and pulsed 
force.  In  the  magnetic  force  mode,  a  magnetic  tip  is  used  to  make  visualizations  of 
magnetic domains on the sample. In the electrical force mode, a charged tip locates and Monica Pino                                                                                        Materials and Methods 
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records  variations  in  surface  charge.  In  the  pulsed  force  mode,  the  sample  oscillates 
underneath the tip, and several pseudo force-distance curves are generated. This allows the 
separation of sample topography, stiffness and adhesion values, producing three different 
images (Dagani, 2007; Roiter and Minko, 2005). 
The AFM provides a three-dimensional surface profile, and the samples viewed by 
AFM do not required any special coating. However, the AFM can only display images of a 
maximum height in the order of micrometres and a maximum scanning area of 150 nm × 
150 nm (Giessibl, 2003). 
In these studies, surface topography/roughness of the non-treated PEEK (bright and 
matt sides) and UHMWPE films and 5M or 10M NaOH pre-treated PEEK (bright and matt 
sides) and UHMWPE specimens was assessed using Atomic Force Microscopy (AFM, 
MultiMode IV, Veeco). 5 × 5 µm, 25 × 25 µm and 45 × 45 µm-sized images were recorded 
using contact mode (scan rate of 1 Hz). The roughness parameter Ra – arithmetical mean 
deviation (ISO/DIN 25178-2) – was evaluated in two different ways:  
1)  five  random  lines  were  placed  across  the  whole  scanned  surface  giving  line 
profiles, with Ra calculated directly for those lines and averaged, and  
2) NanoScope software (Veeco) was used to calculate Ra from the whole recorded 
image.  
Therefore, the aim of the AFM experiments was to evaluate the influence of the 
NaOH  pre-treatments  on  the  surface  of  the  films  and  to  observe  any  changes  in  their 
topography after the NaOH pre-treatments.  
3.4.6  WATER CONTACT ANGLE (CA) 
The contact angle (CA) is a quantitative measure of the wettability of a solid by a 
liquid. The contact angle is the angle formed by the solid surface and the tangent line to the 
upper surface at the end point. Thus, the contact angle is determined by drawing a tangent 
at the contact where the liquid and the solid intersect. For instance, if the liquid used is Monica Pino                                                                                        Materials and Methods 
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water, the solid is defined as hydrophilic or hydrophobic. The solid is hydrophilic when it 
has a high affinity for water, so the droplet (water drop) spreads on the surface of the solid 
and the contact angle is between 0
o and 30
o. The solid is considered hydrophobic when the 
water is not spread and instead forms a spherical cap at equilibrium on the surface of the 
solid and the contact angle is larger than 90
o (Kowk and Neumann, 1999; Israelachvili, 
2004).  
Also it is possible to analysis the drop shape in order to determine the surface energy. 
The surface energy refers to the interaction between the cohesion and adhesion forces, so 
the surface energy can be measured. A hydrophobic solid, which presents a large contact 
angle,  has  poor  wettability  and  poor  adhesiveness,  and  hence  it  has  low  surface  free 
energy. A hydrophilic solid, where the contact angle is small, has better wettability, better 
adhesiveness, and higher surface energy (De-Gennes, 1985: Tadmor, 2004;).  
The physical properties between the solid and the liquid such as wettability, affinity, 
adhesiveness and repellency can be determined by means of the contact angles (Tadmor, 
2004; Israelachvili, 2004).  
To  assess  the  wettability  of  PEEK  and  UHMWPE  films,  both  before  and  after 
surface  modifications  with  5  or  10M  NaOH,  water  contact  angle  measurements  were 
performed, following the sessile drop method using a KSV Cam100 Contact Angle System 
(Lot-Oriel, UK). Prior to each measurement, the samples were rinsed with ultra pure water 
and dried with compressed air. Approximately 5 l of ultra pure water was placed on the 
specimen surfaces using a manual syringe. The drop shape was recorded for 30 sec with 
0.5 sec intervals. The measurements were carried out in triplicate on samples which were 
not incubated in SBF. The main interest was to look at the wettability and determine if the 
5M and 10M NaOH pre-treatments had modified the surface of the films, either increasing 
or decreasing wettability, which will have an effect on the subsequent 1.5 SBF treatments. 
Therefore, the aim of the CA was to assess the wettability of the materials, before 
and after surface modifications with 5M or 10M NaOH. Monica Pino                                                                                        Materials and Methods 
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3.4.7  REFLECTED LIGHT DIFFERENTIAL CONTRAST MICROSCOPY (DIC) 
Reflected light differential contrast (DIC) microscopy is used to examine opaque 
specimens, which are not highly reflective and do not absorb or transmit any significant 
light  (the incident  light).  The uneven surfaces  on the specimen  can  make optical  path 
differences, which can be converted by reflected light DIC microscopy into amplitude or 
intensity changes creating a topographical profile. This profile is a 3D image of the surface 
geometry, which gives distinctive raised and lowered areas on the surface of the specimen 
(van Munster et al., 1998; Ishiwata et al., 2005).  
In the DIC microscope, light is reflected from the specimen, separated by fraction of 
a  micrometer  (the  shear  distance).  Thus  their  resulting  image  consists  of  these  two 
superimposed components,  because their separation is  too  small to  be resolved by the 
microscope. However, each point (e.g. pixel) in the image originates from two closely 
spaced and overlapping Airy disks originating from adjacent points on the specimen, and 
each  disk  has  an  intensity  that  corresponds  to  its  respective  optical  path  difference 
produced by the specimen. Therefore, image contrast is known as the differential since it is 
a function of the optical path gradient across the specimen surface, with steeper gradients 
producing greater contrast (Ishiwata et al., 2005). 
The method to establish the reflected light DIC is to use a Nomarski prism, which is 
attached  to  a  mobile  carriage  within  a  rectangular  frame  (slider)  that  fits  into  the 
microscope nosepiece base, above the revolting objective turret (Nomarski, 1955; Francon, 
1961).  Thus,  the  Nomarski  prism  is  translated  back  and  forth  laterally  across  the 
microscope  optical  axis.  The  formation  of  the  final  image  in  difference  contrast 
microscopy is the results of interference between two different wavefronts that reach the 
image plane slightly out of phase with each other, giving an algebraic summation of the 
intensities to the image plane (van Munster et al., 1998). 
A Nikon reflected light DIC microscope with Nomarski prism was used to measure 
the area of the apatite deposited on the 5M or 10M NaOH pre-treated PEEK (bright and 
matt) and UHMWPE films treated with 1.5 SBF treatments on 3, 7, 15 and 30 days. The 
test was conducted in duplicate, so two identical samples of each sample were measured 
under the DIC microscope. The images were recorded in black and white. Monica Pino                                                                                        Materials and Methods 
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3.4.8  THIN FILM X-RAY DIFFRACTION (TF-XRD) AND WIDE ANGLE X-RAY 
DIFFRACTION (WAXD) 
Thin  film  X-ray  diffraction  (TF-XRD)  is  an  analytical  technique  which  reveals 
information about the crystal structure and preferred orientation of coatings anchored on 
thin films. X-rays are electromagnetic radiation with wavelengths between 0.01 nm and 10 
nm, similar to the interatomic distances in a crystal. Therefore, crystal structures diffract 
X-rays.  Thus,  the  structural  arrangement  of  atoms  and  molecules  in  materials  can  be 
probed since the wavelength of X-rays is comparable to the size of atoms (Warren, 1990; 
Drenth, 1994; Als-Nielsen and McMorrow, 2001). 
Basically, X-rays interact with the electrons in atoms. When X-ray photons collide 
with electrons, some photons from the incident beam will be deflected away from their 
original  direction  of  travel.  In  the  elastic  scattering  process  (Thomson  Scattering)  the 
wavelengths of these scattered X-rays do not change, that is, the X-ray photons do not lose 
any energy and only momentum is transferred in the scattering process. Thus, the X-rays 
measured in diffraction are the elastically scattered X-rays, which carry information about 
the electron distribution in materials. On the other hand, during the inelastic scattering 
process (Compton Scattering), X-rays transfer some of their energy to the electrons and the 
scattered X-rays will have different wavelengths to the incident X-rays (Brumberger, 1993; 
Drenth, 1994; Als-Nielsen and McMorrow, 2001). 
The diffraction pattern allows the distribution of atoms in materials to be deduced 
since  the  diffracted  waves  consist  of  sharp  peaks  with  the  same  symmetry  as  the 
distribution of atoms. Thus, the peaks in an X-ray diffraction pattern are directly related to 
the interatomic distances (Brumberger, 1993; Drenth, 1994). 
Thin film diffraction refers to a collection of XRD technique used to characterise thin 
films sample grown on substrates. Thin film diffraction methods such as hard X-rays (short 
wavelength X-ray i.e. 1 keV – 120 keV) can penetrate through the outer layers of the 
sample and measure the properties of both the  film  and the substrate  (Warren, 1990). 
However, a major interest is to identify the coating, therefore, the scattering angle should 
be as low as possible not to penetrate the film or substrate. It is common to use 1
o to 5
o, 
depending on the XRD equipment (Als-Nielsen and McMorrow, 2001). Monica Pino                                                                                        Materials and Methods 
 
 
  108 
The crystalline phase composition of these samples was examined using a Siemens 
D5000  diffractometer  in  detector  scan  mode  with  a  thin  film  analyser.  Samples  were 
aligned at 3
o to the incident beam. A step size of 0.02
o (2θ) and a scan time of 5 seconds 
were used. Data was collected from 20
o to 40
o on the surfaces of the HDPE, UHMWPE 
and PEEK specimens pre-treated with 1, 5 or 10M NaOH and treated in 1.5 SBF for 15 
days. 
For the second batch of specimens, PEEK and UHMWPE pre-treated with 5 or 10M 
NaOH and immersed in 1.5 SBF for 15 and 30 days, a Standard transmission wide-angle 
X-ray diffraction (WAXD) was carried out at room temperature using a Philips X‟Pert Pro 
-  PAN analytical  instrument using  Nickel  Filter  CuKα-radiation (λ=  0.15418  nm). The 
voltage power was 40 kV and emission current was 40 mA. The scan range was selected to 
be in between 3o and 40o with a step size of 0.0084o and counting time of 20.480 sec per 
step. All specimens were tested in triplicate. 
Therefore, the aim of the TF-XRD and WAXD tests was to examine the crystalline 
phase composition of the apatite deposited on the polymer films during the immersion time 
in the 1.5 SBF treatment after and before of being pre-treated with NaOH. 
3.4.9  SCRATCH TEST 
The Scratch test is a method of assessing the adhesion of the coatings. The adhesion 
of the coating to the polymer film is a property that can be determined as the interfacial 
forces between the two surfaces (the coating and the substrate). This technique generally 
uses a scratch with a sharp tip on a selected area of the coating. The material of the tip is 
commonly either diamond or a hard metal. The tip is drawn linearly across the coated 
surface under constant, increasing or progressive load until the coating starts to fail at a 
certain critical load. The critical loads can be detected precisely using an acoustic sensor 
attached  to  the  load  arm  and  some  have  a  built-in  optical  microscope  to  collect 
observations. The adhesive properties can then be quantified using the critical load data. 
Scratch testers can also measure the applied force, the friction force (the tangential force) 
and the penetration depth. These parameters and the acoustic emission results provide the 
adhesion properties of the coatings (Long et al., 2002; Liu et al., 2003; Liu et al, 2005). Monica Pino                                                                                        Materials and Methods 
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In the basic scratch tests the diamond tip is moved by the scratch tester (a pen shaped 
device) within a radius of 50 to 200 µm across the coated surface of the polymeric film at a 
constant speed while an increasing normal force is applied at constant loading rate (Liu et 
al.,  2005).  Therefore,  the  scratch  test  introduces  stresses  to  the  interface  between  the 
coating and the substrate, which results in a delaminating or chipping (cohesive failure) of 
the coating. The normal force at which the first failure of the coating is detected is known 
as the critical load (Liu et al., 2003).  
The failure in the scratch tester can be divided into three categories according to the 
failure  type:  1)  Cracking,  2)  Chipping  (cohesive  failure),  and  3)  elimination  (adhesive 
failure). A load cell is used to measure the change in friction or acoustic emission. Thus, 
the intensity of the acoustic emission is dependant on the type of coating failure during the 
adhesion test. Therefore, it is important to determine the coating failure after the scratch 
test using an optical microscope (Long et al., 2002; Liu et al., 2003; Liu et al, 2005). 
The scratch test was performed by Dr. T. Liskiewicz in the Chemistry Department of 
Leeds  University  using  a  nanoindenter  with  a  maximum  depth  of  1500  nm.  Also,  the 
hardness  and  the  elastic  modulus  by  nano-indentation  were  measured.  Scratches  were 
produced in duplicate for each coating by linearly increasing the load on a 50 µm-radius 
spherical diamond stylus with a scanning speed of 20 µm s
-1 and at loading rates of 0.49, 
1.60 or 7.3 N mm
-1 to reach final loads of 0.9, 3.0 or 1.8 N, respectively. 
The samples analysed by the above procedure were PEEK bright side, PEEK matt 
side and UHMWPE pre-treated with 5M or 10M NaOH and treated with 1.5 SBF for 30 
days. 
Therefore, the aim of the scratch test was to assess to adhesion of the apatite layers 
on the polymer substrate in order to deduce their mechanical stability. Monica Pino                                                                                        Materials and Methods 
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3.4.10  STATISTICAL ANALYSIS 
All experimental results presented in the following chapter of this thesis have been 
derived from at least three repetitions per test, and in some cases of up to 15, in order to 
estimate a representative value. Thus, all results are given as the mean of the measurements 
taken,  together  with  the  respective  standard  deviations.  No  additional  formal  pre-
processing, such as removal of outliers, was performed.  
While the mean represents an estimate of the expected value of the measurement, the 
standard  deviation  is  the  square  root  of  an  unbiased  estimator  of  the  variance  of  the 
population from which the measurements are drawn, assuming that the measurements are 
taken from independent, identically distributed samples. 
Thus, the standard deviation provides a measure of confidence of the estimate of the 
expected value. It tends to be smaller as the number of measurements increases, which 
reflect the greater confidence of the mean values as more measurements were taken (i.e. 15 
measurements were taken by each sample in the EDX; and 3 measurements were taken per 
specimen in the AAS).  
For two groups of measurements (e.g. treated and non-treated) with different mean 
values, a small standard deviation indicates a greater confidence that the difference in the 
results is statistically representative. 
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CHAPTER 4 
RESULTS 
4.1  INTRODUCTION 
The skirt of an artificial cornea must integrate the implant to the host sclera to 
prevent implant extrusion, a major cause of failure of current artificial corneal devices. 
Thus, it is highly desirable to encourage the response of the cornea to the implant by using 
a more bioactive material. The most important criterion for a polymer to be bioactive in 
vivo is to have the ability to induce apatite deposition on its surface in vitro. Apart from 
inducing the apatite formation,  it is essential to stimulate the growth of apatite and to 
accelerate the SBF coating process. 
A pre-treatment with 1, 5 or 10M NaOH followed by treatment with 1.5 SBF have 
been  applied  to  HDPE,  UHMWPE  and  PEEK  films,  to  increase  their  bioactivity.  The 
layers  have been studied  by  using different  techniques: Scanning Electron Microscopy 
(SEM), Energy Dispersive X-ray spectroscopy (EDX), Laser Raman spectroscopy (Raman 
IR),  Fourier  Transform  Infrared  spectroscopy  (FTIR),  flame  Atomic  Absorption 
spectroscopy  (AAS),  Atomic  Force  Microscopy  (AFM),  water  Contact  Angle  (CA), 
reflected light Differential Contrast (DIC) microscopy, Thin Film X-Ray Diffraction (TF-
XRD) and Wide-angle X-ray Diffraction (WAXD), to assess their bioactivity and their 
mechanical properties, as well to gain a better understanding of the apatite nucleation and 
growth on the polymer surfaces. It is also important to look at the effect caused by NaOH 
to  the  films  and  to  determine  the  most  suitable  NaOH  pre-treatment  for  the  further 
treatment in 1.5 SBF. 
This chapter presents the results of the in vitro assessment of the layers for the skirt 
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4.2  WATER CONTACT ANGLE (CA) 
Figure 4.2.1 shows the water contact angle (CA) of PEEK on both sides (bright and 
matt) and UHMWPE films before and after pre-treatment with 5M or 10M NaOH for 48 
hours. Figure 4.2.2 shows the pictures of the CA of PEEK and UHMWPE (non-treated and 
NaOH pre-treated) films. Overall, the water contact angle decreases with the concentration 
of NaOH. For PEEK, the water contact angle decreased with the concentration of NaOH 
pre-treatment,  for both  sides of such polymer,  demonstrating that the  NaOH treatment 
increased the wettability on PEEK. In contrast, no significant differences in water CA were 
found for UHMWPE. Interestingly, non-treated samples have similar water CA. 
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Figure 4.2.1 Averaged water contact angle and the Standard Deviation (error bar) of the 
non-treated films, PEEK (bright and matt sides) and UHMWPE, and 5M or 10M NaOH 
pre-treated samples, PEEK (bright and matt sides) and UHMWPE (B= bright, M= matt) 
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Figure 4.2.2 Pictures of the water contact angle of the non-treated films, PEEK (bright 
and matt sides) and UHMWPE and 5M or 10M NaOH pre-treated PEEK (bright and matt 
sides) and UHMWPE 
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4.3  ATOMIC FORCE MICROSCOPY (AFM) 
Results of surface topography and corresponding roughness (Ra) data of the non-
treated  and  NaOH  pre-treated  PEEK  (bright  and  matt)  and  UHMWPE  specimens  as 
measured  by  AFM  are  presented  in  Tables  4.3.1  and  4.3.2  respectively.  The  Ra  was 
evaluated in two different ways: a) five random lines were placed across the whole scanned 
surface giving line profiles, with calculated Ra directly for those lines and averaged and b) 
software (NanoScope – Veeco) was used to calculate Ra from the whole recorded image. 
Therefore, the Ra results are different for the whole image compared to the line profile 
values (Figure 4.3.1).  
 
Figure 4.3.1 Example of Atomic Force Microscope (AFM) line profiles of PEEK (matt) 
pre-treated with 5M NaOH using a scan size of 25 microns (μm). The profiles for two 
different lines are shown (red, green), with arrows indicating the analysis range. 
Ra values obtained from the AFM micrographs demonstrate that Ra was not strongly 
affected by the NaOH treatment on PEEK (bright side) since Ra slightly increased after the 
pre-treatment.  On the  contrary,  Ra decreased  for PEEK (matt surface)  and UHMWPE, 
particularly after treatment  with  10M  NaOH. A similar trend could  be observed when 
using Ra deduced from the AFM line profiles. It should be noted that the vertical scale on 
the AFM scans is set automatically; therefore there is a factor of over 20 between the 
maximum and minimum vertical scales. Monica Pino                                                                                                                  Results  
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Table 4.3.1 Roughness (Ra) in nanometres (nm) from the Atomic Force Microscope (AFM) 
using scan sizes of 25 x 25 or 5 x 5 microns (μm) of PEEK (bright and matt) non-treated 
samples  and  pre-treated  samples  with  NaOH  (B=  bright,  M=  matt,  S.D.=  standard 
deviation) 
 
  Ra from the whole image  Ra from line profiles 
Scan size  2525 μm  55 μm  2525 μm  55 μm 
Ra units  nm  S.D.  nm  S.D.  nm  S.D.  nm  S.D. 
PEEK B  4.37  2.06  1.00  1.40  13.23  1.74  5.56  2.11 
PEEK B 5M NaOH  14.07  1.81  8.35  1.61  8.64  2.09  4.54  1.70 
PEEK B 10M NaOH  13.85  2.11  7.22  1.37  15.06  1.58  4.08  2.10 
PEEK M  18.43  2.26  13.69  1.34  17.38  1.73  11.38  1.98 
PEEK M 5M NaOH  17.59  1.36  18.17  1.62  21.78  1.87  13.40  1.96 
PEEK M 10M NaOH  13.51  1.38  7.86  1.83  13.70  2.23  5.51  1.64 
 
 
Table 4.3.2 Roughness (Ra) in nanometres (nm) from the Atomic Force Microscope (AFM) 
using scan sizes of 45 x 45, 25 x 25 or 5 x 5 microns (μm) of UHMWPE(UH) non-treated 
samples and pre-treated samples with 5M or 10M NaOH (S.D = Standard Deviation) 
 
  Ra from the whole image  Ra from line profiles 
Scan size  45  45 
μm 
25  25 
μm 
5  5 
μm 
45 45 
μm 
25  25 
μm 
5  5  
μm 
Ra units  nm  nm  nm  nm  nm  nm 
UHMWPE  123.43  129.98  74.64  83.12  88.33  15.62 
S.D.  1.32  1.86  1.56  1.50  1.91  2.20 
UHMWPE 5M NaOH  114.32  59.48  14.90  50.26  91.26  12.10 
S.D.  1.61  1.41  1.87  1.80  1.45  2.13 
UHMWPE 10M NaOH  64.22  65.09  13.12  73.36  32.86  5.86 
S.D.  1.71  1.41  2.18  1.67  1.98  1.57 
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Figures  4.3.2-4.3.4  show  the  topographical  micrographs  of  the  non-treated  and 
NaOH pre-treated PEEK (bright and matt) and UHMWPE specimens. The bright side of 
non-treated PEEK is less spiky compared to the matt side of PEEK, which appears to be 
rough and with lots of sharp peaks. The surface of the bright side of PEEK was slightly 
more affected by the NaOH pre-treatments as the spiky patterns seem to be more appearing 
compared to the non-treated PEEK bright. On the other hand, the topography surfaces for 
PEEK (matt side) and UHMWPE seem to be slightly flatter in comparison to the non-
treated specimens, especially after pre-treatment with 10M NaOH. In general, there are 
noticible changes in topography of the specimens after the NaOH pre-treatments, which 
are also present in the Ra values. Monica Pino                                                                                                                  Results  
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Figure 4.3.2 3D topography from the Atomic Force Microscope (AFM) using scan sizes of 
25 x 25 and 5 x 5 μm of the non-treated PEEK and UHMWPE films  Monica Pino                                                                                                                  Results  
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Figure 4.3.3 3D topography from the Atomic Force Microscope (AFM) using scan sizes of 
25 x 25 and 5 x 5 μm of the 5 or 10M NaOH pre-treated PEEK (bright and matt) Monica Pino                                                                                                                  Results  
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Figure 4.3.4 3D topography from the Atomic Force Microscope (AFM) using scan sizes of 
45 x 45, 25 x 25 and 5 x 5 microns (μm) of the 5M or 10M NaOH pre-treated UHMWPE 
films 
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4.4  SCANNING ELECTRON MICROSCOPY (SEM) 
4.4.1  INITIAL SCREENING OF POLYMERS WITH NaOH ACTIVATION 
Apatite formation on the polymers (PEEK, HDPE and UHMWPE) films after 1M, 
5M or 10M NaOH pre-treatment, are shown in the SEM micrographs in Figures 4.4.1 to 
4.4.3. In these figures the word ‘spectrum’ indicates the location where an EDX spectrum 
was taken; these spectra are shown in section 4.5. For the PEEK films, pre-treated with 
different concentrations of NaOH solution and immersed in 1.5 SBF for up to 15 days, an 
apatite layer was first formed on the surface of the PEEK films on day 3 when the PEEK 
film was pre-treated with 10M NaOH, on day 7 when 5M NaOH pre-treatment was used, 
and on day 15 after 1M NaOH pre-treatment (Figure 4.4.1). A similar dependence was 
found for apatite formation on HDPE films; however the apatite growth seemed to proceed 
faster. On HDPE films, apatite was found on day 1 with 10M NaOH pre-treatment, on day 
3 when 5M NaOH was used and on day 7 after 1M NaOH pre-treatment (Figure 4.4.2). On 
the UHMWPE films, apatite attached to the surface on day 3 for both 10M and 5M NaOH 
pre-treatments, and on day 7 when 1M NaOH pre-treatment was used (Figure 4.4.3). In the 
early stages of the treatment in 1.5 SBF after the NaOH pre-treatment, calcium phosphate 
clusters initiate and then grow forming a thin and porous layer on the polymer film. As the 
immersion  time  in  1.5  SBF  progresses,  additional  nucleation  and  growth  occurred 
producing a more consolidated apatite layer (Figures 4.4.1 – 4.4.4), followed by a second 
layer above the initial compacted layer, with the appearance of ‘snow balls’, since the 
apatite depositions on the last days in the SBF treatment produce larger apatite particles 
(Figure  4.4.4).  Another  observation  is  the  appearance  of  cracks  on  the  initial  calcium 
phosphate layer with the increase in 1.5 SBF time, which are very prominent on PEEK pre-
treated with 1M or 5M NaOH and incubated for 15 days in 1.5 SBF (Figure 4.4.1), and 
also on UHMWPE pre-treated with 5M NaOH and soaked in 1.5 SBF for 7 days (Figure 
4.4.3).  However,  these  cracks  are probably the results  of drying the films  for electron 
microscopy.  
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Figure 4.4.1 SEM micrographs of the PEEK films pre-treated with 1, 5 and 10M NaOH and soaked in 1.5 SBF for 1,3, 7 and 15 days. 
(Scale bars= 40 µm) Monica Pino                                                                                                                  Results 
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Figure 4.4.2 SEM micrographs of the HDPE films pre-treated with 1M NaOH and 1.5 SBF 
for 3 and 7 days (top); HDPE films in 5M NaOH and 1.5 SBF for 3 and 15 days (middle); 
and HDPE films in 10M NaOH and 1.5 SBF for 1 and 7days (bottom). (Scale bars=40 µm) Monica Pino                                                                                                                  Results 
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Figure 4.4.3 SEM micrographs of the UHMWPE films pre-treated with 1, 5, and 10M 
NaOH and soaked in 1.5 SBF for 1 day and 7 days. (Scale bars= 40 µm for 1M NaOH for 
at 1 day and 7 days, 5M NaOH at 7 days and 10M NaOH at 1 day. Scale bars= 3 mm for 
5M NaOH at 1 day and 10M NaOH at 7 days) Monica Pino                                                                                                                  Results 
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As seen in Figures 4.4.1 to 4.4.3, for all pre-treated polymers (HDPE, UHMWPE 
and  PEEK)  immersion  in  1.5  SBF  treatments  initially  resulted  in  the  formation  of 
individual  agglomerates,  which  were  typically  less  than  5  μm  across.  With  increasing 
immersion  time  in  1.5  SBF,  further  apatite  deposition  resulted  in  growth  of  these 
agglomerates,  producing  continuous,  thicker  and  more  compact  coatings.  These  layers 
contain spherical aggregates with diameters up to 8-10 μm (Figure 4.4.4), consisting of 
nanoparticles of apatite crystallites, which are characteristic for coatings precipitated from 
1.5 SBF treatment. Figure 4.4.4 shows the spectra from the shadowing technique under 
EDX of the cross section of the polymer film pre-treated with 5M NaOH and soaked in 1.5 
SBF  for  18  days,  which  was  used  to  measure  the  thickness  of  the  aggregate  layers 
presented in the calcium phosphate deposited layer.  
In contrast, films that had not been pre-treated with NaOH, showed no calcium 
phosphate deposition, even after immersion for 18 days in 1.5 SBF.  
 
 
Figure 4.4.4 Spectra of the shadowing technique under EDX of the cross section of the 
polymer film pre-treated with NaOH and soaked in 1.5 SBF for 18 days. Dark shadow 
represents the thickness of the apatite layer. (Scale bar= 20 µm) Monica Pino                                                                                                                  Results 
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4.4.2  ASSESSMENT OF ACTIVATION OF PEEK AND UHMWPE WITH HIGH 
NaOH CONCENTRATION AND PROTRACTED SBF INCUBATION 
The second series study also showed that an apatite layer was deposited on PEEK 
and UHMWPE after 5M or 10M NaOH pre-treatment and subsequent immersion in 1.5 
SBF for up to 30 days. This is almost double the time compared with the previous set of 
results, in which the pre-treated films were soaked in 1.5 SBF for up to 15-18 days. It is 
important to mention that the PEEK film has a bright side and a matt side; therefore, SEM 
was performed on both sides, which has not been done in the previous set of results. Figure 
4.4.5 shows the SEM scans of both sides of PEEK pre-treated with 5M NaOH and soaked 
in 1.5 SBF treatment for up to 30 days. An apatite layer appeared on both surfaces of the 
PEEK films on day 3 of the SBF treatment, slightly more appearing on the matt side than 
on the bright side, and a second apatite layer started to form after day 15 and growth 
continuously  until  day  30.  Also,  some  cracks  were  noticed  after  day  15  in  the  SBF 
treatment, with more cracks observed on the matt side (Figure 4.4.5). Figure 4.4.6 shows 
the SEM scans of PEEK films on both sides after being pre-treated with 10M NaOH and 
immersed in 1.5 SBF for 30 days. A similar tendency was found on 10M NaOH pre-treated 
PEEK films compared with the 5M NaOH pre-treated PEEK films (Figure 4.4.5); yet the 
second layer of apatite appeared earlier, at day 7 rather and day 15, as well as the presence 
of cracks. Thus, the growth of apatite seemed to proceed faster on PEEK films pre-treated 
with the higher concentration of NaOH (Figure 4.4.6). Figure 4.4.7 shows the SEM scans 
of UHMWPE films pre-treated with 5M or 10M NaOH and soaked in 1.5 SBF for up to 30 
days. A similar behaviour to that found on the PEEK samples could be observed for the 
case of UHMWPE: as the strength of the NAOH pre-treatment increases, from 5M to 10M 
NaOH, a faster nucleation and growth of apatite occurred. Apatite growth also increased 
with the immersion time in the 1.5 SBF treatment. The cracks were more predominant on 
the  UHMWPE  films  pre-treated  with  10M  NaOH  compared  with  the  5M  NaOH  pre-
treatment (Figure 4.4.7).  Monica Pino                                                                                                                  Results 
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Figure 4.4.5 SEM micrographs of the PEEK films on the bright and matt sides pre-treated 
with 5M NaOH and soaked in 1.5 SBF for up to 30 days. (Scale bars= 50 µm) Monica Pino                                                                                                                  Results 
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Figure 4.4.6 SEM micrographs of the PEEK films on the bright and matt sides pre-treated 
with 10M NaOH and soaked in 1.5 SBF for up to 30 days. (Scale bars= 20 µm for PEEK 
bright at 7 and 15 days and PEEK matt at 15 and 30 days. Scale bars= 50 µm for PEEK 
matt side at 3 and 7 days. Scale bars= 100 µm for PEEK bright side at 3 and 30 days) 
 Monica Pino                                                                                                                  Results 
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Figure 4.4.7 SEM micrographs of the UHMWPE films pre-treated with 5 or 10M NaOH 
and soaked in 1.5 SBF for up to 30 days. (Scale bars= 50 µm) Monica Pino                                                                                                                  Results 
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4.5  ENERGY DISPERSIVE X-RAY SPECTROSCOPY (EDX) 
4.5.1  INITIAL SCREENING OF POLYMERS WITH NaOH ACTIVATION 
Energy  Dispersive  X-ray  (EDX)  spectra  of  PEEK,  HDPE  and  UHMWPE  pre-
treated with 1M, 5M or 10M of NaOH solutions and soaked in 1.5 SBF for up to 15 days 
showed similar trends (Figures 4.5.1 to 4.5.3). Calcium (Ca) and phosphorous (P) with 
small fractions of magnesium (Mg) and sodium (Na) were found, indicating that these 
deposits are crystalline apatite. Magnesium (Mg
2+) and sodium (Na
+) ions can substitute 
for  calcium  (Ca
2+)  ions  in  apatites,  which  is  in  agreement  with  the  composition  of 
biological apatites from human bones and teeth which are non-stoichiometric with trace 
components  such  as  magnesium  (Mg
2+),  sodium  (Na
+),  carbonate  (CO
 2
3 ),  phosphate 
(HPO
 2
4 ), fluorine (F
-) or chloride (Cl
-).  
The  prominent  peaks  of  Calcium  (Ca)  and  phosphorous  (P)  were  found  on  all 
polymers,  PEEK,  HDPE  and  UHMWPE,  after  different  times  during  the  1.5  SBF 
treatments, previously pre-treated with different NaOH solutions, as shown in the EDX 
spectra in Figures 4.5.1 to 4.5.3, respectively.  
The  increasing  height  of  these  peaks  implies  a  strong  dependence  on  the 
concentration of the NaOH pre-treatment and also on the immersion time in the 1.5 SBF 
treatments, as shown particularly in the EDX spectrum of PEEK in Figure 4.5.1, as well in 
the case of HDPE displayed on the EDX scan in Figure 4.5.2. However, this dependence is 
less evident in the case of UHMWPE shown on the EDX spectrum in Figure 4.5.3. For 
example,  on  PEEK  films  pre-treated  with  different  strengths  of  NaOH  solution  and 
immersed in 1.5 SBF for up to 15 days, the calcium  (Ca) and phosphorous (P) peaks 
appeared first on the EDX spectrum on day 3 when the film was pre-treated with 10M 
NaOH, on day 7 when 5M and 10M NaOH pre-treatments were used, and on day 15 after 
1M NaOH pre-treatment (Figure 4.5.1). A similar pattern was present on HDPE films, but 
occurring slightly earlier, with the calcium (Ca) and phosphorous (P) peaks identified first 
on day 1 when HDPE was pre-treated with 10M NaOH, on day 3 when 5M NaOH solution 
was used, and on day 7 when the film was subjected to 1M NaOH (Figure 4.5.2). In the 
case of UHMWPE, calcium (Ca) and phosphorous (P) peaks emerged until day 7 after all Monica Pino                                                                                                                  Results 
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NaOH  pre-treatments,  1M,  5M  and  10M  (Figure  4.5.3).  This  could  indicate  that  the 
calcium (Ca) and phosphorous (P) peaks appearance may depend on the structure of the 
polymer  as  well  as  on  the  concentration  of  the  NaOH  pre-treatment  used  and  on  the 
immersion time in 1.5 SBF treatments. 
The average Ca/P molar ratio was obtained from the EDX of the layer precipitated 
on PEEK, HDPE and UHMWPE films, pre-treated with 1M, 5M or 10 M NaOH aqueous 
solution and immersed in 1.5 SBF for 3, 7 and 15 days was 1.19, 1.26-1.35, and 1.33-1.44, 
respectively. It should be noted that the Ca/P ratio increased with immersion time in 1.5 
SBF treatments. The Ca/P molar ratio was very similar for all polymers pre-treated with 
different concentration of NaOH solution and treated with 1.5 SBF, the major variation of 
the Ca/P molar ratio was found from the immersion days in the 1.5 SBF. Thus, it seems 
that the Ca/P is not strongly related to the type of polymer. The increase of the Ca/P was 
found more directly proportional to the time of exposure of the polymers in the 1.5 SBF 
treatment. 
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Figure 4.5.1 EDX spectra of PEEK pre-treated with 1, 5, and 10M NaOH and soaked in 1.5 SBF for 3, 7 and 15 days  Monica Pino                                                                                                                  Results 
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Figure 4.5.2 EDX spectra of HDPE pre-treated with 1M NaOH and soaked in 1.5 SBF for 
3 and 7 days (top); HDPE with 5M NaOH and 1.5 SBF for 3 and 15 days (middle); and 
HDPE with 10M NaOH and 1.5 SBF for 1 and 7 days (bottom) Monica Pino                                                                                                                  Results 
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Figure 4.5.3 EDX spectra of UHMWPE pre-treated with 1, 5, and 10M NaOH and soaked 
in 1.5 SBF for 1 and 7 days Monica Pino                                                                                                                  Results 
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4.5.2  ASSESSMENT OF ACTIVATION OF PEEK AND UHMWPE WITH HIGH 
NaOH CONCENTRATION AND PROTRACTED SBF INCUBATION  
Films  of  PEEK  and  UHMWPE  were  treated  for  longer  periods  in  1.5  SBF 
compared with the previous set of EDX scans (Figures 4.5.1 to 4.5.3). Therefore, Figures 
4.5.4 to 4.5.6 show EDX spectra of PEEK (bright and matt surfaces) and UHMWPE films 
pre-treated with 5M or 10M NaOH and 1.5 SBF for up to 30 days. The apatite layer 
appeared on both surfaces of the PEEK films after 3 days in SBF, with the matt side 
apparently somewhat more favourable for apatite deposition than the bright side, both for 5 
and 10M  NaOH-treated samples.  Growth continued until  day 30, proceeding faster on 
PEEK pre-treated with the higher concentration of NaOH. Independent of concentration, 
however cracking appeared after day 15 in SBF, which was more pronounced on the matt 
side. Similar behaviour was observed for the UHMWPE structures; i.e. nucleation and 
growth of apatite occurred faster as the strength of the NaOH pre-treatment increased from 
5M to 10M NaOH, as well as with the immersion time used for the 1.5 SBF treatment. It 
was found that NaOH pre-treatments impart sites on the polymers for the deposition and 
growth of apatite deposited from the SBF treatments. The control films that were not pre-
treated with NaOH showed no deposition or growth of apatite even after 30 days in 1.5 
SBF. Monica Pino                                                                                                                  Results 
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Figure 4.5.4 EDX spectra of the bright and matt sides of PEEK pre-treated with 5M NaOH 
and soaked in 1.5 SBF for 3, 7, 15 and 30 days Monica Pino                                                                                                                  Results 
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Figure 4.5.5 EDX spectra of the bright and matt sides of PEEK pre-treated with 10M 
NaOH and soaked in 1.5 SBF for 3, 7, 15 and 30 days Monica Pino                                                                                                                  Results 
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Figure 4.5.6 EDX spectra of UHMWPE pre-treated with 5M or 10M NaOH and soaked in 
1.5 SBF for 3, 7, 15 and 30 days Monica Pino                                                                                                                  Results 
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For this second set of experiments, the average calcium (Ca) and phosphorous (P) 
content found using EDX to analyse the deposited layers on PEEK and UHMWPE films 
pre-treated NaOH and immersed in 1.5 SBF are shown in Figure 4.5.7. The Ca and P 
content increased both with the NaOH concentration used during the pre-treatment as well 
as with the immersion time in 1.5 SBF, for both polymers – i.e. PEEK and UHMWPE. 
Also, more Ca and P was deposited on the matt PEEK side compared to the bright side. 
The Ca/P molar ratio (Figure 4.5.8) in the deposited layers was not strongly affected 
by the NaOH concentrations for all polymers (Table 4.5.1). Indeed, the Ca/P molar ratio 
increased from 0.74 (day 3) to 1.58 (day 30) on PEEK (bright side) treated with 5 M 
NaOH compared to from 1.27 to 1.60 for PEEK (matt side). Thus, the Ca/P molar ratio at 
the end of day 30 is similar (1.58 and 1.60) for both sides of PEEK. 
The PEEK surfaces  differences  were  even less  noticeable  when  pre-treating the 
polymer films with 10M NaOH. For instance, on day 3, the Ca/P ratios were 1.37 and 1.40 
and on day 30, 1.64 and 1.67 for the bright and matt sides of PEEK films pre-treated with 
10M NaOH, respectively. For UHMWPE samples, Ca/P increased from 1.42 and 1.49 to 
1.61 and 1.64 from day 7 to day 30 in the 1.5 SBF pre-treated with 5M and 10M NaOH, 
respectively. 
The most remarkable difference found in the Ca/P molar ratio of HDPE, PEEK and 
UHMWPE  was  due  to  the  immersion  time  in  the  1.5  SBF  rather  than  in  the  higher 
concentration  of  the  NaOH  pre-treatment.  Thus,  it  seems  that  above  5M  NaOH  pre-
treatments the effect on increased the Ca/P molar ratio and the acceleration of the apatite 
deposition on the polymers is nullified. Moreover, it seems that the Ca/P is not strongly 
dependent on the type of the polymer. The increase of the Ca/P was found directly related 
to the time of exposure of the polymers in the 1.5 SBF treatment. 
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Figure 4.5.7 Average calcium (Ca) and phosphorous (P) in atomic %  deposited on PEEK (PK) and UHMWPE (UH) films pre-treated with 5M or 10 M 
NaOH and immersed in 1.5 SBF for 3, 7, 15 and 30 day, obtained from the EDX test (B= bright, M= matt) 
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Figure 4.5.8 Average Ca/P molar ratio of PEEK and UHMWPE films pre-treated with 5M or 10M NaOH and immersed in 1.5 SBF for 3, 7, 15 and 30 
days, obtained from the EDX test (B= bright, M= matt) (bar error=standard deviation) Monica Pino                                                                                                                                                                                                                      Results 
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Table 4.5.1 The average calcium (Ca) phosphorous (P) and Ca/P molar ratio from the EDX of PEEK and UHMWPE films pre-treated with 5M or 10M 
NaOH and immersed in 1.5 SBF for 3, 7, 15 and 30 days (S.D = standard deviation) 
1.5 SBF 
 
Day 3 
 
Day 7 
 
Day 15 
 
Day 30 
 
 
Ca 
 
P 
 
Ca:P 
 
Ca 
 
P 
 
Ca:P 
 
Ca 
 
P 
 
Ca:P 
 
Ca 
 
P 
 
Ca:P 
 
PEEK 5M NaOH Bright                          
Average  0.23  0.32  0.73  14.77  10.26  1.44  19.03  12.25  1.55  22.54  14.28  1.58 
S.D.  0.02  0.19  0.04  0.56  0.18  0.08  0.31  0.02  0.03  0.20  0.31  0.03 
                         
PEEK 5M NaOH Matt                         
Average  12.57  9.89  1.27  17.75  11.83  1.50  20.47  12.97  1.58  24.01  15.03  1.60 
S.D.  0.45  0.84  0.10  0.55  0.65  0.05  0.24  0.47  0.07  0.20  0.05  0.01 
                         
PEEK 10M NaOH Bright                         
Average  16.33  11.91  1.37  19.82  13.15  1.51  21.94  13.79  1.59  24.82  15.12  1.64 
S.D.  0.57  0.21  0.06  0.12  0.06  0.01  0.05  0.03  0.01  0.20  0.26  0.04 
                         
PEEK 10M NaOH Matt                         
Average  16.95  12.08  1.40  20.95  13.80  1.52  23.00  14.27  1.61  26.21  15.71  1.67 
S.D.  0.49  0.19  0.06  0.03  0.40  0.04  0.17  1.49  0.02  0.12  0.24  0.03 
                         
UHMWPE 5M NaOH                          
Average  0.00  0.00  -  14.45  10.20  1.42  17.43  11.40  1.53  20.24  12.55  1.61 
S.D.  0.00  0.00  -  0.42  0.23  0.07  0.15  0.28  0.04  0.13  0.34  0.05 
                         
UHMWPE 10M NaOH                          
Average  0.00  0.00  -  17.15  11.50  1.49  18.81  12.08  1.56  21.44  13.04  1.64 
S.D.  0.00  0.00  -  0.64  0.07  0.05  0.18  0.06  0.02  0.08  0.06  0.01 Monica Pino                                                                                                                  Results 
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4.6  LASER RAMAN SPECTROSCOPY  
The  high-density  polyethylene  (HDPE)  and  ultra  high  molecular  weight 
polyethylene  (UHMWPE)  films  were  characterized  with  Raman  spectroscopy.  Figures 
4.6.1 and 4.6.2 show Raman spectra of HDPE and UHMWPE films, non-treated as well as 
exposed  to  5M  NaOH  and  immersed  in  1.5  SBF  for  18  days,  respectively.  The 
characteristic peaks of the HDPE and UHMWPE are located in three zones. The features 
present at 1040-1150 cm
-1 are due to the C-C stretching vibrations, those observed at 1250-
1350 cm
-1 are CH2 twisting vibrations, and peaks at 1390-1550 cm
-1 are attributed to CH2 
bending vibrations.  
In addition to the features mentioned on the previous paragraph, the spectrum of 
HDPE samples, which had been pre-treated with 5M NaOH and immersed in 1.5 SBF for 
18 days (Figure 4.6.1), displayed two small peaks, which are not present in the spectra for 
the  non-treated  HDPE  films  (Figure  4.6.1).  The  peak  at  873.0  cm
-1  was  assigned  to 
carbonate  ions,  which  occupies  one  of  the  sites  in  carbonated  apatite  due  to  the  ν2 
vibrational mode (Rehman and Bonfield, 1997; Legeros et al., 1987), whereas the peak at 
962.1  cm
-1  most  likely  represents  a  phosphate  ν1  band,  which  often  is  observed  in 
hydroxyapatite and carbonated apatites (Rehman and Bonfield, 1997). 
The spectra of the UHMWPE pre-treated with 5M NaOH solution and immersed in 
1.5 SBF for 18 days (Figure 4.6.2) exhibits three peaks, which are not observed in the non-
treated UHMWPE spectra (Figure 4.6.2). The peaks at 873.4 and 961.6 cm
-1 result from 
carbonate  and  phosphate  ions,  respectively.  The  peak  at  1470.8  cm
-1  corresponds  to 
carbonate ions, occupying the second site in carbonated apatite due to the ν1 band (Rehman 
and Bonfield, 1997). This feature is known to depend on the maturation and formation of 
apatite crystals. Thus, it is interesting to note that it is not observed in the corresponding 
(pre-treated) HDPE spectra, possibly due to the fact that less apatite formed on NaOH-
treated HDPE when compared to UHMWPE samples.  
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Figure 4.6.1 Raman spectra of non-treated HDPE (top) and HDPE pre-treated with 5M 
NaOH and soaked in 1.5 SBF for 18 days (bottom) 
 
 
 
Figure 4.6.2 Raman spectra of non-treated UHMWPE (top) and UHMWPE pre-treated 
with 5M NaOH and soaked in SBF for 18 days (bottom) Monica Pino                                                                                                                  Results 
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Figure 4.6.3 shows Raman spectra of the apatite scraped from all polymers, high-
density polyethylene (HDPE), ultra high molecular weight polyethylene (UHMWPE) and 
polyether ether ketone (PEEK) films pre-treated with 5M NaOH and immersed in 1.5 SBF 
treatments for 18 days. The apatite was scraped off all three materials and combined to 
produce sufficient materials for spectra to be obtained. The peaks at 2880 cm
−1 and 1440 
cm
−1 are assigned to the vsCO3 vibration (Petra et al., 2005; Hofmann et al., 2007) and the 
v3CO3 band (Ha et al., 1997), respectively. Peaks at 1076 cm
−1 and 1130 cm
−1, as well as 
the shoulder at 1170 cm
−1, are attributed to the P-O asymmetric stretching mode, also 
reported by Ning et al. (2004). The shoulder-like appearance of the 1076 cm
−1 feature may 
origin from some overlap with the 1070 cm
−1 vibration, which corresponds to the CO
 2
3  v1 
band (Penel et al., 1998). Finally, the peaks at, 2850 cm
−1 may be related to the H-C-O 
functional group from the polymeric films, and 1290 cm
−1 to P-O (phosphate region). 
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Figure 4.6.3 Raman spectrum of the layer scraped from PEEK, HDPE and UHMWPE pre-
treated with 5M NaOH then the immersed in SBF for 18 days 
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4.7  FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
FTIR  spectra  of  non-treated  HDPE  films  and  those  exposed  to  5M  NaOH  and 
immersed in 1.5 SBF for 18 days, are shown in Figure 4.7.1. Characteristic HDPE features 
are  found,  which  are  in  agreement  with  spectra  reported  in  the  literature  (Muller  and 
Muller,  2006;  Pandey  et  al.,  2006).  The  intense  peaks  at  2920  cm
−1  and  2850  cm
−1 
correspond to asymmetric and symmetric CH2 stretching vibrations, respectively; those at 
1558 cm
−1 and 1471 cm
−1 result from the C-H bending deformation, the less pronounced 
feature at 1371 cm
−1 can be assigned to the C-H symmetric deformation of terminal methyl 
group  and  the  intense  peak  at  720  cm
−1  origins  from  C-H  rocking  deformation.  The 
spectrum of the treated HDPE sample with 5M NaOH and SBF immersion shows a very 
small peak at 3210 cm
−1,which is probably due to the OH groups of the apatite; a strong 
peak  at  1600  cm
−1  is  likely  due  to  CO3 band,  which  overlaps  possibly  with  the  C-H-
vibration of the polymer, a broad doublet at about 1468 and 1425 cm
−1 is assigned to CO3 
absorption in precipitated apatites (Elliot, 1994); features at 1039 cm
−1 and 728 cm
−1 are 
most likely due to structural and P-O bond of the phosphate groups (Pandey et al., 2006). It 
is worth noticing in the case of treated HDPE in 5M NaOH and SBF, that the characteristic 
polymer bands tend to weaken when apatite forms, which may illustrate the formation of 
apatite from carbonate and phosphate. 
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Figure 4.7.1  FTIR of  non-treated  HDPE  and  pre-treated  HDPE  with  5M NaOH after 
immersion in SBF for 18 days 
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Similar observations as was the case for the FTIR of HDPE (Figure 4.7.1) can be 
made for UHMWPE non-treated and pre-treated with 5M NaOH and 1.5 SBF for 18 days 
(Figure 4.7.2). Strong characteristic peaks resulting from the UHMWPE film are present at 
2920 and 2850 cm
−1. These bands correspond to asymmetric and symmetric CH2 stretching 
vibrations, respectively, whereas the features at 1471 and 720 cm
−1 are due to the C-H 
bending and rocking deformations, respectively. Treated UHMWPE shows, in addition to 
the polyethylene features (which, again weaken for treated samples with NaOH solution 
and 1.5 SBF solution), peaks at 1030 cm
−1 and 1440 cm
−1, which we assigned to structural 
and P-O bonds of the phosphate groups and, respectively, CO3 absorption in precipitated 
apatites.  
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Figure 4.7.2 FTIR of non-treated UHMWPE and pre-treated UHMWPE with 5M NaOH 
after immersion in SBF for 18 days 
 
 
CH2 
CH2 
C-H  C-H 
CO3 
P-O 
Non-treated UHMWPE 
Treated UHMWPE Monica Pino                                                                                                                  Results 
 
 
  147 
Figure 4.7.3 shows the IR spectra of corresponding PEEK films, non-treated PEEK 
samples, and treated PEEK samples with 5M NaOH solution and 1.5 SBF treatments for 
18 days. In the spectrum of the non-treated PEEK specimen, all the characteristic bands are 
present (diphenyl ketone bands at 1650, 1490 and 928 cm
−1; arylether band at 1230 cm
−1, 
C-O-C stretching vibration of diaryl groups at 1190 and 1160 cm
−1 (Simonin and Liao, 
2000), three features at 1310, 1280 and 1010 cm
−1 typical of sulphonyl groups, used as 
solvents in the polymerization process; as well as a peak at 1600 cm
−1 that is related to 
C=C in the benzene ring in PEEK). Interestingly, in the spectra of treated PEEK with 5M 
NaOH and 1.5 SBF solutions, some shift in these characteristic polymer bands can be 
observed,  in  addition  to  peaks  originating  from  apatite.  However,  identification  of  all 
apatite peaks was challenging, as the spectra of PEEK itself is very complex. 
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Figure  4.7.3  FTIR  of  non-treated  PEEK  and  pre-treated  PEEK  with  5M  NaOH  after 
immersion in SBF for 18 days 
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4.8  REFLECTED LIGHT DIFFERENTIAL CONTRAST (DIC) MICROSCOPY  
Table  4.8.1  lists  the  averaged  area  of  the  deposited  layers  and  percentage  of 
area/image area from the reflected light Differential Contrast (DIC) microscope pictures of 
PEEK (bright and matt sides) and UHMWPE films pre-treated with 5M or 10M NaOH and 
incubated in 1.5 SBF treatments for 3, 7, 15 and 30 days. Overall, the area of the apatite 
deposition on the matt surface of PEEK films is always greater than on the PEEK bright 
surface for both 5 and 10M NaOH-trated samples independent of the immersion time in 
SBF, even though the area increases with the immersion time for both sides of PEEK. Area 
and percentage of area covered in the image continued until day 30 of the SBF treatment, 
with higher values on PEEK pre-treated with higher concentration of NaOH (Figures 4.8.1 
and 4.8.2). A similar characteristic was observed for the UHMWPE specimens (Figure 
4.8.3), where the area increased with the strength of NaOH, from 5M to 10M. In agreement 
with  the SEM micrographs,  it was  found  that the apatite area increased both  with  the 
NaOH concentration used for the pre-treatments as well as the immersion time in 1.5 SBF, 
for PEEK and UHMWPE. Interestingly, the areas and the percentage of the area/image at 
the end of day 30 are similar (around 42%) on both PEEK surfaces pre-treated with 5 or 
10M NaOH. In the case of UHMWPE, a difference of the area and area/image was found 
at the end of the SBF treatment on day 30 when the films has been pre-treated with 5M or 
10M NaOH, showing a more favourable response for the higher concentration of NaOH.  Monica Pino                                                                                                                  Results 
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Figure  4.8.1  Reflected  light  Differential  Contrast  (DIC)  microscope  images  of  PEEK 
(bright  and  matt  sides)  films  pre-treated  with  5M  NaOH  and  incubated  in  1.5  SBF 
treatments for 3, 7, 15 and 30 days Monica Pino                                                                                                                  Results 
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Figure  4.8.2  Reflected  light  Differential  Contrast  (DIC)  microscope  images  of  PEEK 
(bright  and  matt  sides)  films  pre-treated  with  10M  NaOH  and  incubated  in  1.5  SBF 
treatments for 3, 7, 15 and 30 days Monica Pino                                                                                                                  Results 
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Figure 4.8.3 Reflected light Differential Contrast (DIC) microscope images of UHMWPE 
films pre-treated with 5M or 10M NaOH and incubated in 1.5 SBF treatments for 3, 7, 15 
and 30 days Monica Pino                                                                                                                                                                                                                      Results 
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Table 4.8.1 Percentage of area/image area from the reflected light Differential Contrast (DIC) microscope pictures of PEEK (bright and matt sides) and 
UHMWPE films pre-treated with 5M or 10M NaOH and incubated in 1.5 SBF treatments for 3, 7, 15 and 30 days (B= bright, M= matt, S.D.= standard 
deviation) 
 
1.5 SBF  Day 3  Day 7  Day 15  Day 30 
  Area/Image Area  Area/Image Area  Area/Image Area  Area/Image Area 
  (%)  (%)  (%)  (%) 
PEEK 5M NaOH - B         
Average  1.42  6.50  27.38  37.81 
S.D.  0.41  0.37  0.36  2.60 
PEEK 10M NaOH - B         
Average  4.17  22.35  31.12  42.95 
S.D.  0.14  0.62  2.88  1.16 
PEEK 5M NaOH - M         
Average  2.40  11.03  30.63  40.24 
S.D.  0.42  0.13  0.76  1.71 
PEEK 10M NaOH - M         
Average  5.65  26.25  32.70  46.99 
S.D.  0.18  4.56  1.23  3.80 
UHMWPE 5M NaOH          
Average  0.42  6.39  29.54  35.35 
S.D.  0.09  0.06  0.88  0.53 
UHMWPE 10M NaOH          
Average  4.93  16.15  31.38  52.33 
S.D.  2.18  0.22  0.88  0.25 Monica Pino                                                                                                                  Results 
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4.9  THIN FILM X-RAY DIFFRACTION (TF-XRD) AND WIDE-ANGLE X-RAY 
DIFFRACTION (WAXD) 
The  thin  film  X-ray  (TF-XRD)  patterns  of  the  HDPE,  PEEK  and  UHMWPE 
samples pre-treated with 1, 5 or 10M NaOH followed by 1.5 SBF treatment for 15 days 
contained the typical peaks of the polymers and some peaks of the adhesive used to secure 
the samples on the holder. These results showed no indication of any layer on the polymers 
probably due to the angle permitted by diffractometer, which greater than 3
o, and perhaps 
the deposited layer was too thin to be detected by these X-rays. 
Despite  the  lack  of  results  from  TF-XRD,  further  structural  information  was 
obtained from wide-angle X-ray diffraction (WAXD). The WAXD patterns of PEEK and 
UHMWPE treated only with 1.5 SBF for 15 and 30 days (these films were not pre-treated 
with  any  NaOH  pre-treatments)  are  shown  in  Figures  4.9.1  and  4.9.2.  The  respective 
WAXD patterns of PEEK and UHMWPE before and after 5 or 10M NaOH pre-treatments 
and SBF treatments for 15 and 30 days are shown in Figures 4.9.3 to 4.9.6 respectively. 
Reassuringly,  diffraction  peaks  corresponding  to  the  respective  polymer  (PEEK  and 
UHMWPE) as well as features typical for HA were observed. Indeed, the broad peaks 
between 18
o and 31
o were attributed to the (001), (110), (113), (200) and (213) diffractions 
from  the polymers, and the features  at  11
o  and between 25
o  and 35
o  to  HA, albeit  of 
somewhat of good crystallinity (Weng et al., 1997; Reis et al., 2003). In general, there is 
no explicit evidence of diffraction peaks other than HA, which indicates that the deposited 
layers on PEEK and UHMWPE was HA or carbonate hydroxyapatite (peaks 11
o to 35
o). 
The relative intensities of apatite (HA or CDHA) peaks (002), (112), (211) or (300), as 
observed from the Figures 4.10.3 to 4.10.6, increases with the concentration of NaOH from 
5M to 10M. 
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Figure 4.9.1 WAXD patterns of non-treated PEEK and PEEK treated only with 1.5 SBF 
for 15 and 30 days 
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Figure 4.9.2 WAXD patterns of non-treated UHMWPE and UHMWPE treated only with 
1.5 SBF for 15 and 30 days Monica Pino                                                                                                                  Results 
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Figure 4.9.3 WAXD patterns of non-treated PEEK and PEEK pre-treated with 5M or 10M 
NaOH followed by 1.5 SBF for 15 days 
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Figure 4.9.4 WAXD patters of non-treated PEEK and PEEK pre-treated with 5M or 10M 
NaOH followed by 1.5 SBF for 30 days 
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Figure 4.9.5 WAXD patterns of non-treated UHMWPE and UHMWPE pre-treated with 
5M or 10M NaOH followed by 1.5 SBF for 15 days Monica Pino                                                                                                                  Results 
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Figure 4.9.6 WAXD patterns of non-treated UHMWPE and UHMWPE pre-treated with 
5M or 10M NaOH followed by 1.5 SBF for 30 days 
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4.10  SCRATCH TEST 
A  Micro-Materials  nanoindenter  was  used  to  test  PEEK  (bright  and  matt)  and 
UHMWPE pre-treated with 5M or 10M NaOH followed by 1.5 SBF for 30 days. The 
coatings were too thick, few tens of μm, for adhesion measurements with this nanoindenter 
as the maximal depth it could reach was 1.5 μm. Instead, the hardness and elastic modulus 
of the specimens were intended to be measured by simple nano-indentations. However, the 
results were inconsistent and not reasonable due to the fact that the deposit layers were not 
homogeneous, thus a rigid diamond indenter was too stiff to use for soft/flexible materials. 
Consequently, the specimens with thinner deposited layers such as 5M or 10M NaOH pre-
treated PEEK and UHMWPE incubated only for 15 days in SBF were also subjected to 
this technique but the results were also inconsistent. Thus, it seems that the coatings were 
perhaps too fragile to be characterized with a rigid diamond indenter. 
4.11  ATOMIC ABSORPTION SPECTROSCOPY (AAS) 
Table 4.11.1 summarises the total amount of calcium (Ca) present in the samples 
after the NaOH pre-treatments followed by 1.5 SBF treatment for 30 days to investigate 
the amount of the Ca formed during the SBF treatment; and the Ca released during water 
immersion for 3 and 7 days.  
On the whole, it was found that more calcium was initially deposited on samples 
pre-treated with 10M NaOH compared with 5M NaOH for both the PEEK and UHMWPE 
polymers. However, the Ca formed was then released again within 3 days of immersion in 
water, with UHMWPE yielding slightly more (>10%) than PEEK (<8%) compared with 
the total calcium initially present for both polymers; and from PEEK films, Ca could be 
extracted  for  4  more  days.  Interestingly,  for  UHMWPE,  it  appears  that  after  7  days 
immersion there is less Ca present in the parent solution, indicating that Ca may have re-
precipitated  on  these  polymers.  This  implies  that  for  PEEK  the  release  of  calcium 
continues after day 3 in water whereas for UHMWPE the calcium release seems to be 
stable. 
 Monica Pino                                                                                                                  Results 
 
 
  161 
Table 4.11.1 Total (Ca) present in the samples after the NaOH pre-treatments followed by 
1.5 SBF for 30 days and the Ca released in water of PEEK and UHMWPE after pre-
treated with 5M or 10M NaOH and 1.5 SBF for 30 days. (S.D = standard deviation) 
 
  Total Ca 
on the samples 
Total Ca in parent solution 
(µg) 
  Before immersion in water  Immersion time in water 
Samples:  (µg ± S.D.)  Day 3  Day 7 
PEEK 5M NaOH 1.5 SBF  1747.58 ± 0.53  132.50  235.86 
PEEK 10M NaOH 1.5 SBF  2697.83 ± 0.58  169.12  370.66 
UHMWPE 5M NaOH 1.5 SBF  1773.30 ± 0.12  186.14  157.34 
UHMWPE 10M NaOH 1.5SBF  1933.65 ± 0.14  287.82  264.74 
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CHAPTER 5 
DISCUSSION  
5.1  INTRODUCTION 
The main aim of this research was to increase the bioactivity of polymer materials 
which may be suitable for the design of the skirt section of implants for artificial corneas. 
Polyether  ether  ketone  (PEEK),  high-density  polyethylene  (HDPE)  and  ultra-high 
molecular weight polyethylene (UHMWPE) films were investigated.  
The results obtained show that apatite was formed on the surfaces of HDPE, PEEK 
and  UHMWPE  films  which  were  pre-treated  with  highly  concentrated  NaOH  and 
subsequently  immersed  in  1.5 SBF.  This  method  can therefore  render these  thin films 
bioactive, making them potential skirt materials if they are to be integrated in the artificial 
corneal implants. 
In order to gain a better understanding of apatite nucleation and growth on polymer 
surfaces,  the  apatite  formed  on  PEEK,  HDPE  and  UHMWPE  films  from  1.5  SBF 
treatments  with  different  concentrations  of NaOH pre-treatments  was  studied, with  the 
ultimate objective of improving ophthalmic biomaterials for keratoprostheses (KPRO). 
In this chapter, the effectiveness of NaOH and the influence of immersion time in 
SBF  are  discussed  in  order  to  determine  the  optimum  concentration  of  NaOH  for 
stimulating the apatite deposition from the SBF treatment and the most effective incubation 
time in SBF according to the apatite phase formed. The apatite formation is also examined 
to establish the phases required to get hydroxyapatite (HA). Finally, the results obtained 
from the different analysis are compared. Monica Pino                                                                                                            Discussion 
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5.2  EFFECTIVENESS OF NAOH PRE-TREATMENT 
An apatite layer was formed within a short period of time on HDPE, PEEK and 
UHMWPE films after pre-treatment with different concentrations of NaOH followed by 
immersion in 1.5 SBF treatments for up to 30 days. This finding was corroborated by 
Fourier transform infrared spectroscopy (FTIR) and Raman spectroscopy, combined with 
scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDX) 
analysis, and further supported by the wide-angle X-ray diffraction (WAXD) data. This 
apatite layer is expected to respond in a similar way to the apatite found in dentine, enamel 
and bone in teeth, from which the dentil lamina used in the osteo-odonto-keratoprosthesis 
(OOKP) is made, containing mostly dentine. The OOKP has demonstrated good retention 
of the implant due to its non-rejection issue from the host eye because the patient’s own 
tooth is used to make the skirt of this semi-artificial cornea implant. The apatite is the 
bioactive material in the skirt since it contains carbonate and phosphate ions, promoting 
potentially good in vitro test and in vivo bioactivity on polymer films. 
No apatite was deposited on any of the polymer films by the SBF treatment unless 
they were pre-treated in NaOH. This finding was confirmed by X-ray diffraction (WAXD) 
patterns when the polymer films were treated with 1.5 B SBF for 30 days without pre-
treatment  and  no  apatite  peaks  such  as  hydroxyapatite  (HA)  or  calcium  deficient 
hydroxyapatite (CDHA) were found. 
Pre-treatment  of  the  surface  with  NaOH  aids  the  formation  of  potential  apatite 
nuclei on polymeric surfaces. The nuclei formed initiate the deposition of calcium and 
phosphate ions from the surrounding fluid (Kokubo and Takadama, 2006) and stimulate 
the growth of the apatite coating when immersed in 1.5 strength SBF. Thus, NaOH pre-
treatment imparts surface function sites (chemical re-activation of functional groups (e.g 
OH-) that act as potential nuclei) on the polymers for the formation and growth of apatite 
deposited from the SBF treatments, as previously reported on different substrates (Kokubo 
et al., 1990; Kokubo et al., 1991; Janasova et al., 2002; Oyane et al., 2005a and b; Muller 
and Muller, 2006). In fact, results from various groups have demonstrated the need for 
NaOH pre-treatment. Jonasova et al. (2002), for example, used SBF to form an apatite 
layer on the surface of NaOH-treated titanium. Similarly, Oyane et al. (2005 and 2005) 
reported apatite growth on NaOH-treated poly(ε-caprolactone (PCL) and on O2 plasma-Monica Pino                                                                                                            Discussion 
 
 
  164 
treated  PCL.  Neither  could  Filmon  et  al.  (2002)  detect  any  deposition  of  calcium-
phosphorous (CaP) phases on poly-hydroxyethyl methacrylate (PHEMA) in SBF unless 
the  PHEMA  was  previously  modified  with  carboxymethyl.  Grassmann  and  Lobmann 
(2004) reported similar results to Filmon et al. (2002), concluding that CaCO3 enhanced 
CaP coating on polyacrylamide. Tanahashi and Matsuda (1997) have detailed the influence 
of functional groups on apatite formation on self-assembled monolayers (SAMs) in SBF. 
Yu et al. (2005) concluded that PEEK was an inert material in SBF and did not induce 
CHA  (carbonate  hydroxyapatite)  formation,  unless  PEEK  was  reinforced  with 
hydroxyapatite. 
In agreement with these previous reports and others (Kokubo et al., 1990; Kokubo 
et al., 1991; Muller and Muller, 2006), it was found in this study that the NaOH pre-
treatment provides favourable sites for nucleation and the growth of apatite. In fact, on all 
NaOH pre-treated HDPE, UHMWPE and PEEK samples  an apatite layer formed over 
time. This finding is in strong contrast to polymer films that were simply immersed in 1.5 
SBF without exposure to NaOH, in which case no apatite growth was observed, as has also 
been observed by others (Ha et al., 1997; Yu et al., 2005). 
In addition, Stancu et al. (2004) and Chirila et al. (2007) reported no calcification 
on phosphated polymers such as PHEMA and mono-acryloyloxyethyl (MAEP), suggesting 
that phosphate groups inhibit the CaP phase growth because calcium ions were double-
bonded  by  phosphate  groups  from  the  polymers  rather  than  from  the  SBF  medium, 
suppressing the deposition of CaP since no further nucleation and crystallization occurred 
to form hydroxyapatite, despite using NaOH to produce functional groups. 
A strong dependency of apatite growth and NaOH-concentration was found in the 
WAXD and SEM analysis and from the reflected light differential contract microscopy 
(DIC).  Overall, the  area and the percentage  area/image of the  apatite deposited on  all 
polymers increased with the strength of NaOH, from 5M to 10M. When utilizing NaOH-
solutions at low concentration (e.g. 1M) for the pre-treatment, apatite deposition occurred 
only after 7 days in 1.5 SBF incubation for pre-treated HDPE and UHMWPE, and after 15 
days for pre-treated PEEK. With 5M NaOH pre-treatments, HDPE and UHMWPE showed 
apatite  in  3  days  and  PEEK  on  day  7  after  1.5  SBF  soaking.  With  higher  NaOH-
concentration (10M NaOH), HDPE pre-treated films showed apatite already by day 1 after 
1.5 SBF immersion, while PEEK and UHMWPE pre-treated exhibited apatite formation Monica Pino                                                                                                            Discussion 
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after 3 days in 1.5 SBF. As expected from the WAXD patterns, the relative intensities of 
apatite peaks increases with NaOH strength, suggesting that the higher concentrations of 
NaOH  pre-treatment  favoured  apatite  nucleation.  It  is  apparent  that  at  NaOH 
concentrations of 5M or 10M the pre-treatment lead to similar apatite deposition. 
In  agreement  with  the  SEM  results  in  this  study,  it  was  found  from  EDX  and 
WAXD that the calcium (Ca) and phosphorous (P) content increased both with the NaOH 
concentration used during the pre-treatment as well as with the immersion time in 1.5 SBF, 
for all the polymers tested, HDPE, UHMWPE and PEEK.  
Beneficially, the Ca/P molar ratio in the deposited layers was relatively unaffected 
by the NaOH concentrations for all structures. Indeed, the Ca/P molar ratio increased from 
0.74 (day 3) to 1.58 (day 30) on PEEK (bright surface) treated with 5 M NaOH  and, 
similarly from 1.27 (day 3) to 1.60 (day 30) for PEEK (matt side). Thus, the Ca/P ratio at 
the end of day 30 is of a similar value (1.60) on both PEEK surfaces. The differences 
between the PEEK surfaces were even less pronounced when treating the polymer films 
with 10M NaOH. For instance on day 3, the Ca/P was 1.37 (bright) and 1.40 (matt) and on 
day 30, 1.64 (bright) and 1.67 (matt) for such PEEK films. For UHMWPE, the Ca/P ratio 
increased from 1.42 (5M) and 1.49 (10M) to 1.61 (5M) and 1.64 (10M) from day 7 to day 
30  in  the  1.5  SBF  pre-treated  with  5M  and  10M  NaOH,  respectively.  From  these 
observations it is evident that 5M NaOH treatment is sufficient to get apatite deposition on 
PEEK and UHMWPE when subsequently immersed in  1.5 SBF for 7, 15 or 30 days. 
However,  it  may  be  that  the  10M  NaOH  pre-treatment  accelerates  the  calcium  and 
phosphorous nucleation at the beginning of the SBF treatments. 
Figure 5.2.1 illustrates that the PEEK water contact angle (CA) decreased as the 
concentration increased from 5M to 10M NaOH. This was observed independent of which 
surface was analysed, indicating that the NaOH increased the wettability of this polymer. 
In strong contrast, no major dependence on NaOH concentration used in this pre-treatment 
was found in the CA for UHMWPE, although CA decreases slightly when 10M NaOH is 
used  on  UHMWPE.  Thus,  10M  NaOH  increased  the  wettability  of  the  PEEK  and 
UHMWPE,  and  5M  NaOH  increased  the  wettability  only  on  both  PEEK  surfaces. 
However,  the  roughness  values  (Ra)  as  obtained  from  the  AFM  micrographs  seemed 
relatively  unaffected  by  the  NaOH  for  PEEK  (bright  side),  indeed,  if  anything  Ra 
increased.  Controversially,  Ra  appeared  to  decrease  for  PEEK  (matt  surface)  and Monica Pino                                                                                                            Discussion 
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UHMWPE,  especially  after  treatment  with  10M  NaOH,  as  was  also  shown  in  the 
topographical micrographs, where changes in topography are visible. A similar trend was 
observed when Ra was deduced from the AFM line profiles compared with Ra from the 
whole image. Moreover, UHMWPE has about 30 times higher roughness compared with 
PEEK, and the similar water contact angle (CA) values of UHMWPE films (non-treated, 
5M  and 10M  NaOH)  might  indicate that the  high roughness  of UHMWPE masks the 
beneficial effects of NaOH pre-treatments in terms of increasing the wettability (Figure 
5.2.1). 
 
Water Contact Angle vs Ra 25x25 whole image
0
20
40
60
80
100
PEEK nontreated B
PEEK nontreated M
PEEK 5M NaOH - B
PEEK 5M NaOH - M
PEEK 10M NaOH - B
PEEK 10M NaOH - M
UHMWPE nontreated
UHMWPE 5M NaOH
UHMWPE 10M NaOH
Sample Code
W
a
t
e
r
 
C
o
n
t
a
c
 
A
n
g
l
e
 
(
d
e
g
r
e
e
s
)
0
20
40
60
80
100
120
140
160
R
a
 
v
a
l
u
e
s
 
f
r
o
m
 
t
h
e
 
w
h
o
l
e
 
i
m
a
g
e
 
(
n
m
)
 
Figure 5.2.1 Water contact angle (CA, coloured bars) vs. Ra from the whole image (scan 
size = 25 x 25 µm) (grey bars) of non-treated and treated PEEK (bright and matt) and 
UHMWPE specimens. (B= bright, M= matt, error bar= standard deviation) 
 
Interestingly, the NaOH pre-treatment appears to modify the surface topography 
and the surface chemistry of the polymers, which determine the apatite formation from the 
SBF treatment on the polymers. This is demonstrated in Figure 5.2.2 which shows that the Monica Pino                                                                                                            Discussion 
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Ca/P molar ratios  obtained after the immersion  in  the SBF for 30 days  were strongly 
affected by the surface modifications resulting from NaOH pre-treatment.  
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Figure 5.2.2 Water contact angle (CA, coloured bars) vs. Ca/P from EDX (grey bars) of 
non-treated and treated PEEK (bright and matt) and UHMWPE specimens. (B= bright, 
M= matt, error bar= standard deviation) 
 
The  favourable  effect  of  NaOH  -imparting  functional  sites  on  the  HDPE, 
UHMWPE and PEEK polymers for the deposition and growth of apatite from the SBF 
treatments may at least in part be attributed to an increased wettability of the polymer films 
after such treatment, as well as to the modified topography. Independent of the polymer 
used, the apatite growth is unaffected by the concentration of NaOH pre-treatment if this is 
at least 5M NaOH. The resulting Ca/P molar ratios were similar to those found in dentine 
(Ca/P= 1.61) and enamel (Ca/P=1.63) (Legeros, 1991; Daculsi et al., 1997). The apatite 
formation from the SBF during different immersion time is discussed in the following 
sections. Monica Pino                                                                                                            Discussion 
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5.3  INFLUENCE OF THE IMMERSION TIME IN SBF 
In addition to the NaOH concentration, immersion time in SBF was found to affect 
apatite formation. With increasing immersion time, further apatite nucleation and growth 
was observed, resulting in a thicker and more compact apatite layer. The apatite layer was 
deposited from the SBF treatments within a short period of time on the surfaces of NaOH 
pre-treated HDPE, UHMWPE and PEEK. This result was supported by wide-angle X-ray 
diffraction (WAXD), as well by Raman spectroscopy and FTIR, in conjunction with the 
SEM and EDX analysis. 
Interestingly, various pathways to obtain an apatite coating from different SBF have 
been investigated on a variety of materials. Kawashita et al. (2003) showed that carboxyl 
group-containing polymer gels in SBF can form apatite on fibres, and Huang et al. (1997) 
used  SBF-K9  to  investigate  the  bioactivity  on  a  Bioglass®-reinforced  high  density 
polyethylene composite and demonstrated the formation of a biologically-active carbonate 
hydroxyapatite (CHA) layer on the composite surface after immersion in SBF, showing 
that in vitro bioactivity could be obtained in a composite. Use of slightly modified SBF has 
been  reported  to  result  in  thicker  carbonated  apatite  layers  and/or  the  formation  of 
homogeneous apatites. For instance, Muller and Muller (2006) have modified SBF with a 
different HCO

3 on NaOH-treated titanium, and Kim et al. (1999) have used 0.75-2.00 
strength  SBF  to  study  the  apatite  formed  on  polyethylene  terephthalate  (PET). 
Accordingly, 1.5 SBF is  often used to  accelerate the apatite coating process  and most 
importantly as a treatment to produce Ca/P layer on materials before implantation. 
As  confirmed  by  the  SEM  and  EDX  analysis  here,  the  apatite  layer  developed 
earlier on HDPE (1-3 days in SBF) than on PEEK (3-7 days in SBF) and UHMWPE (7 
days in SBF). Gradual nucleation and growth of apatite occurred with the prolongation of 
immersion  time  in  1.5  SBF  treatments,  as  previously  reported  on  different  substrates 
(Kokubo et al., 1990; Kokubo et al., 1991; Janasova et al., 2002; Oyane et al., 2005a and 
b; Muller and Muller, 2006). Moreover, the area and the percentage area of the image of 
the apatite growth with immersion time in SBF for the NaOH pre-treated specimens, is 
confirmed by the reflected light Differential Contrast microscopy (DIC) analysis. It was 
found that the Ca and P amounts increased both with the immersion time in 1.5 SBF as 
well as with the NaOH concentration, for all polymers as deduced from the EDX results.  Monica Pino                                                                                                            Discussion 
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Thus, for all NaOH pre-treated polymers (HDPE, UHMWPE and PEEK) immersion 
in 1.5 SBF treatments initially resulted in the formation of individual agglomerates, which 
were typically less than 5 μm across. With increasing immersion time in 1.5 SBF, further 
apatite deposition led to growth of these agglomerates, producing continuous, thicker and 
more compact coatings. These layers contain spherical aggregates with diameters up to 8-
10  μm,  consisting  of  nanoparticles  of  apatite  crystallites,  which  are  characteristic  for 
coatings precipitated from 1.5 SBF treatment. 
It was noticed that the results from the SEM and DIC techniques demonstrated the 
same tendency: the apatite increased with the immersion time in 1.5. SBF. However, there 
is a slight discrepancy in the SEM micrograph and DIC microscope images, which can be 
attributed to the differences in the SEM and DIC in terms of the sample area analysed. In 
the SEM the micrographs profile was in μm and in the DIC microscope the profile was in 
mm. The apatite layer was not homogenously distributed over the sample especially in the 
early days (1-3) of the 1.5 SBF treatments. The SEM is an electron microscope and the 
DIC is an optical microscope.  
In  addition  to  the  features  mentioned  above,  the  Raman  spectra  of  NaOH  pre-
treated HDPE, PEEK and UHMWPE demonstrated that carbonate and phosphate bands 
were present after 15-18 days in the 1.5 SBF incubation. These bands are associated with 
hydroxyapatite and carbonated apatites (Legeros et al., 1987; Elliot, 1994; Rehman and 
Bonfield, 1997; Ha et al., 1997; Penel et al., 1998; Ning et al., 2004; Petra et al., 2005; 
Hofmann et al., 2007). It is worth mentioning that the characteristic peaks of the polymers 
(Simonin  and  Liao,  2000)  were  shifted  and/or  weakened  by  apatite  formation,  as  also 
confirmed by the FTIR spectra, as the polymer signals were reduced  by  the overlying 
apatite signals. 
Further information was also obtained from WAXD spectra. The diffraction peaks 
observed in the WAXD patterns of polymers pre-treated with NaOH and immersed in 1.5 
SBF  for  15  and  30  days  are  attributed  to  calcium  phosphates  (e.g.  calcium  deficient 
hydroxyapatite  –CDHA-  or  octa-calcium  phosphate  –OCP-)  and  to  apatite,  indeed  to 
hydroxyapatite  (HA)  and/or  carbonate  hydroxyapatite  (CHA).  These  results  are  in 
agreement with those of Fang et al. (2007) and Wang and Bonfield (2001). The intensity of 
the HA peaks increases substantially from day 15 to day 30 in the SBF treatments although 
the increase due to different concentrations of NaOH is less strong, suggesting that the Monica Pino                                                                                                            Discussion 
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longer period of time in contact with the 1.5 SBF favoured the growth of HA on PEEK and 
UHMWPE structures. Reassuringly, that longer period in SBF lead to thicker apatite layers 
on the treated polymers. 
Consequently, apatite (HA and/or CDHA) layers were formed on HDPE, PEEK and 
UHMWPE after incubation in 1.5 SBF treatments previously pre-treated with different 
NaOH  strengths.  The  apatite  growth  is  increased  by  the  immersion  time  in  SBF  and 
concentration of NaOH. This is discussed in the next section. 
5.4  APATITE FORMATION 
This  apatite  layer  is  expected  to  enhance  the  in  vitro  bioactivity  of  polymeric 
objects, illustrating the potential for use of such synthetic materials as artificial cornea 
designs. 
However, it is critical to keep in mind that the bioactivity of the apatite-polymer 
depends on the structure and composition of the formed apatite (Kim et al., 2000). As a 
consequence, on polymer surfaces, an apatite coating has been investigated and various 
phases  have been demonstrated.  Varma  et  al. (1999)  have produced a  porous  calcium 
deficient  hydroxyapatite  (CDHA)  coating  on  Ca(OH)2  treated  phosphorylated  chitosan 
films. Choong et al. (2004) studied both in vitro and in vivo the effect on the processes of 
calcium phosphate coatings deposited on PCL from SBF. It should be noted that Choong et 
al. (2004) did not identify the CaP phases they produced; they commented that the coatings 
were structurally similar to hydroxyapatite. 
Carbonate and phosphate were found on the apatite produced on the NaOH pre-
treated films, as evidenced by FTIR and Raman spectroscopy and also reported by Legeros 
et al. (2003). Good integration of carbonate and phosphate in the apatite phase is suggested 
by  the  fact  that  due  to  CH2  vibration  of  the  HDPE,  PEEK  and  UHMWPE  polymeric 
substrates  the  polymer  bands  weakened  considerably  for  pre-treated  films  with  a  long 
immersion time in 1.5 SBF.  
The  Ca/P  atomic  ratio  of  stoichiometric  apatite  Ca10(PO4)6(OH)2  is  1.67 
(Dorozhkin,  2009).  The  Ca/P  of  calcium-deficient  hydroxyapatite  (CDHA)  is  1.5>1.67 
(Dorozhkin, 2007) and the Ca/P of octa-calcium phosphate (OCP) is  1.33 (Dorozhkin, Monica Pino                                                                                                            Discussion 
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2007; Dorozhkin, 2009). The average Ca/P molar ratio of the NaOH pre-treated polymer 
films after 3, 7 and 15 days in 1.5 SBF immersion was 1.19, 1.26-1.35, and 1.33-1.44, 
respectively,  which  indicates  that  calcium-deficient  apatite  (Chirila  et  al.,  2007)  with 
gradually increasing Ca was produced in this study. 
Varma et al. (1999) used SBF on Ca(OH)2 treated phosphorylated chitosan films to 
produce a porous calcium deficient hydroxyapatite coating with a Ca/P of 1.34. They also 
reported that the Ca/P ratio increased with the SBF immersion time. Kim et al. (1999) 
describe a Ca/P of 1.45 using 1.5 SBF on PET. When an apatite is deposited from an 
aqueous solution, some sites for PO
 3
4  ions are often substituted by HPO
 2
4 and CO
 2
3 ions. 
As a consequence, vacancies are produced in the Ca
2+ sites. A substitution of CO
 2
3 for 
PO
 3
4 results in one P and half a Ca deficiencies originating in a Ca/P ratio above 1.67, 
while one HPO
 2
4 substituted for PO
 3
4 results in half Ca deficiency resulting in a Ca/P ratio 
lower than 1.67 (Kim et al., 2000). Accordingly, the Ca/P ratio of apatite could be the less 
than the stoichiometric phase, in cases where more CO
 2
3 ions occupy HPO
 2
4  instead of 
PO
 3
4  sites. 
Additionally, various authors (Kim et al., 1999; Varma et. al., 1999; Kim et al., 
2000; Chirila et al., 2007) have reported a Ca/P lower than 1.67 in similar experiments 
claiming that they produced calcium-deficient apatite. In the WAXD patterns in this study, 
there is no explicit evidence of diffraction peaks other than those for HA or CDHA, which 
indicates that the deposited layers on PEEK and UHMWPE were HA and/or CDHA after 
15 and 30 days immersed in 1.5 SBF previously pre-treated in NaOH. Accordingly, the 
Ca/P increases approximately from 1.45 to 1.67, indicating the change of phase of the 
apatite from CDHA to HA with immersion time in SBF until the stoichiometric phase of 
apatite was produced on both PEEK and UHMWPE. 
In conclusion, it should be noted that calcium-deficient apatite was produced on the 
NaOH pre-treated HDPE, PEEK and UHMWPE films subsequently immersed in 1.5 SBF 
up to  15 days,  and that hydroxyapatite was  produced when the pre-treated films were 
incubated in SBF for a longer period of time, from 15 to 30 days. 
Further analysis of the hydrophilicity, the topographical changes and the values of 
Ra at the later stages of the treatment during immersion in 1.5 SBF should be conducted to 
provide additional information on the changes associated with the development of apatite Monica Pino                                                                                                            Discussion 
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layers.  In  addition,  more  fundamental  studies  including  detailed  statistical  analysis  are 
required to fully elucidate the influence of surface roughness, surface chemistry on the 
wettability and apatite formation of artificial sclera materials. 
5.5  APPLICATION FOR SKIRT MATERIALS IN CORNEAL IMPLANFTS 
HDPE, PEEK and UHMWPE were selected for this study. UHMWPE has a clinical 
history as a successful biomaterial for hip, knee, spine (Kurtz, 2004) and ophthalmologic 
implants  (Allan,  1999).  PEEK  is  also  used  in  medical  implants  in  the  orthopaedic, 
cardiovascular and dental fields (Roeder et al., 2009) and it has been shown to produce 
hydroxyapatite-like surfaces (Ha et al., 1997; Abu-Bakar et al., 2003; Tan et al., 2003; Fan 
et al., 2004; Yu et al., 2005). In addition, PEEK can be engineered with a wide range of 
physical,  mechanical  and  surface  properties  (Kurtz  and  Devine,  2007).  HDPE  is  of 
particular  interest  as  a  biomaterial  since  it  can  easily  be  processed  and  has  already 
demonstrated its biocompatibility when hydroxyapatite particles have been incorporated 
(Bonfield et al., 1984).  
Thus,  HDPE,  PEEK  and  UHMWPE  are  promising  candidates  to  tackle  at  least 
some of the problems with current keratoprosthesis (KPRO) technologies. However, the 
bioactivity of these polymers has to be significantly improved for them to be used as skirt 
materials  for  artificial  corneal  implants.  This  bioactivity  may  be  achieved  through  a 
suitable “coating”. 
Consequently,  apatite  was  formed  on  their  surfaces,  when  pre-treating  HDPE, 
PEEK and UHMWPE with highly concentrated NaOH and by subsequent immersion in 
1.5 Simulated Body Fluid (SBF), which renders such thin-film structures bioactive, making 
them promising skirt materials if they are to be integrated into artificial corneal implants. 
Ideally, the calcium deficient apatite (CDHA) and/or hydroxyapatite (HA) apatite 
layer  contained  phosphate  and  carbonate  ions,  promoting  potentially  good  in  vivo 
bioactivity on polymeric films since it has been proven in this study that they are bioactive 
in vitro.  
Most beneficially, the HA and CDHA formed is very close to the apatite found in 
teeth,  from  which  the  lamina  of  the  osteo-odonto-keratoprothesis  (OOKP)  is  made,  a Monica Pino                                                                                                            Discussion 
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design that promotes excellent long-term retention results (Falcinelli et al., 2005; Liu et al., 
2007) but requires the donation of one of the patient’s teeth. Furthermore, it is clinically 
easier to implant a prosthesis with a polymeric skirt than one with a rigid skirt, such as a 
OOKP.  
Furthermore, it is expected for mechanical compatibility to be improved between 
the sclera and polymers compared to the sclera and tooth dentine. 
Thus, this present study clearly demonstrates that apatite layers can form on the 
surfaces of HDPE, PEEK and UHMWPE, provided that these polymers are pre-treated 
with  NaOH  followed  by  immersion  in  1.5  SBF.  This  finding  is  important  as  it  is  the 
presence of apatite that provides the skirts used in OOKPs with good bioactivity since it 
contains carbonate and phosphate ions, resulting in possible retention of the implant in 
vivo. Considering this, it can be expected that the layers formed on the treated HDPE, 
PEEK and UHMWPE films will respond similar to the apatite found in dentine, enamel 
and  bone  of  teeth,  from  which  the  dentil  lamina  of  the  osteo-odonto-keratoprosthesis 
(OOKP) are fabricated (Falcinelli et al., 2005; Liu et al., 2007). This promises good in 
vitro and in vivo bioactivity of such HDPE, PEEK and UHMWPE films. In this context it 
is  interesting  to  note  that  the  apatite  layer  produced  on  the  treated  HDPE,  PEEK  and 
UHMWPE  films  is  slightly  Ca  deficient  (compared  to  hydroxyapatite),  similar  to  the 
apatite contained in dentine, enamel and bone mineral (Legeros et al., 2003) (the Ca/P 
molar ratio of dentine is 1.61; whilst the one of dental enamel is 1.63 (Legeros, 1991; 
Daculsi et al.). To further validate the feasibility of this approach, cell culture studies have 
to  be  performed  on  treated  materials,  PEEK  and  UHWMPE  films.  Fibroblast  growth 
studies on the NaOH pre-treated specimens immersed in 1.5 SBF for 15 and 30 days have 
recently started, the results of which will be quantified in terms of cell attachment and 
proliferation. 
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CHAPTER 6 
CONCLUSIONS AND FUTURE WORK 
6.1  CONCLUSIONS 
Apatite layers were formed within 1, 3 and 7 days on high-density polyethylene 
(HDPE), polyether ether ketone (PEEK), and ultra-high molecular weight polyethylene 
(UHMWPE) films after 1, 5 or 10M NaOH pre-treatment followed by incubation in 1.5 
Simulated Body Fluid (SBF) for up to 30 days; which promises to render such thin films 
bioactive since the common characteristic of the bioactive materials in vitro is to produce a 
Ca/P layer of biological apatite – a necessity if they are to be integrated into artificial 
cornea implants.  
The apatite nucleation and growth are affected by the immersion time in 1.5 SBF 
and by the concentration of NaOH (control films that were not treated in NaOH showed no 
apatite formation after 1.5 SBF immersions). The Ca/P molar ratio of the apatite deposited 
on the polymers increased with NaOH strength and with SBF incubation time.  
Immersion  in  NaOH  (before  the  subsequent  SBF  incubation  step)  resulted  in 
improved wettability, which increased with the NaOH. In addition, the NaOH treatment 
led to some changes in the topography (i.e. increase/decrease of roughness) of the polymer 
surfaces. Thus, the favourable effect of NaOH on apatite formation may be attributed to an 
increased  wettability  of  the  polymer  films  after  such  treatment,  as  well  as  a  modified 
topography. Effectively, the resulting modifications of the surface topography and surface 
chemistry determine apatite formation on the polymers. 
In the NaOH pre-treated specimens the apatite layer developed earlier on HDPE (1-
3 days in SBF) than on PEEK (3-7 days in SBF) and UHMWPE (7 days in SBF). Increase 
in the immersion time in SBF enhanced the deposition of the apatite layer, which was thick 
and compact. For all polymers, immersion in SBF initially resulted in the formation of Monica Pino                                                                            Conclusions and Future Work 
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individual agglomerates, which were typically less than 5 μm across on polymer surface, 
indicating  the  development  of  apatite  nucleating  points  on  the  polymer  surfaces.  With 
increasing immersion time in SBF, further apatite deposition resulted in growth of these 
agglomerates,  producing  a  continuous,  thicker  and  more  compact  layer.  These  layers 
contained spherical aggregates with diameters up to 8-10 μm, consisting of nanoparticles 
of apatite crystallites, which are characteristic for apatite coatings precipitated from SBF 
solutions. 
Independent of the polymer used, the apatite growth is affected below 5M NaOH by 
the  concentration  of  NaOH  pre-treatment.  Evidently,  5M  NaOH  treatment  could  be 
sufficient  to  enhance  the  deposition  of  apatite  on  HDPE,  PEEK  and UHMWPE  when 
subsequently immersed in 1.5 SBF for 7, 15 or 30 days. On the other hand, 10M NaOH 
treatments resulted in a more rapid formation of the apatite layer compared with lower 
molarity pre-treatment solutions. Additionally, more Ca was initially deposited on samples 
with 10M NaOH compared with 5M NaOH for all polymer structures.  
Desirably,  the  calcium-deficient  apatite  (CDHA)  and/or  hydroxyapatite  (HA) 
apatite layer contained phosphate and carbonate ions, potentially promoting good in vitro 
bioactivity on polymeric films. The Ca/P molar ratio increases from 1.45 to 1.67 with 
increased SBF immersion time (7-15 to 15-30 days), indicating a change of phase of the 
apatite  from  calcium  deficient  apatite  (CDHA)  to  hydroxyapatite  (HA);  which  can  be 
expected to be highly bioactive and having a good crystallinity.  
Most beneficially is that the calcium deficient apatite (CDHA) formed with Ca/P 
1.50>1.67 is very close to the apatite found in dentine (Ca/Pdentine = 1.61) and enamel 
(Ca/Penamel  =  1.63),  which  is  mainly  composed  of  calcium-phosphate  related  to 
hydroxyapatite (HA). Dentine and enamel are the bioactive materials used to make the 
lamina  of  the  semi-synthetic  artificial  cornea  implant,  the  osteo-odonto-keratoprothesis 
(OOKP),  a  design  that  demonstrated  good  long-term  retention  results  due  to  its  non-
rejection properties from the host eye because the patient’s own tooth is used to make the 
skirt of the cornea implant, although it does require the donation of one of the patient’s 
teeth. 
In addition to the above findings, the inorganic layers were found to be chemically 
stable as the calcium deposited on the films did not dissolve fully when immersed in water 
for one week. Monica Pino                                                                            Conclusions and Future Work 
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6.2  FUTURE WORK 
The  research  detailed  in  this  thesis  has  demonstrated  the  potential  of  bioactive 
polymer  materials  to  be  used  as  the  skirt  for  an  artificial  corneal  implant.  To  further 
validate the feasibility of this approach, the next step is to culture cells on the treated 
materials. Thus, fibroblast growth studies on the NaOH pre-treated specimens immersed in 
1.5 SBF for 30 days have recently started at Moorfields Eye Hospital, London and results 
of this cell culture study will be quantified in terms of attachment and proliferation. 
While the characterisation tests used in this thesis have shown that apatite layers 
developed on the polymers, these results can be validated further using the follow-on tests 
described below.  
Since the results from the scratch test were inconclusive, it is recommended that 
further  work  be  carried  out  to  investigate  the  adhesion  of  the  deposited  layers  on  the 
samples pre-treated with 5 or 10M NaOH followed by immersion in 1.5 SBF for 7, 15 and 
30 days using nanoindenter with a different depth (e.g. <1500 nm). 
The  data  obtained  from  the  flame  atomic  absorption  spectroscopy  (AAS)  was 
conclusive and very interesting. The test should be repeated with the immersion time in 
water extended to more than 7 days, until the calcium (Ca) release would be stable. 
The water contact angles (CA) were determined on the films after and before the 
NaOH pre-treatment  and the results  were very interesting. Therefore,  it would be also 
important to analyse the hydrophilicity of the films after immersion in 1.5 SBF using the 
same technique. 
The roughness value (Ra) and the topography of the films were performance with 
Atomic Force Microscopy (AFM) to analyse the effects of the pre-treatment, and these 
results were conclusive. Thus, it would be advised to do this test also after the immersion 
in 1.5 SBF to analyse the topographical changes and the values of Ra through time. 
Additionally, the carbonate, phosphates and hydroxyl ionic groups were determined 
using Laser Raman spectroscopy and Fourier transform infrared spectroscopy (FTIR) in 
the first batch on the samples treated in 1.5 SBF for 15-18 days. The results showed peaks 
which were slightly flatted, and it was possible to conclude the presence of phosphate and 
carbonate groups on the apatite deposition. However, it would be relevant to apply these Monica Pino                                                                            Conclusions and Future Work 
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two tests for samples treated in 1.5 SBF for longer time (e.g. 30 days) to  confirm the 
presence of any ionic groups. 
Apart from the tests already done during this research either for the batch I or batch 
II, additional analysis techniques to characterise the apatite layer and to determine the 
fundamental changes in the surface chemistry of the polymers upon NaOH pre-treatment 
could  be  applied.  X-ray  photoelectron  spectroscopy  (XPS)  is  a  very  sensitive  surface 
technique that could confirm and clarify some of the findings which resulted from the other 
characterisation techniques used in this research. It could be carried out before and after 
the NaOH pre-treatment and SBF treatment, allowing further characterisation, such as a) 
the chemical inertness/stability of UHMWPE against NaOH treatment since the CA for 
non-treated  and  treated  samples  were  very  similar,  with  the  possibility  that  the  high 
roughness of the UHMWPE could mask the beneficial effects of the NaOH treatment (e.g. 
increasing wettability), b) the differences in chemical composition between the bright and 
matt PEEK surfaces.  
During  the  course  of  this  research,  the  solid  and  compact  films,  despite  being 
flexible, were bioactive after the procedure proposed from this work. However, the skirt 
materials for the corneal implants should be porous, which is required for proper fixation 
in  vivo.  Further  work  toward  porous  HDPE,  PEEK  and  UHMWPE  films  is  therefore 
necessary in future studies. The porosity of the skirt material should be improved to allow 
fibroblast in-growth and collagen deposition to provide the adequate anchorage of the skirt 
into the sclera. 
Finally, the corneal implant design should be investigated in the future to address 
aspects such as aesthetics, cost and implant procedure. Monica Pino                                                                                                            References 
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